≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other specified/unspecified hearing loss

DOID EFO Endpoint Browser PheWeb

H8_HL_NAS

sensorineural hearing loss: Hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H91.8, H91.9
  • Hospital discharge: ICD-9 — 389[8-9]
  • Hospital discharge: ICD-8 — 389
  • Cause of death: ICD-10 — H91.8, H91.9
  • Cause of death: ICD-9 — 389[8-9]
  • Cause of death: ICD-8 — 389

2 out of 7 registries used, show all original rules.

4060

4. Check minimum number of events

None

4060

5. Include endpoints

None

4060

6. Filter based on genotype QC (FinnGen only)

3918

Control definitions (FinnGen only)

Control exclude
H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 30941 15915 14885
Only index persons 27863 14799 13064
Unadjusted period prevalence (%)
Whole population 0.44 0.46 0.42
Only index persons 0.52 0.54 0.50
Median age at first event (years)
Whole population 68.04 69.82 66.22
Only index persons 68.95 70.43 67.26

-FinnGen-

Key figures

All Female Male
Number of individuals 3918 2024 1894
Unadjusted period prevalence (%) 0.79 0.72 0.87
Median age at first event (years) 67.30 64.32 70.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4060
Matched controls
40600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H93.1
ICD-10 Finland
Tinnitus
9.9
323.0
388
429
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
231.8
307.7
240
11
DAX08
NOMESCO Finland
Fitting of hearing aid
36.6
307.7
553
174
H91.8
ICD-10 Finland
Other specified hearing loss
72.5
307.7
514
81
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
115.9
307.7
369
35
Z97.4
ICD-10 Finland
Presence of external hearing-aid
34.2
307.7
705
248
DFF00
NOMESCO Finland
Pure tone audiometry
23.1
307.7
1138
673
H91.1
ICD-10 Finland
Presbycusis
9.3
307.7
486
586
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.7
307.7
969
2536
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
27.3
307.7
894
415
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
116.1
307.7
311
29
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
116.6
307.7
1959
322
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
38.0
307.7
339
97
H02
ICPC
Hearing complaint
7.4
307.7
1336
2536
H91.9
ICD-10 Finland
Hearing loss, unspecified
427.0
307.7
3349
443
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
79.4
307.7
609
90
R5120
NOMESCO Finland
Preparation of an aid
24.5
307.7
557
262
Z01.1
ICD-10 Finland
Examination of ears and hearing
14.5
307.7
1625
1790
DFF15
NOMESCO Finland
Speech audiometry
22.4
307.7
499
252
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
38.8
307.7
640
195
N07CA01
ATC
betahistine; oral
5.9
282.4
556
1063
R5140
NOMESCO Finland
Monitoring the use of the aid
4.5
279.0
809
2147
UDC00
NOMESCO Finland
Ear microscopy
6.9
274.7
454
729
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
84.5
232.5
123
15
Z3229
NOMESCO Finland
Other healthcare associate professional
4.6
229.1
603
1472
H29
ICPC
Ear symptom/complaint other
3.8
226.5
809
2473
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
43.4
197.7
118
28
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
14.5
196.1
179
129
Z71.8
ICD-10 Finland
Other specified counselling
2.6
179.0
1753
9284
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
+∞
174.2
166
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
30.6
171.9
113
38
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
32.7
153.8
99
31
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
40.4
149.9
91
23
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
18.9
135.3
107
58
H81
ICPC
Excessive ear wax
2.6
133.2
972
4373
H81.0
ICD-10 Finland
Ménière disease
7.6
118.0
171
235
H80.9
ICD-10 Finland
Otosclerosis, unspecified
21.4
117.6
88
42
SPAT1043
SPAT
Audiometry
3.5
117.0
445
1387
RK520, ,
NOMESCO Finland
33.8
114.5
73
22
H61.2
ICD-10 Finland
Impacted cerumen
3.5
113.3
434
1358
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.2
112.3
1281
6950
DC1AD
NOMESCO Finland
Temporalbone CT
17.4
111.9
92
54
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
219.7
104.1
107
5
Z25.1
ICD-10 Finland
Need for immunization against influenza
3.7
103.6
356
1036
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
102.0
409
1314
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
10.3
102.0
115
115
R1260
NOMESCO Finland
Evaluation of communicative skills
7.4
99.6
146
203
R42
ICD-10 Finland
Dizziness and giddiness
2.2
98.8
1152
6252
ZXA00
NOMESCO Finland
Right side
2.0
90.2
1304
7630
H13
ICPC
Plugged feeling ear
2.2
89.1
921
4738
R4110
NOMESCO Finland
Physiotherapy
2.0
87.8
1364
8173
ZXA05
NOMESCO Finland
Left side
2.0
85.9
1213
7014
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
14.5
85.3
77
54
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
35.8
84.4
53
15
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.5
84.3
212
490
DFX03
NOMESCO Finland
Review, maintenance and user education for hearing aid
29.3
78.0
52
18
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
9.1
76.8
94
105
SPAT1041
SPAT
Comprehensive hearing test
11.1
76.4
81
74
DFE00
NOMESCO Finland
Insertion of cochlear implant
+∞
75.2
72
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
74.8
1312
8103
TDA90, ,
SPAT
3.0
74.6
364
1306
RK320, ,
NOMESCO Finland
10.2
71.8
81
81
Z01.7
ICD-10 Finland
Laboratory examination
2.1
71.1
802
4228
H92.0
ICD-10 Finland
Otalgia
3.4
69.9
262
803
H65.3
ICD-10 Finland
Chronic mucoid otitis media
6.2
67.1
116
192
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
6.1
66.1
116
195
RK110, ,
NOMESCO Finland
9.6
63.1
74
78
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
62.7
438
1881
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
5.7
61.0
115
207
H84
ICPC
Presbyacusis
3.9
60.7
185
493
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
7.9
59.5
82
106
ZXA10
NOMESCO Finland
Bilateral
2.0
58.9
834
4737
R39.1
ICD-10 Finland
Other difficulties with micturition
3.6
57.6
198
573
M79.6
ICD-10 Finland
Pain in limb
1.7
56.7
1741
12434
Z29.8
ICD-10 Finland
Other specified prophylactic measures
4.0
56.5
166
431
ZYC01
NOMESCO Finland
Remote contact by phone
2.8
53.9
295
1122
DFF59
NOMESCO Finland
Other assessment of balance
8.3
53.0
70
86
DDA00
NOMESCO Finland
Stapedotomy
14.3
52.8
48
34
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
21.9
52.5
39
18
IHA10
NOMESCO Finland
Structured mapping of problematic alcohol use
7.7
52.2
73
96
DFX00
NOMESCO Finland
Connecting cochlear implant
+∞
52.2
50
*
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
51.8
1360
9256
H81.3
ICD-10 Finland
Other peripheral vertigo
3.8
51.1
159
430
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.6
50.8
326
1341
H71
ICD-10 Finland
Cholesteatoma of middle ear
8.2
50.4
67
83
Z2221
NOMESCO Finland
Medical doctor
1.7
50.2
1153
7550
R01AD09
ATC
mometasone; nasal
1.7
50.1
1621
11626
DFF16
NOMESCO Finland
Speech-in-noise audiometry
+∞
50.1
48
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.7
49.2
276
1062
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
4.0
48.9
143
370
RK120, ,
NOMESCO Finland
17.9
48.1
39
22
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.1
47.6
523
2699
H28
ICPC
Limited function/disability (H)
6.6
47.2
76
117
H83.3
ICD-10 Finland
Noise effects on inner ear
7.7
46.3
65
86
N02BE01
ATC
paracetamol; systemic, rectal
2.0
46.0
3549
31548
H66.9
ICD-10 Finland
Otitis media, unspecified
2.8
45.3
243
913
38920
ICD-8 Finland
Other deafness, Deafness, one ear
+∞
44.9
43
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
44.7
470
2382
R51.80
ICD-10 Finland
Headache
2.0
44.6
592
3262
M25.5
ICD-10 Finland
Pain in joint
1.7
44.5
1238
8484
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
2.1
44.3
462
2335
Z3226
NOMESCO Finland
Physiotherapist
1.8
44.1
804
4901
H65.2
ICD-10 Finland
Chronic serous otitis media
5.9
43.9
79
136
H01
ICPC
Ear pain/earache
2.1
43.8
443
2213
A28
ICPC
Limited function/disability NOS
1.7
43.5
918
5834
A98
ICPC
Health maint/preventive medicine
2.3
43.5
3752
34181
L17
ICPC
Foot/toe symptom/complaint
1.6
42.9
1244
8597
EB1AA, ,
SPAT
2.4
42.6
299
1281
38699, ,
ICD-8 Finland
11.7
42.1
43
37
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
+∞
41.7
40
*
D33.30
ICD-10 Finland
Acoustic neuroma
+∞
41.7
40
*
Z71.9
ICD-10 Finland
Counselling, unspecified
2.2
41.3
368
1747
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
41.2
1172
8045
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
41.0
1634
12154
A02BC02
ATC
pantoprazole; systemic
1.6
41.0
2718
22698
L28
ICPC
Limited function/disability (L)
1.7
40.8
901
5786
R06.0
ICD-10 Finland
Dyspnoea
1.6
40.6
1162
7984
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
39.4
759
4685
38998
ICD-8 Finland
Other deafness, Alia definita
+∞
38.6
37
*
H91
ICD-10 Finland
Other hearing loss
7.4
38.6
56
77
J01DB01
ATC
cefalexin; oral
1.7
38.0
3166
27629
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
37.9
1075
7348
H60.3
ICD-10 Finland
Other infective otitis externa
3.8
37.6
115
307
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
37.6
1364
9878
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.8
37.0
191
703
38999
ICD-8 Finland
Other deafness, Impairment of hearing, one or both ears
+∞
36.5
35
*
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
9.6
35.9
42
44
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
35.8
1695
12981
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
35.5
1093
7600
R5110, ,
SPAT
2.0
35.2
424
2250
ZYC01, ,
SPAT
2.0
35.1
418
2209
R05
ICD-10 Finland
Cough
1.7
35.0
838
5470
A97
ICPC
No disease
1.7
34.9
826
5374
R05
ICPC
Cough
1.6
34.9
950
6406
TDA90
NOMESCO Finland
Removal wax from ear
6.0
34.6
61
103
AA1AD
NOMESCO Finland
CT of head and brain
1.6
34.5
1217
8721
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.7
34.1
78
167
J01CA04
ATC
amoxicillin; systemic
1.6
33.4
3047
26619
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.0
33.4
424
2290
RK420, ,
NOMESCO Finland
329.8
32.9
33
*
R52.9
ICD-10 Finland
Pain, unspecified
2.0
32.9
416
2243
ZXH06, ,
SPAT
2.4
32.4
224
951
R74
ICPC
Upper respiratory infection acute
1.6
32.4
1023
7131
H04
ICPC
Ear discharge
2.9
32.3
152
532
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
6.7
31.8
50
75
R4130
NOMESCO Finland
Speech therapy
3.0
31.8
143
488
R83
ICPC
Respiratory infection other
1.6
31.7
793
5219
H02AB06
ATC
prednisolone; systemic
1.5
31.5
1829
14483
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
31.3
711
4565
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
31.1
849
5709
M54.5
ICD-10 Finland
Low back pain
1.5
30.8
1312
9743
3899X
ICD-9 Finland
Deafness, Unspecified deafness
+∞
30.2
29
*
38900
ICD-8 Finland
Other deafness, Deafness, both ears
+∞
30.2
29
*
H93.2
ICD-10 Finland
Other abnormal auditory perceptions
6.6
30.2
48
73
R03AC02
ATC
salbutamol; inhalant
1.5
30.0
1997
16180
WX110, ,
SPAT
2.3
29.9
236
1063
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.9
29.4
142
504
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
29.3
669
4294
U07
ICPC
Urine symptom/complaint other
1.9
29.2
379
2060
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
6.3
29.1
49
79
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
28.7
740
4895
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
2.6
28.6
169
667
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
28.4
441
2538
G44.2
ICD-10 Finland
Tension-type headache
1.8
28.2
475
2799
Z00.8
ICD-10 Finland
Other general examinations
2.0
28.2
327
1708
S18
ICPC
Laceration/cut
1.4
27.6
1808
14523
G04CA02
ATC
tamsulosin; oral
1.5
27.5
996
7115
RK530, ,
NOMESCO Finland
+∞
27.1
26
*
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
62.5
27.0
31
5
N17
ICPC
Vertigo/dizziness
1.7
26.7
529
3264
Z01.2
ICD-10 Finland
Dental examination
1.4
26.4
1562
12279
Z3231
NOMESCO Finland
Registered nurse
1.5
26.3
1078
7890
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
26.2
455
2705
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
26.1
659
4327
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
26.1
304
1590
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.4
25.9
51
96
EB1SA, ,
SPAT
2.4
25.6
188
821
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.9
25.4
320
1719
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
25.1
1589
12613
H02AB04
ATC
methylprednisolone; systemic
1.7
25.1
541
3410
R21
ICPC
Throat symptom/complaint
1.6
25.0
642
4228
J01FA10
ATC
azithromycin; systemic
1.4
25.0
1918
15747
H43
ICPC
Ear, Other diagnostic procedure
9.2
24.7
30
33
H60.8
ICD-10 Finland
Other otitis externa
2.8
24.7
124
450
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
24.7
1455
11394
R01AD08
ATC
fluticasone; nasal
1.5
24.5
933
6712
U02
ICPC
Urinary frequency/urgency
1.6
24.5
571
3671
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
24.5
924
6635
R01AD58
ATC
fluticasone, combinations; nasal
1.6
24.3
740
5072
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
24.3
1119
8362
AXX01, ,
SPAT
2.3
24.2
190
854
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
24.0
1390
10834
R4120
NOMESCO Finland
Occupational therapy
2.0
23.9
276
1438
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
23.7
1818
14880
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
5.2
23.6
48
93
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
23.6
628
4170
N06AX11
ATC
mirtazapine; oral
1.4
23.3
1234
9454
R53
ICD-10 Finland
Malaise and fatigue
1.5
23.2
962
7030
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.7
23.1
74
205
J01AA02
ATC
doxycycline; systemic
1.4
23.0
2915
25933
J01MA02
ATC
ciprofloxacin; systemic
1.4
23.0
1486
11786
A23
ICPC
Risk factor NOS
1.8
22.9
345
1963
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.0
22.8
102
348
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.4
22.5
154
651
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
22.5
266
1398
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
8.8
22.4
28
32
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
22.4
731
5078
ZY010, ,
SPAT
3.6
22.4
72
200
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
22.3
2455
21246
C07AB07
ATC
bisoprolol; oral
1.4
22.3
1987
16610
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
22.3
808
5741
R5130, ,
SPAT
6.5
22.2
36
56
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
22.1
702
4846
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
22.0
2534
22075
J01FA06
ATC
roxithromycin; oral
1.4
21.9
1424
11280
G47.3
ICD-10 Finland
Sleep apnoea
1.5
21.9
770
5432
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
21.9
298
1642
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
29.2
21.8
29
10
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
21.8
845
6082
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
21.7
897
6540
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
21.7
754
5307
R07.3
ICD-10 Finland
Other chest pain
1.7
21.6
405
2454
D19
ICPC
Teeth/gum symptom/complaint
1.5
21.5
1004
7491
N03AX16
ATC
[U] pregabalin
1.5
21.5
832
5984
H65.0
ICD-10 Finland
Acute serous otitis media
3.6
21.4
69
192
R06AX27
ATC
desloratadine; oral
1.5
21.4
896
6548
WX002
NOMESCO Finland
Sedation and analgesia
1.5
21.4
740
5202
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
21.3
542
3555
A11
ICPC
Chest pain NOS
1.8
21.1
347
2026
N30.0
ICD-10 Finland
Acute cystitis
1.5
21.0
642
4389
RK220, ,
NOMESCO Finland
7.7
20.8
29
38
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
20.7
290
1611
M01AH05
ATC
etoricoxib; oral
1.4
20.5
2132
18166
S29
ICPC
Skin symptom/complaint other
1.5
20.4
769
5493
GD1AA, ,
SPAT
1.6
20.3
498
3235
R02
ICPC
Shortness of breath/dyspnoea
1.6
20.2
530
3498
Z29.0
ICD-10 Finland
Isolation
6.8
19.9
31
46
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.6
19.8
499
3261
L12
ICPC
Hand/finger symptom/complaint
1.5
19.6
596
4066
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
3.0
19.6
87
296
N02AX02
ATC
tramadol; systemic, rectal
1.4
19.4
1609
13194
Z2446
NOMESCO Finland
Social worker
1.9
19.3
244
1312
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
7.5
19.1
27
36
RL210, ,
NOMESCO Finland
7.2
19.1
28
39
C10AA07
ATC
rosuvastatin; oral
1.4
18.9
1212
9525
H60
ICD-10 Finland
Otitis externa
2.1
18.9
174
835
M01AB05
ATC
diclofenac; systemic, rectal
1.3
18.7
2332
20303
M03BX02
ATC
tizanidine; oral
1.3
18.7
2076
17762
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.0
18.7
209
1078
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
18.6
1460
11850
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
100.5
18.6
20
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
18.5
1231
9727
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
18.4
297
1723
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
18.4
518
3471
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.8
18.4
291
1679
SFA10
NOMESCO Finland
One-surface restoration
1.3
18.2
1820
15305
R01AD12
ATC
fluticasone furoate; nasal
1.4
18.2
925
6977
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
18.0
460
3014
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
17.8
700
5030
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.1
17.8
177
875
J20
ICD-10 Finland
Acute bronchitis
1.7
17.8
351
2155
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
4.4
17.8
44
101
A02BC05
ATC
esomeprazole; systemic
1.4
17.7
1433
11657
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
4.5
17.7
43
97
R35
ICD-10 Finland
Polyuria
1.8
17.6
276
1588
RK290, ,
NOMESCO Finland
14.6
17.6
29
20
R06.5
ICD-10 Finland
Mouth breathing
1.8
17.5
292
1710
XG460
NOMESCO Finland
Short time oxymetry
3.0
17.4
78
267
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.3
17.4
126
548
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.7
17.3
365
2278
K02.1
ICD-10 Finland
Caries of dentine
1.3
17.3
1933
16474
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
17.3
581
4043
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
17.2
334
2041
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
17.1
606
4262
XF404
NOMESCO Finland
Ambulatory ECG
1.7
17.1
332
2029
L15
ICPC
Knee symptom/complaint
1.4
17.1
878
6628
A04
ICPC
Weakness/tiredness general
1.5
17.1
595
4172
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
3.3
17.1
63
192
UJF32
NOMESCO Finland
Coloscopy
1.4
17.0
952
7291
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
17.0
935
7139
R60.0
ICD-10 Finland
Localized oedema
1.5
17.0
502
3398
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
17.0
2185
18986
ZXD20
NOMESCO Finland
Day surgery
1.6
17.0
454
3005
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
4.5
16.8
40
89
Z45.3
ICD-10 Finland
Adjustment and management of implanted hearing device
+∞
16.7
16
*
R07.0
ICD-10 Finland
Pain in throat
1.9
16.6
216
1173
N01
ICPC
Headache
1.7
16.5
329
2023
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
16.5
221
1212
A85
ICPC
Adverse effect medical agent
3.5
16.5
56
162
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
16.4
428
2815
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
16.4
119
518
WX402
NOMESCO Finland
General anaesthesia
1.4
16.4
758
5610
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
16.3
1808
15345
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
16.3
598
4232
K30
ICD-10 Finland
Functional dyspepsia
1.6
16.2
383
2462
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
16.1
1302
10554
D11
ICPC
Diarrhoea
1.6
16.1
379
2433
C10AA05
ATC
atorvastatin; oral
1.3
16.0
1624
13605
XF402
NOMESCO Finland
ECG with work load test
1.6
15.9
392
2544
R55
ICD-10 Finland
Syncope and collapse
1.6
15.9
437
2909
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
15.8
3258
30185
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
15.7
1001
7814
L03
ICPC
Low back symptom/complaint
1.4
15.7
969
7525
M02AA07
ATC
piroxicam; topical
1.3
15.7
1301
10576
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
15.6
365
2337
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
15.6
704
5180
3897A
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]
+∞
15.6
15
*
XKD00
NOMESCO Finland
Uroflowmetry
1.5
15.6
604
4320
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.2
15.5
125
569
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
15.5
2440
21674
A02BC03
ATC
lansoprazole; oral
1.4
15.4
1021
8016
H90
ICD-10 Finland
Conductive and sensorineural hearing loss
14.8
15.3
25
17
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
15.2
631
4569
D01
ICPC
Abdominal pain/cramps general
1.6
15.2
403
2659
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.6
15.2
90
357
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
15.1
861
6595
L08
ICPC
Shoulder symptom/complaint
1.4
15.1
791
5973
H26.4
ICD-10 Finland
After-cataract
1.6
15.0
419
2797
R5599
NOMESCO Finland
Other rehabilitation service
2.4
15.0
100
420
C10AA01
ATC
simvastatin; oral
1.3
14.9
1660
14038
D07AC01
ATC
betamethasone; topical
1.3
14.9
1274
10384
DCD00
NOMESCO Finland
Myringoplasty
5.4
14.9
29
54
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
14.9
468
3206
S02CA02
ATC
flumetasone and antiinfectives; otic
1.9
14.9
195
1061
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
6.8
14.8
23
34
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
14.7
675
4981
M79.1
ICD-10 Finland
Myalgia
1.5
14.6
468
3219
R13
ICD-10 Finland
Dysphagia
1.7
14.6
267
1605
SFA30
NOMESCO Finland
Three-surface restoration
1.3
14.6
1383
11435
Z26.8
ICD-10 Finland
Need for immunization against other specified single infectious diseases
3.6
14.5
47
132
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
6.6
14.5
23
35
S06.0
ICD-10 Finland
Concussion
1.6
14.4
362
2357
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.4
14.4
935
7307
M54.3
ICD-10 Finland
Sciatica
1.8
14.3
211
1191
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.8
14.3
227
1312
K85
ICPC
Elevated blood pressure
1.4
14.2
644
4736
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.0
14.2
158
814
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
14.2
672
4982
R12
ICD-10 Finland
Heartburn
1.7
14.0
272
1662
R03BA02
ATC
budesonide; inhalant
1.4
14.0
599
4361
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
3.2
13.9
55
175
R03DC03
ATC
montelukast; oral
1.5
13.9
514
3639
R51
ICD-10 Finland
Headache
2.0
13.8
160
836
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.7
13.8
264
1606
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
13.7
602
4400
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
13.7
355
2328
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
6.2
13.7
23
37
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
13.7
1359
11280
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
13.7
276
1703
R3110
NOMESCO Finland
Psychosocial training
4.2
13.7
36
87
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
13.6
175
947
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
13.6
228
1338
38910
ICD-8 Finland
Other deafness, Deafness, one ear and partial deafness in other
+∞
13.5
13
*
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.6
13.5
300
1896
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
34.1
13.5
17
5
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
13.4
881
6887
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
13.4
219
1275
GX1K5
NOMESCO Finland
Diffusion capacity
4.2
13.4
35
84
D12
ICPC
Constipation
2.0
13.4
149
768
R06AE07
ATC
cetirizine; oral
1.3
13.4
1433
12010
SDA03
NOMESCO Finland
Periodontal treatment
1.3
13.3
1258
10366
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
13.3
215
1249
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
13.2
992
7913
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
3.7
13.2
41
112
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
13.2
433
2993
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
13.1
885
6943
A02BC01
ATC
omeprazole; systemic
1.3
13.1
973
7743
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.1
13.1
125
609
R5430
NOMESCO Finland
Interpreter's services
12.2
13.1
23
19
XG405
NOMESCO Finland
Education on PEF monitoring
2.8
13.0
64
231
S01BC05
ATC
ketorolac; ophthalmic
1.9
13.0
152
797
J01DA01
ATC
[U] cefalexin
1.3
12.9
2178
19299
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
12.9
247
1504
U71
ICPC
Cystitis/urinary infection other
1.7
12.8
240
1453
TQW40, ,
SPAT
1.6
12.8
341
2252
P01AB01
ATC
metronidazole; oral, rectal
1.3
12.8
1320
10995
OAB42, ,
SPAT
1.5
12.7
424
2940
UJF32, ,
SPAT
2.0
12.7
127
631
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
12.7
1057
8550
T16
ICD-10 Finland
Foreign body in ear
3.8
12.6
37
97
ZYC05, ,
SPAT
2.3
12.6
96
428
F29
ICPC
Eye symptom/complaint other
1.5
12.6
349
2325
H73.1
ICD-10 Finland
Chronic myringitis
32.1
12.6
16
5
WZC30
NOMESCO Finland
Teaching
1.4
12.5
588
4347
3898X
ICD-9 Finland
Deafness, Other specified forms of deafness
+∞
12.5
12
*
DFF05, ,
SPAT
3.2
12.5
49
156
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.4
12.4
44
131
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
12.4
396
2720
XG466
NOMESCO Finland
Sleep oxymetry
2.1
12.4
111
529
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
12.4
1280
10653
KMAK, ,
NOMESCO Finland
1.3
12.4
1595
13650
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
12.3
343
2286
J45.8
ICD-10 Finland
Mixed asthma
2.1
12.3
117
570
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
12.3
1229
10181
ZX120
NOMESCO Finland
Intravenous
1.5
12.2
349
2340
EBA00, ,
SPAT
2.2
12.2
99
453
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
12.2
1462
12391
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
12.2
267
1683
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
12.2
344
2301
PA6AD
NOMESCO Finland
CT of neck arteries
1.9
12.1
144
760
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
12.1
340
2273
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
12.1
677
5155
K80
ICPC
Cardiac arrhythmia NOS
1.6
12.0
302
1967
N30
ICD-10 Finland
Cystitis
1.6
12.0
264
1665
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
12.0
400
2770
R96
ICPC
Asthma
1.5
12.0
329
2186
H03
ICPC
Tinnitus, ringing/buzzing ear
2.6
11.9
65
248
A01
ICPC
Pain general/multiple sites
1.5
11.9
355
2402
ZY010
NOMESCO Finland
Hospital outpatient
1.9
11.9
149
800
H69.0
ICD-10 Finland
Patulous Eustachian tube
4.4
11.9
29
66
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
11.9
339
2273
Z50.5
ICD-10 Finland
Speech therapy
3.0
11.9
50
166
B01AC04
ATC
clopidogrel; oral
1.4
11.8
648
4913
M19.8
ICD-10 Finland
Other specified arthrosis
1.9
11.8
145
774
L57.0
ICD-10 Finland
Actinic keratosis
1.5
11.8
411
2873
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
11.8
213
1278
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
11.8
181
1037
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
11.7
326
2175
J45
ICD-10 Finland
Asthma
1.5
11.6
326
2176
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
11.6
445
3166
J01DA06
ATC
[U] cefuroxime
1.4
11.6
462
3311
H66
ICD-10 Finland
Suppurative and unspecified otitis media
2.5
11.6
71
287
M54
ICD-10 Finland
Dorsalgia
1.5
11.6
374
2573
L01
ICPC
Neck symptom/complaint
1.4
11.6
503
3665
S20.2
ICD-10 Finland
Contusion of thorax
1.8
11.6
187
1087
D06
ICPC
Abdominal pain localized other
1.6
11.5
277
1788
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
11.5
923
7413
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
11.4
245
1536
RK240, ,
NOMESCO Finland
120.4
11.4
12
*
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
120.4
11.4
12
*
SFA20
NOMESCO Finland
Two-surface restoration
1.3
11.4
1855
16265
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
11.4
958
7738
B01AF02
ATC
apixaban; oral
1.4
11.4
530
3909
H51
ICPC
Ear, I&d/flush/aspiration
2.8
11.4
56
203
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
3.4
11.3
40
119
M48.0
ICD-10 Finland
Spinal stenosis
1.4
11.3
456
3276
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
11.3
316
2108
A08
ICPC
Swelling
1.7
11.3
223
1369
Z2445
NOMESCO Finland
Psychologist
2.1
11.3
109
535
XA800
NOMESCO Finland
Neuropsychological investigation
1.9
11.3
136
722
SAA01, ,
SPAT
3.4
11.2
39
115
R4190
NOMESCO Finland
Nutritional therapy
1.9
11.2
132
695
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.0
11.2
126
653
R03BA05
ATC
fluticasone; inhalant
1.4
11.2
581
4364
J01FA09
ATC
clarithromycin; systemic
1.3
11.2
960
7776
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
11.2
164
927
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
11.1
256
1633
ZXH09, ,
SPAT
2.4
11.1
72
299
XCK00
NOMESCO Finland
Perimetry
1.7
11.1
224
1383
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.6
11.1
62
240
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
11.1
1333
11268
B01AB05
ATC
enoxaparin; parenteral
1.3
11.1
1120
9267
ZXC10
NOMESCO Finland
Use of laser
2.4
11.1
73
306
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.5
11.1
331
2242
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
11.0
257
1644
N05CF01
ATC
zopiclone; oral
1.3
11.0
1170
9737
M54.2
ICD-10 Finland
Cervicalgia
1.6
11.0
244
1542
N05AB04
ATC
prochlorperazine; systemic, rectal
2.3
11.0
85
382
G04BD12
ATC
mirabegron; oral
1.4
11.0
434
3107
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
11.0
549
4098
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
11.0
585
4413
S04
ICPC
Lump/swelling localized
1.5
11.0
355
2444
S21
ICPC
Skin texture symptom/complaint
1.4
11.0
535
3977
DC1AI
NOMESCO Finland
Cone beam CT of ear
43.4
10.9
13
*
J02AC01
ATC
fluconazole; systemic
1.3
10.9
1192
9960
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
10.8
1763
15428
K59.0
ICD-10 Finland
Constipation
1.7
10.8
208
1268
R03AC03
ATC
terbutaline; inhalant
1.4
10.8
450
3251
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
10.8
246
1565
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
10.8
775
6116
A03
ICPC
Fever
1.4
10.8
485
3552
J01FF01
ATC
clindamycin; systemic
1.3
10.8
893
7190
D07AB08
ATC
desonide; topical
1.5
10.8
357
2468
ZXE00
NOMESCO Finland
One hour or less
1.3
10.7
1325
11225
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
10.7
702
5465
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
10.7
349
2405
IHA10, ,
SPAT
2.2
10.7
89
412
R2110
NOMESCO Finland
Giving the first information
1.7
10.7
205
1249
M02AA10
ATC
ketoprofen; topical
1.4
10.7
536
4001
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.3
10.7
77
336
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic
2.1
10.7
98
472
S80.0
ICD-10 Finland
Contusion of knee
1.6
10.6
235
1486
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.8
10.6
153
861
4133
FHL
Stapedectomy sampling
8.0
10.6
23
29
R09.8
ICD-10 Finland
Other specified symptoms and signs involving the circulatory and respiratory systems
3.7
10.6
32
86
H01.0
ICD-10 Finland
Blepharitis
1.7
10.6
203
1238
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
10.5
198
1200
R00.2
ICD-10 Finland
Palpitations
1.6
10.5
236
1496
SAA04
NOMESCO Finland
Special examination of mouth
1.8
10.5
158
899
SPAT1336
SPAT
Request for examination
1.9
10.5
135
732
R4110, ,
SPAT
1.4
10.5
444
3217
XQ800
NOMESCO Finland
Prick test
1.7
10.5
198
1202
J05AB11
ATC
valaciclovir; oral
1.4
10.5
472
3459
M01AX05
ATC
glucosamine; oral
1.3
10.5
700
5466
N05CF02
ATC
zolpidem; oral
1.4
10.4
542
4070
38801
ICD-8 Finland
Deaf mutism, Congenita
+∞
10.4
10
*
QAE99, ,
SPAT
2.8
10.4
50
179
UJD10, ,
SPAT
2.1
10.4
94
450
R06AX22
ATC
ebastine; oral
1.4
10.4
503
3731
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
10.4
1024
8432
UJH02
NOMESCO Finland
Anoscopy
1.9
10.3
134
729
XA402
NOMESCO Finland
ENMG
2.2
10.3
86
399
A06AD11
ATC
lactulose; oral
1.4
10.3
586
4463
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.9
10.3
121
637
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
4.3
10.3
26
61
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.0
10.3
111
568
P20
ICPC
Memory disturbance
1.4
10.3
556
4202
J34.2
ICD-10 Finland
Deviated nasal septum
1.8
10.2
154
877
N03AX12
ATC
[U] gabapentin; oral
1.4
10.2
517
3864
N06AX16
ATC
venlafaxine; oral
1.4
10.2
403
2884
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
10.2
320
2189
WX290, ,
SPAT
2.0
10.2
103
515
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
10.2
636
4916
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
10.2
328
2257
R50.9
ICD-10 Finland
Fever, unspecified
1.4
10.1
505
3764
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
10.1
644
4990
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
10.1
579
4414
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
10.1
232
1480
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
10.0
215
1349
J01EA01
ATC
trimethoprim; systemic
1.3
10.0
886
7190
R31
ICD-10 Finland
Unspecified haematuria
1.4
10.0
384
2734
Z00.0
ICD-10 Finland
General medical examination
1.3
10.0
637
4938
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
10.0
168
989
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
40.2
10.0
12
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
9.9
291
1964
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
9.9
274
1826
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
9.9
291
1965
G04CA01
ATC
alfuzosin; oral
1.4
9.8
433
3161
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
8.1
9.8
21
26
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
8.1
9.8
21
26
WZC30, ,
SPAT
1.5
9.8
283
1902
H70.1
ICD-10 Finland
Chronic mastoiditis
9.5
9.7
19
20
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
2.8
9.7
47
169
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
9.7
434
3177
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
9.7
691
5443
E0000UV, ,
ATC
1.2
9.7
1394
11990
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.4
9.7
371
2641
DCD10
NOMESCO Finland
Tympanoplasty
13.4
9.7
16
12
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.3
9.6
35
107
K96
ICPC
Haemorrhoids
2.1
9.5
93
459
R52.2
ICD-10 Finland
Other chronic pain
1.9
9.5
124
676
A27
ICPC
Fear of other disease NOS
1.7
9.5
179
1086
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
9.5
200
1249
Z92.2
ICD-10 Finland
Personal history of long-term (current) use of other medicaments
15.0
9.5
15
10
ZXC60
NOMESCO Finland
Application of heat
2.6
9.5
51
194
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
3.8
9.5
28
74
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
9.5
216
1376
A49
ICPC
General and Unspecified, Other preventive procedure
3.3
9.4
35
108
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
100.3
9.4
10
*
H91.3
ICD-10 Finland
Deaf mutism, not elsewhere classified
+∞
9.4
9
*
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
2.0
9.4
94
469
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
9.3
325
2270
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
9.3
1252
10673
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
9.3
197
1232
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
9.3
188
1162
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
9.3
1331
11425
J01DC02
ATC
cefuroxime; systemic
1.7
9.3
159
940
C10AX09
ATC
ezetimibe; oral
1.3
9.3
575
4432
C08CA01
ATC
amlodipine; oral
1.2
9.3
1448
12546
S02
ICPC
Pruritus
1.9
9.3
117
631
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.7
9.3
170
1024
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
9.3
433
3191
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.3
9.3
1096
9208
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.4
9.2
391
2833
H57.1
ICD-10 Finland
Ocular pain
1.9
9.2
112
597
UKC02
NOMESCO Finland
Cystoscopy
1.3
9.2
589
4562
J01
ICD-10 Finland
Acute sinusitis
1.8
9.2
147
853
R053, ,
ICD-10 Finland
1.9
9.2
105
549
R30.0
ICD-10 Finland
Dysuria
1.8
9.2
135
765
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.6
9.2
185
1144
L60.0
ICD-10 Finland
Ingrowing nail
1.7
9.2
152
892
R03BC03
ATC
nedocromil; inhalant
1.6
9.1
205
1301
R04
ICPC
Breathing problem other
1.8
9.1
127
707
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.9
9.1
106
557
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.6
9.1
186
1153
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.7
9.1
173
1053
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
9.1
281
1916
GX1D5
NOMESCO Finland
Flow volume spirometry
5.0
9.1
19
38
N03AX09
ATC
lamotrigine; oral
1.8
9.1
120
658
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
9.1
428
3160
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.7
9.0
153
903
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
9.0
265
1789
L02
ICPC
Back symptom/complaint
1.5
9.0
301
2086
R01AD05
ATC
budesonide; nasal
1.6
9.0
224
1459
R29
ICPC
Respiratory symptom/complaint other
1.6
8.9
211
1356
P06
ICPC
Sleep disturbance
1.4
8.9
364
2619
R11
ICD-10 Finland
Nausea and vomiting
1.5
8.9
294
2031
ZA1.0
ICD-10 Finland
Shoulder region
2.0
8.9
87
430
Y94.8
ICD-10 Finland
Other leisure activity accident
2.0
8.9
93
471
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
3.4
8.9
31
92
QBE99, ,
SPAT
3.0
8.9
38
128
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
8.9
604
4723
N02BF01
ATC
gabapentin; oral
1.5
8.8
315
2211
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
8.8
2240
20379
H31
ICPC
Ear, Medical examin/health eval partial
8.6
8.8
18
21
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
8.8
520
3982
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.5
8.8
233
1539
JFA15, ,
SPAT
3.2
8.8
34
108
F73
ICPC
Eye infection/inflammation other
2.2
8.8
67
301
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
8.7
149
881
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.7
8.7
147
866
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
8.7
239
1589
WZA30, ,
SPAT
2.9
8.7
39
135
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
8.7
128
726
H83.1
ICD-10 Finland
Labyrinthine fistula
50.1
8.7
10
*
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
2.1
8.7
78
374
L04
ICPC
Chest symptom/complaint
1.6
8.6
206
1327
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
8.6
136
787
K58
ICD-10 Finland
Irritable bowel syndrome
2.2
8.6
73
342
H69.9
ICD-10 Finland
Eustachian tube disorder, unspecified
4.4
8.6
21
48
C01DA14
ATC
isosorbide mononitrate; oral
1.3
8.6
627
4949
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
8.6
1458
12724
WZC00, ,
SPAT
1.4
8.6
451
3390
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.6
8.6
194
1235
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
8.6
495
3776
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.5
8.5
272
1867
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.5
8.5
230
1524
W19
ICD-10 Finland
Unspecified fall
1.4
8.5
334
2387
M01AC06
ATC
meloxicam; systemic, rectal
1.2
8.5
1180
10075
H02.3
ICD-10 Finland
Blepharochalasis
1.6
8.5
213
1389
NG1EA, ,
SPAT
2.8
8.5
41
148
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
8.5
344
2474
L13
ICPC
Hip symptom/complaint
1.3
8.4
660
5257
50499
ICD-8 Finland
Deflected nasal septum
2.3
8.4
62
274
H25
ICD-10 Finland
Senile cataract
2.6
8.4
46
177
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
2.2
8.4
66
300
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
8.4
419
3123
WZB00, ,
SPAT
1.5
8.4
246
1661
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
8.3
290
2026
3882A
ICD-9 Finland
Other disorders of ear, Sudden hearing loss, unspecified
+∞
8.3
8
*
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
8.3
8
*
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
8.3
127
728
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
8.3
183
1157
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.3
681
5459
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
8.3
345
2492
Z97.8
ICD-10 Finland
Presence of other specified devices
8.5
8.3
17
20
R31
NOMESCO Finland
Adaptation training
10.7
8.3
15
14
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.4
8.3
308
2180
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.9
8.3
104
562
H60.1
ICD-10 Finland
Cellulitis of external ear
2.8
8.3
39
139
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.7
8.2
150
905
M54.8
ICD-10 Finland
Other dorsalgia
1.7
8.2
140
829
R01AD01
ATC
beclometasone; nasal
1.4
8.2
450
3405
S00.0
ICD-10 Finland
Superficial injury of scalp
2.0
8.2
87
444
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
6.5
8.2
20
31
R19.4
ICD-10 Finland
Change in bowel habit
1.9
8.1
99
529
U01
ICPC
Dysuria/painful urination
1.5
8.1
242
1638
R4160, ,
SPAT
4.4
8.1
20
46
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.3
8.1
639
5092
A02BA02
ATC
ranitidine; systemic
1.3
8.1
657
5255
DFF00, ,
SPAT
2.5
8.1
49
198
R03BA01
ATC
beclometasone; inhalant
1.4
8.1
444
3357
F01
ICPC
Eye pain
2.0
8.1
87
446
XA410
NOMESCO Finland
BAEP
33.4
8.1
10
*
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
17.2
8.1
12
7
WYA30, ,
SPAT
3.2
8.1
30
93
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
8.0
153
933
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
2.0
8.0
83
420
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
22.1
8.0
11
5
L72.1
ICD-10 Finland
Trichilemmal cyst
1.5
8.0
212
1400
J05AB01
ATC
aciclovir; systemic
1.3
8.0
689
5559
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
8.0
510
3950
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.4
7.9
354
2589
SPAT1044
SPAT
Tympanometry
2.3
7.9
57
250
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.7
7.9
127
741
N05BA04
ATC
oxazepam; oral
1.3
7.8
879
7319
H53.8
ICD-10 Finland
Other visual disturbances
2.4
7.8
49
202
P29
ICPC
Psychological sympt/compl other
1.6
7.8
182
1168
G51.0
ICD-10 Finland
Bell palsy
2.0
7.8
82
418
N27
ICPC
Fear of neurological disease other
2.1
7.8
69
330
N06AB04
ATC
citalopram; systemic
1.3
7.8
668
5386
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.6
7.7
179
1146
C05AA08
ATC
fluocortolone; rectal, topical
1.4
7.7
421
3180
I49.5
ICD-10 Finland
Sick sinus syndrome
1.7
7.7
145
881
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.6
7.7
174
1107
H61.8
ICD-10 Finland
Other specified disorders of external ear
2.9
7.7
35
122
K02.2
ICD-10 Finland
Caries of cementum
1.6
7.7
157
974
R06AX13
ATC
loratadine; oral
1.4
7.7
398
2981
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.9
7.7
91
482
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
7.7
820
6785
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.7
7.6
129
762
GX2D5
NOMESCO Finland
Sleep oximetry
3.3
7.6
28
86
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
7.6
334
2434
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
7.6
680
5505
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
7.6
126
740
P01
ICPC
Feeling anxious/nervous/tense
1.4
7.6
281
1986
U13
ICPC
Bladder symptom/complaint other
1.8
7.6
106
592
P03
ICPC
Feeling depressed
1.5
7.6
240
1646
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.4
7.6
431
3278
N06AX21
ATC
duloxetine; oral
1.4
7.6
346
2540
L11
ICPC
Wrist symptom/complaint
1.5
7.6
268
1879
-44
ICPC
Preventive immunization/medic
0.6
7.6
111
1883
DDB00
NOMESCO Finland
Stapedectomy
11.9
7.6
13
11
M79.7
ICD-10 Finland
Fibromyalgia
1.9
7.5
93
500
J01MA14
ATC
moxifloxacin; systemic
1.4
7.5
293
2091
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.3
7.5
52
224
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
1.9
7.5
91
486
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
7.5
105
587
L29.9
ICD-10 Finland
Pruritus, unspecified
1.9
7.5
92
494
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.1
7.4
65
309
N30.8
ICD-10 Finland
Other cystitis
2.6
7.4
40
153
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
7.4
514
4023
78139
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Symptoma auditus aliud sive NUD
80.2
7.4
8
*
H71
ICPC
Acute otitis media/myringitis
2.8
7.4
35
125
D10
ICPC
Vomiting
1.7
7.4
140
853
S01.0
ICD-10 Finland
Open wound of scalp
1.4
7.4
272
1923
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
7.3
163
1035
G04CB01
ATC
finasteride; oral
1.4
7.3
403
3050
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.7
7.3
118
689
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.0
7.3
71
352
M01AX17
ATC
nimesulide; oral
1.3
7.3
803
6667
R5140, ,
SPAT
2.4
7.3
49
209
N03AE01
ATC
clonazepam; systemic
1.6
7.3
174
1124
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.4
7.3
364
2714
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.3
1154
9964
L95
ICPC
Osteoporosis
1.7
7.3
140
858
XG405, ,
SPAT
3.2
7.2
28
89
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.9
7.2
87
464
K05.38
ICD-10 Finland
Other chronic periodontitis
1.8
7.2
100
558
38790
ICD-8 Finland
Other disease of ear and mastoid process, Degeneratio nervi acustici
15.8
7.2
11
7
N05AH04
ATC
quetiapine; oral
1.3
7.2
519
4084
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
7.2
74
374
ZXD05
NOMESCO Finland
Urgent procedure
1.2
7.2
990
8422
R75
ICPC
Sinusitis acute/chronic
1.7
7.2
129
776
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.5
7.2
232
1599
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.5
7.2
190
1256
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
4.5
7.2
17
38
H02AB07
ATC
prednisone; oral
1.3
7.2
448
3456
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
7.2
1265
11034
R1430, ,
SPAT
2.3
7.2
51
223
H80
ICD-10 Finland
Otosclerosis
30.1
7.1
9
*
EB1CA, ,
SPAT
2.9
7.1
31
106
IAA01, ,
SPAT
3.4
7.1
24
70
J30.0
ICD-10 Finland
Vasomotor rhinitis
2.0
7.1
76
390
IHZ07, ,
SPAT
3.3
7.1
26
80
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.1
842
7047
A92
ICPC
Allergy/allergic reaction NOS
1.9
7.1
80
418
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.5
7.1
185
1220
J46
ICD-10 Finland
Status asthmaticus
1.8
7.0
94
519
DGW00
NOMESCO Finland
Dilatation of eustachian tube
8.8
7.0
14
16
H92.2
ICD-10 Finland
Otorrhagia
10.0
7.0
13
13
S22.3
ICD-10 Finland
Fracture of rib
1.5
7.0
233
1615
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
7.0
204
1378
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.6
7.0
142
883
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.6
7.0
165
1064
4141
FHL
Myringoplasty (also for reasons other than inflammation)
4.4
7.0
17
39
N04BC05
ATC
pramipexole; oral
1.5
7.0
246
1726
T91
ICPC
Vitamin/nutritional deficiency
2.8
6.9
34
124
WX140
NOMESCO Finland
Parabulbar anesthesy
1.6
6.9
168
1089
N06AB10
ATC
escitalopram; oral
1.3
6.9
562
4493
H69.8
ICD-10 Finland
Other specified disorders of Eustachian tube
4.0
6.9
19
48
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.6
6.9
37
142
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.8
286
2069
F05.9
ICD-10 Finland
Delirium, unspecified
1.9
6.8
85
459
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
1.7
6.8
128
779
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.5
6.8
42
172
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
6.8
698
5741
S22
ICPC
Nail symptom/complaint
1.5
6.8
219
1508
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.7
6.8
35
131
M81.5
ICD-10 Finland
Idiopathic osteoporosis
2.7
6.8
35
131
D06BB03
ATC
aciclovir; topical
1.6
6.8
134
826
R49.03
ICD-10 Finland
Atrophic dysphonia
2.3
6.8
47
203
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.9
6.8
86
467
H74.1
ICD-10 Finland
Adhesive middle ear disease
6.7
6.8
16
24
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
1.8
6.8
93
518
Z23.5
ICD-10 Finland
Need for immunization against tetanus alone
2.6
6.8
38
149
N05AX08
ATC
risperidone; systemic
1.4
6.8
300
2193
W42
ICD-10 Finland
Exposure to noise
40.1
6.8
8
*
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.5
6.7
183
1217
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
1.7
6.7
117
698
R07.1
ICD-10 Finland
Chest pain on breathing
2.3
6.7
50
223
A03CA02
ATC
clidinium and psycholeptics; oral
1.5
6.7
193
1299
N06AG02
ATC
moclobemide; oral
1.7
6.7
127
775
EBA00
NOMESCO Finland
Extraction of tooth
1.2
6.7
1134
9837
M35.7
ICD-10 Finland
Hypermobility syndrome
2.6
6.7
36
138
SPAT1342
SPAT
Referral to specialised care
2.4
6.7
44
186
M77.1
ICD-10 Finland
Lateral epicondylitis
1.5
6.7
189
1268
EMB30
NOMESCO Finland
Adenotomy
2.5
6.7
38
150
F05
ICPC
Visual disturbance other
1.7
6.7
104
602
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
6.7
240
1690
A46
ICD-10 Finland
Erysipelas
1.3
6.6
516
4101
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.0
6.6
69
351
ZXD35
NOMESCO Finland
Usual procedure
1.7
6.6
110
649
N64.4
ICD-10 Finland
Mastodynia
1.9
6.6
81
436
RS221, ,
NOMESCO Finland
2.3
6.6
47
206
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
6.6
147
935
M75.8
ICD-10 Finland
Other shoulder lesions
1.7
6.6
111
657
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
6.6
122
741
SPAT1325
SPAT
Vaccination
1.2
6.6
1102
9550
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.8
6.6
97
553
QXB99, ,
SPAT
1.8
6.6
91
509
K92.1
ICD-10 Finland
Melaena
1.5
6.6
193
1306
S12
ICPC
Insect bite/sting
1.4
6.5
280
2037
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
1.8
6.5
99
570
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
1.8
6.5
83
453
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
6.5
782
6552
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
6.2
6.5
16
26
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
1.7
6.4
120
730
J01DA08
ATC
[U] cefaclor
1.4
6.4
265
1913
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.8
6.4
95
542
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
6.4
168
1109
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
6.4
209
1444
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
6.4
698
5781
H92.1
ICD-10 Finland
Otorrhoea
7.4
6.4
14
19
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
14.3
6.4
10
7
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.4
6.4
291
2137
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.8
6.4
85
470
4222
FHL
Endonasal etmoidectomy
3.0
6.4
27
91
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
3.7
6.4
19
51
H70
ICPC
Otitis externa
2.0
6.3
61
302
G50.1
ICD-10 Finland
Atypical facial pain
2.2
6.3
51
236
WX203
NOMESCO Finland
Infraclavicular plexus blockade
1.9
6.3
74
393
L10
ICPC
Elbow symptom/complaint
1.6
6.3
146
938
RS220, ,
NOMESCO Finland
2.4
6.3
42
179
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
2.1
6.3
54
256
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.0
6.3
61
303
R15
ICD-10 Finland
Faecal incontinence
1.8
6.3
93
531
DFF20
NOMESCO Finland
Audiometry for children
18.0
6.3
9
5
DCA30
NOMESCO Finland
Exploration of middle ear
18.0
6.3
9
5
C01CA24
ATC
epinephrine; parenteral
1.5
6.3
157
1027
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
6.3
220
1543
N05CD07
ATC
temazepam; oral
1.3
6.3
421
3282
3890A
ICD-9 Finland
Deafness, Conductive deafness
+∞
6.2
6
*
H91.0
ICD-10 Finland
Ototoxic hearing loss
+∞
6.2
6
*
N06AB03
ATC
fluoxetine; oral
1.3
6.2
358
2727
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.8
6.2
1034
11858
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.7
6.2
99
577
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.8
6.2
89
503
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
6.2
102
600
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.3
6.2
409
3179
J33.8
ICD-10 Finland
Other polyp of sinus
2.1
6.2
56
271
CK2S4, ,
SPAT
2.1
6.2
56
271
J30.3
ICD-10 Finland
Other allergic rhinitis
1.8
6.2
89
504
D07AC13
ATC
mometasone; topical
1.2
6.2
910
7779
R52.0
ICD-10 Finland
Acute pain
1.7
6.2
98
571
M01AE02
ATC
naproxen; oral, rectal
1.2
6.2
1801
16374
183
Kela drug reimbursment
Lamotrigin and topiramate
3.1
6.2
24
77
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.3
6.1
45
200
D62
ICPC
Digestive, Administrative procedure
3.2
6.1
23
72
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.5
6.1
178
1202
L85.3
ICD-10 Finland
Xerosis cutis
2.4
6.1
40
169
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.5
6.1
205
1425
RK510, ,
NOMESCO Finland
7.7
6.1
13
17
SPAT1104
SPAT
Monitoring of emergency patient
0.6
6.1
82
1421
F99
ICPC
Eye/adnexa disease other
2.7
6.1
30
110
H53.2
ICD-10 Finland
Diplopia
1.7
6.1
101
596
I84
ICD-10 Finland
Hemorrhoids
1.8
6.1
84
470
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
12.5
6.1
10
8
A03FA02
ATC
cisapride; oral, rectal
1.4
6.1
239
1713
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
8.6
6.0
12
14
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
1.9
6.0
70
371
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
6.0
221
1564
R49.01
ICD-10 Finland
Functional dysphonia
1.8
6.0
87
494
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.4
6.0
283
2091

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hearing loss, unspecified
H91.9 [45547996]
3.0e+00
5.3e+00
5.9e+00
1.0e+50
—
6.4e+00
4.7e+00
cases:3.50%
controls:0.18%
cases:10.66%
controls:0.06%
cases:4.62%
controls:0.01%
cases:84.14%
controls:0.00%
—
—
cases:31.36%
controls:0.08%
cases:22.88%
controls:0.26%
133
67
3672
37870
406
23
3402
37939
176
5
3632
37957
3204
0
604
37962
—
1110
27
2429
35370
603
67
2032
25734
Otolaryngology
4 [38004449]
1.4e+00
1.9e+00
2.7e+00
8.3e+00
3.7e+00
3.0e+00
2.0e+00
cases:27.75%
controls:8.91%
cases:17.23%
controls:3.02%
cases:5.49%
controls:0.39%
cases:50.87%
controls:0.03%
cases:15.15%
controls:0.45%
cases:36.85%
controls:2.93%
cases:40.15%
controls:8.21%
1056
3381
2749
34556
656
1146
3152
36816
209
149
3599
37813
1937
10
1871
37952
574
169
3214
37597
1304
1037
2235
34360
1058
2119
1577
23682
Audiology
64 [38004489]
2.5e+00
2.9e+00
3.2e+00
—
4.3e+00
4.5e+00
3.6e+00
cases:9.12%
controls:0.85%
cases:6.12%
controls:0.36%
cases:1.55%
controls:0.06%
—
—
cases:4.38%
controls:0.06%
cases:22.21%
controls:0.31%
cases:23.07%
controls:0.82%
347
324
3458
37613
233
136
3575
37826
59
24
3749
37938
—
166
23
3622
37743
786
111
2753
35286
608
211
2027
25590
Sensorineural hearing loss, bilateral
H90.3 [45576850]
4.8e+00
5.3e+00
—
1.0e+50
—
5.8e+00
4.8e+00
cases:12.88%
controls:0.12%
cases:9.30%
controls:0.05%
—
—
cases:5.70%
controls:0.00%
—
—
cases:17.63%
controls:0.06%
cases:22.96%
controls:0.24%
490
45
3315
37892
354
19
3454
37943
—
217
0
3591
37962
—
624
23
2915
35374
605
62
2030
25739
Examination of ears and hearing
Z01.1 [45547279]
2.0e+00
3.1e+00
4.2e+00
—
5.4e+00
3.4e+00
2.4e+00
cases:7.07%
controls:1.03%
cases:6.46%
controls:0.31%
cases:1.89%
controls:0.03%
—
—
cases:3.48%
controls:0.02%
cases:9.92%
controls:0.35%
cases:11.42%
controls:1.17%
269
389
3536
37548
246
118
3562
37844
72
11
3736
37951
—
132
6
3656
37760
351
124
3188
35273
301
302
2334
25499
Adjustment or review of hearing aid
DAX00 [2001301528]
3.7e+00
4.1e+00
—
—
—
6.1e+00
4.7e+00
cases:2.92%
controls:0.07%
cases:1.68%
controls:0.03%
—
—
—
—
—
—
cases:5.71%
controls:0.01%
cases:7.59%
controls:0.08%
111
28
3694
37909
64
11
3744
37951
—
—
—
202
5
3337
35392
200
20
2435
25781
Audiometric test
21727005 [4071702]
1.6e+00
3.1e+00
3.7e+00
1.0e+50
4.6e+00
2.8e+00
2.2e+00
cases:5.94%
controls:1.28%
cases:5.67%
controls:0.28%
cases:1.18%
controls:0.03%
cases:7.69%
controls:0.00%
cases:2.24%
controls:0.02%
cases:5.40%
controls:0.34%
cases:8.54%
controls:1.04%
226
486
3579
37451
216
107
3592
37855
45
11
3763
37951
293
0
3515
37962
85
9
3703
37757
191
120
3348
35277
225
269
2410
25532
Presbycusis
H91.1 [45591444]
1.9e+00
3.4e+00
3.6e+00
—
3.9e+00
2.8e+00
2.1e+00
cases:2.26%
controls:0.35%
cases:2.78%
controls:0.09%
cases:0.76%
controls:0.02%
—
—
cases:0.63%
controls:0.01%
cases:2.49%
controls:0.16%
cases:3.45%
controls:0.42%
86
134
3719
37803
106
36
3702
37926
29
8
3779
37954
—
24
5
3764
37761
88
55
3451
35342
91
108
2544
25693
Presence of external hearing-aid
Z97.4 [45542504]
3.0e+00
3.5e+00
3.5e+00
1.0e+50
—
3.9e+00
3.6e+00
cases:4.05%
controls:0.21%
cases:2.76%
controls:0.09%
cases:0.45%
controls:0.01%
cases:3.36%
controls:0.00%
—
—
cases:4.86%
controls:0.11%
cases:8.58%
controls:0.26%
154
81
3651
37856
105
33
3703
37929
17
5
3791
37957
128
0
3680
37962
—
172
38
3367
35359
226
66
2409
25735
betahistine; oral
N07CA01 [21604833]
1.7e+00
2.0e+00
2.0e+00
3.7e+00
2.9e+00
2.3e+00
2.2e+00
cases:3.34%
controls:0.64%
cases:2.49%
controls:0.33%
cases:0.92%
controls:0.13%
cases:0.53%
controls:0.01%
cases:1.85%
controls:0.11%
cases:3.00%
controls:0.32%
cases:4.55%
controls:0.55%
127
242
3678
37695
95
125
3713
37837
35
49
3773
37913
20
5
3788
37957
70
40
3718
37726
106
113
3433
35284
120
142
2515
25659
Ménière disease
H81.0 [45567143]
2.0e+00
2.3e+00
2.5e+00
—
3.6e+00
2.9e+00
3.0e+00
cases:1.13%
controls:0.16%
cases:0.53%
controls:0.06%
cases:0.18%
controls:0.02%
—
—
cases:0.48%
controls:0.01%
cases:1.10%
controls:0.06%
cases:1.97%
controls:0.10%
43
61
3762
37876
20
21
3788
37941
7
6
3801
37956
—
18
5
3770
37761
39
22
3500
35375
52
27
2583
25774
Hearing complaint
H02 [2002000476]
1.6e+00
3.6e+00
4.0e+00
—
3.4e+00
1.4e+00
1.1e+00
cases:6.47%
controls:1.34%
cases:14.39%
controls:0.45%
cases:3.26%
controls:0.06%
—
—
cases:1.53%
controls:0.05%
cases:2.43%
controls:0.62%
cases:5.50%
controls:1.85%
246
508
3559
37429
548
169
3260
37793
124
24
3684
37938
—
58
20
3730
37746
86
221
3453
35176
145
478
2490
25323
Repair work or maintenance done on the aid
R5130 [2001310248]
2.7e+00
3.6e+00
—
1.0e+50
1.0e+50
4.4e+00
4.3e+00
cases:1.81%
controls:0.12%
cases:2.21%
controls:0.06%
—
—
cases:4.23%
controls:0.00%
cases:0.53%
controls:0.00%
cases:3.62%
controls:0.05%
cases:11.23%
controls:0.17%
69
47
3736
37890
84
24
3724
37938
—
161
0
3647
37962
20
0
3768
37766
128
17
3411
35380
296
45
2339
25756
Fitting and adjustment of hearing aid
Z46.1 [45595518]
2.3e+00
2.7e+00
2.8e+00
—
—
3.7e+00
3.1e+00
cases:3.29%
controls:0.32%
cases:1.63%
controls:0.12%
cases:0.29%
controls:0.02%
—
—
—
—
cases:6.33%
controls:0.16%
cases:7.93%
controls:0.40%
125
123
3680
37814
62
44
3746
37918
11
7
3797
37955
—
—
224
57
3315
35340
209
104
2426
25697
Fitting of hearing aid
DAX08 [2001301529]
2.7e+00
2.8e+00
—
1.0e+50
—
4.7e+00
3.4e+00
cases:1.89%
controls:0.12%
cases:0.81%
controls:0.05%
—
—
cases:1.89%
controls:0.00%
—
—
cases:5.68%
controls:0.06%
cases:3.87%
controls:0.14%
72
47
3733
37890
31
19
3777
37943
—
72
0
3736
37962
—
201
20
3338
35377
102
36
2533
25765
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
1.3e+00
1.9e+00
1.9e+00
1.0e+50
3.7e+00
2.6e+00
2.0e+00
cases:5.34%
controls:1.58%
cases:3.26%
controls:0.52%
cases:0.47%
controls:0.07%
cases:2.13%
controls:0.00%
cases:1.72%
controls:0.04%
cases:6.10%
controls:0.47%
cases:11.23%
controls:1.62%
203
601
3602
37336
124
197
3684
37765
18
26
3790
37936
81
0
3727
37962
65
16
3723
37750
216
167
3323
35230
296
419
2339
25382
Preparation of an aid
R5120 [2001310247]
2.4e+00
3.3e+00
—
1.0e+50
—
3.8e+00
3.7e+00
cases:1.92%
controls:0.17%
cases:1.47%
controls:0.06%
—
—
cases:2.60%
controls:0.00%
—
—
cases:2.74%
controls:0.06%
cases:7.02%
controls:0.19%
73
64
3732
37873
56
21
3752
37941
—
99
0
3709
37962
—
97
23
3442
35374
185
49
2450
25752
Loudness discomfort Level (LDL)
DFF30 [2001301650]
2.2e+00
3.6e+00
1.0e+50
1.0e+50
—
3.6e+00
3.6e+00
cases:0.76%
controls:0.09%
cases:0.47%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.60%
controls:0.00%
—
—
cases:0.73%
controls:0.02%
cases:3.04%
controls:0.09%
29
33
3776
37904
18
5
3790
37957
5
0
3803
37962
23
0
3785
37962
—
26
7
3513
35390
80
22
2555
25779
Ear microscopy
UDC00 [2001301558]
1.1e+00
1.9e+00
—
1.0e+50
3.9e+00
3.0e+00
2.3e+00
cases:1.45%
controls:0.47%
cases:0.89%
controls:0.14%
—
—
cases:3.94%
controls:0.00%
cases:0.63%
controls:0.01%
cases:2.35%
controls:0.12%
cases:2.62%
controls:0.28%
55
179
3750
37758
34
52
3774
37910
—
150
0
3658
37962
24
5
3764
37761
83
44
3456
35353
69
72
2566
25729
Speech audiometry
252592009 [4091138]
1.9e+00
3.0e+00
—
1.0e+50
1.0e+50
3.4e+00
3.0e+00
cases:1.21%
controls:0.19%
cases:0.71%
controls:0.03%
—
—
cases:1.39%
controls:0.00%
cases:0.18%
controls:0.00%
cases:1.70%
controls:0.06%
cases:3.34%
controls:0.17%
46
71
3759
37866
27
13
3781
37949
—
53
0
3755
37962
7
0
3781
37766
60
21
3479
35376
88
44
2547
25757
Ear symptom/complaint other
H29 [2002000484]
7.7e-01
2.3e+00
3.4e+00
—
2.4e+00
1.3e+00
9.6e-01
cases:3.02%
controls:1.42%
cases:4.75%
controls:0.48%
cases:1.55%
controls:0.05%
—
—
cases:0.61%
controls:0.06%
cases:1.81%
controls:0.48%
cases:4.40%
controls:1.72%
115
537
3690
37400
181
184
3627
37778
59
19
3749
37943
—
23
21
3765
37745
64
171
3475
35226
116
445
2519
25356
Monitoring the use of the aid
R5140 [2001310249]
1.1e+00
1.4e+00
1.6e+00
1.0e+50
2.6e+00
2.2e+00
2.1e+00
cases:4.78%
controls:1.57%
cases:2.76%
controls:0.67%
cases:0.37%
controls:0.07%
cases:2.02%
controls:0.00%
cases:1.03%
controls:0.08%
cases:4.83%
controls:0.59%
cases:11.20%
controls:1.48%
182
597
3623
37340
105
256
3703
37706
14
27
3794
37935
77
0
3731
37962
39
29
3749
37737
171
208
3368
35189
295
382
2340
25419
fluocinolone acetonide and antiinfectives
S02CA05 [21605177]
1.0e+00
1.5e+00
2.6e+00
—
3.2e+00
1.3e+00
1.1e+00
cases:2.23%
controls:0.80%
cases:1.37%
controls:0.30%
cases:0.24%
controls:0.02%
—
—
cases:0.32%
controls:0.01%
cases:1.24%
controls:0.34%
cases:2.73%
controls:0.91%
85
304
3720
37633
52
115
3756
37847
9
7
3799
37955
—
12
5
3776
37761
44
119
3495
35278
72
235
2563
25566
Impacted cerumen
H61.2 [45562307]
1.1e+00
1.8e+00
3.2e+00
—
2.0e+00
1.5e+00
1.2e+00
cases:2.21%
controls:0.78%
cases:1.84%
controls:0.30%
cases:0.50%
controls:0.02%
—
—
cases:0.34%
controls:0.05%
cases:1.44%
controls:0.33%
cases:3.80%
controls:1.19%
84
295
3721
37642
70
112
3738
37850
19
8
3789
37954
—
13
18
3775
37748
51
118
3488
35279
100
307
2535
25494
Other healthcare associate professional
Z3229 [2001311561]
5.9e-01
1.2e+00
1.4e+00
—
3.7e+00
2.9e+00
2.2e+00
cases:1.55%
controls:0.86%
cases:0.84%
controls:0.26%
cases:0.13%
controls:0.03%
—
—
cases:0.71%
controls:0.02%
cases:4.35%
controls:0.24%
cases:6.57%
controls:0.76%
59
328
3746
37609
32
100
3776
37862
5
12
3803
37950
—
27
7
3761
37759
154
86
3385
35311
173
196
2462
25605
Physical Medicine And Rehabilitation
25 [38004468]
4.6e-01
7.4e-01
7.4e-01
5.3e+00
1.4e+00
9.7e-01
9.1e-01
cases:10.85%
controls:7.13%
cases:4.94%
controls:2.41%
cases:0.89%
controls:0.43%
cases:2.60%
controls:0.01%
cases:1.48%
controls:0.36%
cases:5.88%
controls:2.31%
cases:14.88%
controls:6.54%
413
2706
3392
35231
188
915
3620
37047
34
163
3774
37799
99
5
3709
37957
56
137
3732
37629
208
816
3331
34581
392
1688
2243
24113
Chronic mucoid otitis media
H65.3 [45567124]
2.3e+00
2.5e+00
—
1.0e+50
—
2.8e+00
2.5e+00
cases:0.95%
controls:0.10%
cases:0.45%
controls:0.04%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.59%
controls:0.04%
cases:0.76%
controls:0.07%
36
37
3769
37900
17
14
3791
37948
—
5
0
3803
37962
—
21
13
3518
35384
20
17
2615
25784
Tinnitus
H93.1 [45543152]
1.8e+00
2.9e+00
—
1.0e+50
—
3.2e+00
2.0e+00
cases:1.52%
controls:0.25%
cases:1.63%
controls:0.09%
—
—
cases:1.84%
controls:0.00%
—
—
cases:1.58%
controls:0.06%
cases:2.50%
controls:0.34%
58
94
3747
37843
62
36
3746
37926
—
70
0
3738
37962
—
56
23
3483
35374
66
87
2569
25714
Central perforation of tympanic membrane
H72.0 [45538342]
2.3e+00
2.8e+00
—
1.0e+50
—
3.0e+00
1.6e+00
cases:0.71%
controls:0.07%
cases:0.60%
controls:0.04%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.59%
controls:0.03%
cases:0.68%
controls:0.14%
27
27
3778
37910
23
14
3785
37948
—
7
0
3801
37962
—
21
11
3518
35386
18
35
2617
25766
Other specified counselling
Z71.8 [45581061]
6.8e-01
1.0e+00
1.4e+00
3.6e+00
1.2e+00
9.0e-01
7.9e-01
cases:10.64%
controls:5.69%
cases:8.32%
controls:3.18%
cases:1.84%
controls:0.45%
cases:0.79%
controls:0.02%
cases:1.64%
controls:0.50%
cases:7.94%
controls:3.38%
cases:17.23%
controls:8.64%
405
2158
3400
35779
317
1209
3491
36753
70
171
3738
37791
30
8
3778
37954
62
188
3726
37578
281
1197
3258
34200
454
2229
2181
23572
Inspection, maintenance and instruction for use of hearing aid
SPAT1352 [2001700453]
2.3e+00
2.8e+00
—
—
—
2.5e+00
1.9e+00
cases:0.60%
controls:0.06%
cases:0.21%
controls:0.01%
—
—
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.99%
controls:0.14%
23
22
3782
37915
8
5
3800
37957
—
—
—
10
8
3529
35389
26
37
2609
25764
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
6.9e-01
1.4e+00
1.7e+00
1.0e+50
2.3e+00
2.0e+00
1.5e+00
cases:1.45%
controls:0.73%
cases:1.13%
controls:0.29%
cases:0.21%
controls:0.04%
cases:0.21%
controls:0.00%
cases:0.32%
controls:0.03%
cases:1.70%
controls:0.22%
cases:3.30%
controls:0.76%
55
277
3750
37660
43
110
3765
37852
8
15
3800
37947
8
0
3800
37962
12
12
3776
37754
60
79
3479
35318
87
195
2548
25606
Insertion of ventilating tube through tympanic membrane
DCA20 [2001301563]
1.9e+00
2.4e+00
—
—
—
2.8e+00
2.5e+00
cases:0.60%
controls:0.09%
cases:0.29%
controls:0.03%
—
—
—
—
—
—
cases:0.48%
controls:0.03%
cases:0.76%
controls:0.07%
23
36
3782
37901
11
10
3797
37952
—
—
—
17
10
3522
35387
20
17
2615
25784
Outpatient Visit
OP [9202]
6.5e-01
5.4e-01
6.2e-01
5.0e+00
9.0e-01
9.0e-01
8.2e-01
cases:87.60%
controls:78.68%
cases:70.93%
controls:58.67%
cases:18.96%
controls:11.17%
cases:44.93%
controls:0.54%
cases:23.31%
controls:11.01%
cases:75.13%
controls:55.10%
cases:90.51%
controls:80.80%
3333
29847
472
8090
2701
22274
1107
15688
722
4239
3086
33723
1711
204
2097
37758
883
4158
2905
33608
2659
19503
880
15894
2385
20846
250
4955
Evaluation of communicative skills
R1260 [2001310179]
1.9e+00
2.3e+00
—
1.0e+50
—
2.8e+00
2.4e+00
cases:0.58%
controls:0.09%
cases:0.45%
controls:0.04%
—
—
cases:1.18%
controls:0.00%
—
—
cases:0.42%
controls:0.03%
cases:0.83%
controls:0.07%
22
34
3783
37903
17
17
3791
37945
—
45
0
3763
37962
—
15
9
3524
35388
22
19
2613
25782
Cholesteatoma of middle ear
H71 [45557507]
1.9e+00
2.3e+00
—
1.0e+50
—
2.5e+00
2.8e+00
cases:0.66%
controls:0.10%
cases:0.50%
controls:0.05%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.51%
controls:0.04%
cases:1.06%
controls:0.07%
25
39
3780
37898
19
20
3789
37942
—
9
0
3799
37962
—
18
15
3521
35382
28
17
2607
25784
Otitis externa, unspecified
H60.9 [45605727]
9.1e-01
1.3e+00
2.0e+00
—
2.5e+00
1.4e+00
9.9e-01
cases:1.66%
controls:0.67%
cases:1.00%
controls:0.26%
cases:0.21%
controls:0.03%
—
—
cases:0.26%
controls:0.02%
cases:0.93%
controls:0.24%
cases:2.09%
controls:0.78%
63
255
3742
37682
38
100
3770
37862
8
11
3800
37951
—
10
8
3778
37758
33
84
3506
35313
55
202
2580
25599
General evaluation of the need for rehabilitation
R1100 [2001310172]
3.0e+00
3.3e+00
1.0e+50
1.0e+50
—
—
2.7e+00
cases:1.08%
controls:0.05%
cases:0.74%
controls:0.03%
cases:0.34%
controls:0.00%
cases:1.39%
controls:0.00%
—
—
—
—
cases:1.25%
controls:0.09%
41
20
3764
37917
28
10
3780
37952
13
0
3795
37962
53
0
3755
37962
—
—
33
22
2602
25779
Sleep apnoea
G47.3 [45562094]
4.8e-01
6.0e-01
5.8e-01
5.2e+00
8.0e-01
6.7e-01
6.4e-01
cases:8.07%
controls:5.16%
cases:5.83%
controls:3.28%
cases:1.08%
controls:0.60%
cases:3.10%
controls:0.02%
cases:1.29%
controls:0.59%
cases:5.85%
controls:3.08%
cases:10.28%
controls:5.67%
307
1959
3498
35978
222
1244
3586
36718
41
229
3767
37733
118
7
3690
37955
49
222
3739
37544
207
1089
3332
34308
271
1464
2364
24337
Chronic serous otitis media
H65.2 [45581726]
1.9e+00
2.0e+00
—
1.0e+50
—
3.3e+00
1.7e+00
cases:0.47%
controls:0.07%
cases:0.29%
controls:0.04%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.59%
controls:0.02%
cases:0.46%
controls:0.08%
18
27
3787
37910
11
15
3797
37947
—
7
0
3801
37962
—
21
8
3518
35389
12
21
2623
25780
Emergency Room Visit
ER [9203]
3.3e-01
5.0e-01
9.1e-01
5.0e+00
9.9e-01
4.8e-01
4.9e-01
cases:42.65%
controls:34.76%
cases:18.28%
controls:11.93%
cases:3.62%
controls:1.49%
cases:7.98%
controls:0.06%
cases:4.17%
controls:1.60%
cases:17.66%
controls:11.76%
cases:41.56%
controls:30.25%
1623
13187
2182
24750
696
4527
3112
33435
138
566
3670
37396
304
22
3504
37940
158
603
3630
37163
625
4164
2914
31233
1095
7806
1540
17995
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.3e-01
6.4e-01
8.3e-01
4.2e+00
1.3e+00
6.7e-01
4.2e-01
cases:11.98%
controls:7.39%
cases:5.93%
controls:3.23%
cases:1.10%
controls:0.48%
cases:0.89%
controls:0.01%
cases:1.80%
controls:0.48%
cases:5.74%
controls:3.01%
cases:10.85%
controls:7.40%
456
2805
3349
35132
226
1226
3582
36736
42
183
3766
37779
34
5
3774
37957
68
182
3720
37584
203
1064
3336
34333
286
1910
2349
23891
Sensorineural hearing loss, unspecified
H90.5 [45547994]
1.4e+00
3.4e+00
—
—
—
2.6e+00
2.6e+00
cases:0.21%
controls:0.05%
cases:0.39%
controls:0.01%
—
—
—
—
—
—
cases:0.25%
controls:0.02%
cases:0.57%
controls:0.04%
8
20
3797
37917
15
5
3793
37957
—
—
—
9
7
3530
35390
15
11
2620
25790
Neurology
13 [38004458]
3.8e-01
5.7e-01
7.2e-01
4.7e+00
9.9e-01
6.0e-01
5.9e-01
cases:15.77%
controls:11.34%
cases:7.98%
controls:4.68%
cases:1.60%
controls:0.79%
cases:2.76%
controls:0.03%
cases:2.30%
controls:0.87%
cases:8.28%
controls:4.74%
cases:17.84%
controls:10.75%
600
4302
3205
33635
304
1778
3504
36184
61
299
3747
37663
105
10
3703
37952
87
327
3701
37439
293
1677
3246
33720
470
2774
2165
23027
Emergency Medicine
93 [38004510]
4.2e-01
5.4e-01
8.5e-01
4.7e+00
8.3e-01
5.4e-01
5.5e-01
cases:26.44%
controls:19.06%
cases:16.20%
controls:10.17%
cases:3.31%
controls:1.44%
cases:7.93%
controls:0.08%
cases:3.25%
controls:1.45%
cases:17.15%
controls:10.73%
cases:36.43%
controls:24.88%
1006
7229
2799
30708
617
3860
3191
34102
126
548
3682
37414
302
29
3506
37933
123
546
3665
37220
607
3798
2932
31599
960
6418
1675
19383
Acute suppurative otitis media
H66.0 [45572040]
9.4e-01
1.7e+00
3.1e+00
—
—
1.5e+00
9.5e-01
cases:1.26%
controls:0.50%
cases:0.92%
controls:0.16%
cases:0.29%
controls:0.01%
—
—
—
—
cases:0.65%
controls:0.15%
cases:1.59%
controls:0.62%
48
189
3757
37748
35
62
3773
37900
11
5
3797
37957
—
—
23
52
3516
35345
42
161
2593
25640
boric acid
S02AA03 [21605149]
6.4e-01
1.2e+00
2.1e+00
—
2.1e+00
1.1e+00
9.7e-01
cases:1.94%
controls:1.04%
cases:1.23%
controls:0.36%
cases:0.24%
controls:0.03%
—
—
cases:0.24%
controls:0.03%
cases:0.96%
controls:0.32%
cases:2.81%
controls:1.09%
74
394
3731
37543
47
137
3761
37825
9
11
3799
37951
—
9
11
3779
37755
34
112
3505
35285
74
280
2561
25521
Excessive ear wax
H81 [2002000536]
8.1e-01
1.5e+00
2.7e+00
—
1.5e+00
9.2e-01
6.7e-01
cases:7.33%
controls:3.40%
cases:5.07%
controls:1.15%
cases:2.13%
controls:0.15%
—
—
cases:0.50%
controls:0.12%
cases:2.88%
controls:1.17%
cases:7.17%
controls:3.81%
279
1291
3526
36646
193
436
3615
37526
81
57
3727
37905
—
19
44
3769
37722
102
414
3437
34983
189
983
2446
24818
Pure hypercholesterolaemia
E78.01 [2000501514]
2.2e-01
5.3e-01
9.8e-02
5.3e+00
1.2e+00
6.7e-01
3.6e-01
cases:6.31%
controls:5.15%
cases:4.49%
controls:2.68%
cases:0.58%
controls:0.52%
cases:4.54%
controls:0.02%
cases:1.77%
controls:0.56%
cases:5.65%
controls:2.97%
cases:10.25%
controls:7.41%
240
1953
3565
35984
171
1019
3637
36943
22
199
3786
37763
173
9
3635
37953
67
211
3721
37555
200
1053
3339
34344
270
1911
2365
23890
Asthma, unspecified
J45.9 [45562456]
5.6e-01
6.2e-01
5.1e-01
4.2e+00
1.0e+00
7.3e-01
7.0e-01
cases:6.83%
controls:4.02%
cases:3.73%
controls:2.05%
cases:0.74%
controls:0.44%
cases:1.94%
controls:0.03%
cases:1.14%
controls:0.42%
cases:4.18%
controls:2.06%
cases:8.73%
controls:4.52%
260
1525
3545
36412
142
777
3666
37185
28
168
3780
37794
74
11
3734
37951
43
158
3745
37608
148
729
3391
34668
230
1167
2405
24634
Office Visit
OMOP4822458 [581477]
2.8e-01
7.0e-01
7.1e-01
4.3e+00
1.4e+00
7.4e-01
3.3e-01
cases:11.20%
controls:8.67%
cases:4.39%
controls:2.23%
cases:0.63%
controls:0.31%
cases:1.58%
controls:0.02%
cases:1.29%
controls:0.33%
cases:4.27%
controls:2.08%
cases:8.31%
controls:6.12%
426
3289
3379
34648
167
846
3641
37116
24
118
3784
37844
60
8
3748
37954
49
123
3739
37643
151
736
3388
34661
219
1580
2416
24221
Speech therapy
R4130 [2001310235]
8.8e-01
1.5e+00
—
—
2.5e+00
1.6e+00
1.1e+00
cases:0.58%
controls:0.24%
cases:0.53%
controls:0.12%
—
—
—
—
cases:0.16%
controls:0.01%
cases:0.71%
controls:0.14%
cases:1.14%
controls:0.37%
22
91
3783
37846
20
46
3788
37916
—
—
6
5
3782
37761
25
49
3514
35348
30
95
2605
25706
Otitis media, unspecified
H66.9 [45547965]
1.1e+00
1.9e+00
2.4e+00
—
—
1.4e+00
7.5e-01
cases:1.52%
controls:0.52%
cases:0.76%
controls:0.11%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.51%
controls:0.12%
cases:1.02%
controls:0.49%
58
197
3747
37740
29
43
3779
37919
9
8
3799
37954
—
—
18
43
3521
35354
27
126
2608
25675
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.0e-01
5.7e-01
8.7e-01
3.5e+00
1.1e+00
5.9e-01
4.6e-01
cases:16.08%
controls:10.43%
cases:9.77%
controls:5.74%
cases:2.23%
controls:0.95%
cases:0.79%
controls:0.02%
cases:2.40%
controls:0.83%
cases:10.29%
controls:5.99%
cases:20.15%
controls:13.74%
612
3955
3193
33982
372
2180
3436
35782
85
359
3723
37603
30
9
3778
37953
91
312
3697
37454
364
2119
3175
33278
531
3546
2104
22255
Presbyacusis
H84 [2002000539]
1.3e+00
2.7e+00
2.5e+00
—
—
1.1e+00
1.0e+00
cases:0.97%
controls:0.26%
cases:1.26%
controls:0.08%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.31%
controls:0.10%
cases:0.91%
controls:0.34%
37
98
3768
37839
48
31
3760
37931
11
9
3797
37953
—
—
11
37
3528
35360
24
87
2611
25714
Other specified hearing loss
H91.8 [45533421]
3.3e+00
—
1.0e+50
1.0e+50
—
—
4.1e+00
cases:0.74%
controls:0.03%
—
—
cases:1.65%
controls:0.00%
cases:11.37%
controls:0.00%
—
—
—
—
cases:2.85%
controls:0.05%
28
10
3777
37927
—
63
0
3745
37962
433
0
3375
37962
—
—
75
12
2560
25789
Structured mapping of problematic alcohol use
IHA10 [2001304335]
1.3e+00
2.6e+00
—
—
—
2.4e+00
2.4e+00
cases:0.16%
controls:0.04%
cases:0.18%
controls:0.01%
—
—
—
—
—
—
cases:0.28%
controls:0.03%
cases:0.72%
controls:0.07%
6
17
3799
37920
7
5
3801
37957
—
—
—
10
9
3529
35388
19
17
2616
25784
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
4.3e-01
4.3e-01
7.2e-01
3.9e+00
1.0e+00
5.0e-01
3.9e-01
cases:13.61%
controls:9.28%
cases:7.33%
controls:4.88%
cases:1.58%
controls:0.77%
cases:0.76%
controls:0.02%
cases:1.95%
controls:0.70%
cases:8.00%
controls:4.99%
cases:16.89%
controls:12.07%
518
3522
3287
34415
279
1853
3529
36109
60
294
3748
37668
29
6
3779
37956
74
265
3714
37501
283
1766
3256
33631
445
3113
2190
22688
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
4.0e-01
4.7e-01
9.0e-01
3.7e+00
1.0e+00
5.5e-01
4.1e-01
cases:15.03%
controls:10.65%
cases:7.88%
controls:5.08%
cases:1.89%
controls:0.77%
cases:0.71%
controls:0.02%
cases:1.93%
controls:0.71%
cases:8.36%
controls:5.02%
cases:18.03%
controls:12.75%
572
4040
3233
33897
300
1927
3508
36035
72
294
3736
37668
27
7
3781
37955
73
269
3715
37497
296
1776
3243
33621
475
3290
2160
22511
Otalgia
H92.0 [45596177]
1.3e+00
1.7e+00
2.2e+00
1.0e+50
—
1.1e+00
1.1e+00
cases:1.45%
controls:0.40%
cases:0.87%
controls:0.16%
cases:0.18%
controls:0.02%
cases:0.26%
controls:0.00%
—
—
cases:0.45%
controls:0.16%
cases:1.48%
controls:0.51%
55
153
3750
37784
33
60
3775
37902
7
8
3801
37954
10
0
3798
37962
—
16
55
3523
35342
39
131
2596
25670
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.2e-01
3.5e-01
6.8e-01
4.0e+00
1.2e+00
4.3e-01
2.8e-01
cases:10.70%
controls:8.02%
cases:5.83%
controls:4.16%
cases:1.31%
controls:0.67%
cases:0.71%
controls:0.01%
cases:1.80%
controls:0.57%
cases:6.30%
controls:4.18%
cases:12.87%
controls:10.03%
407
3042
3398
34895
222
1580
3586
36382
50
254
3758
37708
27
5
3781
37957
68
216
3720
37550
223
1479
3316
33918
339
2589
2296
23212
Other infective otitis externa
H60.3 [45576803]
1.4e+00
2.1e+00
—
1.0e+50
—
1.6e+00
2.0e+00
cases:0.58%
controls:0.14%
cases:0.26%
controls:0.03%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.25%
controls:0.05%
cases:0.95%
controls:0.12%
22
54
3783
37883
10
12
3798
37950
—
6
0
3802
37962
—
9
18
3530
35379
25
32
2610
25769
Limited function/disability (H)
H28 [2002000483]
2.0e+00
3.4e+00
—
—
—
1.8e+00
1.6e+00
cases:0.32%
controls:0.04%
cases:0.47%
controls:0.02%
—
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.38%
controls:0.08%
12
16
3793
37921
18
6
3790
37956
—
—
—
5
8
3534
35389
10
20
2625
25781
prednisolone; oral, parenteral
H02AB06 [21602734]
3.4e-01
3.9e-01
6.6e-01
3.7e+00
9.7e-01
4.2e-01
4.8e-01
cases:16.56%
controls:12.35%
cases:8.09%
controls:5.61%
cases:2.21%
controls:1.15%
cases:1.58%
controls:0.04%
cases:2.75%
controls:1.05%
cases:8.14%
controls:5.50%
cases:18.37%
controls:12.17%
630
4684
3175
33253
308
2131
3500
35831
84
436
3724
37526
60
15
3748
37947
104
398
3684
37368
288
1946
3251
33451
484
3140
2151
22661
prednisolone
A07EA01 [21600653]
3.5e-01
3.9e-01
6.6e-01
3.7e+00
9.7e-01
4.2e-01
4.8e-01
cases:16.69%
controls:12.40%
cases:8.11%
controls:5.64%
cases:2.21%
controls:1.15%
cases:1.58%
controls:0.04%
cases:2.75%
controls:1.05%
cases:8.14%
controls:5.52%
cases:18.44%
controls:12.24%
635
4703
3170
33234
309
2142
3499
35820
84
438
3724
37524
60
15
3748
37947
104
398
3684
37368
288
1953
3251
33444
486
3157
2149
22644
Dizziness and giddiness
R42 [45568132]
5.7e-01
8.6e-01
1.9e+00
—
2.0e+00
9.0e-01
7.0e-01
cases:6.94%
controls:4.03%
cases:3.34%
controls:1.44%
cases:0.87%
controls:0.13%
—
—
cases:0.92%
controls:0.12%
cases:3.62%
controls:1.50%
cases:8.73%
controls:4.53%
264
1529
3541
36408
127
545
3681
37417
33
51
3775
37911
—
35
46
3753
37720
128
531
3411
34866
230
1169
2405
24632
Bacteria [Presence] in Urine
87829-8 [36304419]
3.2e-01
4.1e-01
7.1e-01
3.8e+00
1.2e+00
4.1e-01
1.7e-01
cases:10.38%
controls:7.79%
cases:5.75%
controls:3.90%
cases:1.23%
controls:0.61%
cases:0.68%
controls:0.02%
cases:1.74%
controls:0.54%
cases:5.74%
controls:3.87%
cases:11.01%
controls:9.41%
395
2954
3410
34983
219
1480
3589
36482
47
231
3761
37731
26
6
3782
37956
66
203
3722
37563
203
1371
3336
34026
290
2429
2345
23372
mometasone; nasal
R01AD09 [21605051]
4.7e-01
6.3e-01
7.2e-01
2.8e+00
9.8e-01
7.0e-01
5.1e-01
cases:11.75%
controls:7.65%
cases:5.72%
controls:3.13%
cases:1.02%
controls:0.50%
cases:0.21%
controls:0.01%
cases:1.11%
controls:0.42%
cases:5.62%
controls:2.87%
cases:10.63%
controls:6.68%
447
2901
3358
35036
218
1189
3590
36773
39
190
3769
37772
8
5
3800
37957
42
159
3746
37607
199
1015
3340
34382
280
1724
2355
24077
Hematology
82 [38004501]
4.5e-01
6.8e-01
5.2e-01
3.3e+00
9.3e-01
7.0e-01
6.8e-01
cases:2.16%
controls:1.39%
cases:1.68%
controls:0.86%
cases:0.45%
controls:0.27%
cases:0.37%
controls:0.01%
cases:0.69%
controls:0.27%
cases:1.81%
controls:0.91%
cases:2.92%
controls:1.50%
82
526
3723
37411
64
327
3744
37635
17
101
3791
37861
14
5
3794
37957
26
103
3762
37663
64
322
3475
35075
77
386
2558
25415
fluticasone furoate; nasal
R01AD12 [21605053]
4.0e-01
5.7e-01
7.2e-01
3.3e+00
7.9e-01
5.0e-01
4.7e-01
cases:11.54%
controls:8.06%
cases:5.65%
controls:3.29%
cases:1.10%
controls:0.54%
cases:0.42%
controls:0.02%
cases:1.37%
controls:0.63%
cases:5.28%
controls:3.28%
cases:11.42%
controls:7.45%
439
3058
3366
34879
215
1248
3593
36714
42
205
3766
37757
16
6
3792
37956
52
237
3736
37529
187
1161
3352
34236
301
1922
2334
23879
fluticasone; nasal
R01AD08 [21605050]
4.0e-01
5.7e-01
7.2e-01
3.3e+00
7.9e-01
5.0e-01
4.7e-01
cases:11.54%
controls:8.06%
cases:5.65%
controls:3.29%
cases:1.10%
controls:0.54%
cases:0.42%
controls:0.02%
cases:1.37%
controls:0.63%
cases:5.28%
controls:3.28%
cases:11.42%
controls:7.45%
439
3058
3366
34879
215
1248
3593
36714
42
205
3766
37757
16
6
3792
37956
52
237
3736
37529
187
1161
3352
34236
301
1922
2334
23879
Hyperplasia of prostate
N40 [45563015]
2.7e-01
3.8e-01
5.4e-01
4.3e+00
1.0e+00
3.9e-01
3.2e-01
cases:7.60%
controls:5.89%
cases:4.07%
controls:2.81%
cases:0.81%
controls:0.48%
cases:2.31%
controls:0.03%
cases:1.21%
controls:0.44%
cases:4.04%
controls:2.78%
cases:9.49%
controls:7.04%
289
2235
3516
35702
155
1067
3653
36895
31
181
3777
37781
88
12
3720
37950
46
168
3742
37598
143
984
3396
34413
250
1817
2385
23984
Noise effects on inner ear
H83.3 [45552759]
1.7e+00
1.9e+00
—
1.0e+50
—
3.1e+00
1.8e+00
cases:0.24%
controls:0.04%
cases:0.16%
controls:0.02%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.31%
controls:0.01%
cases:0.42%
controls:0.07%
9
16
3796
37921
6
9
3802
37953
—
10
0
3798
37962
—
11
5
3528
35392
11
18
2624
25783
Otosclerosis, unspecified
H80.9 [45581747]
3.4e+00
—
—
1.0e+50
—
—
3.2e+00
cases:0.53%
controls:0.02%
—
—
—
—
cases:0.18%
controls:0.00%
—
—
—
—
cases:0.49%
controls:0.02%
20
7
3785
37930
—
—
7
0
3801
37962
—
—
13
5
2622
25796
Vestibular function test
42987007 [4180728]
1.6e+00
—
—
1.0e+50
—
3.0e+00
1.9e+00
cases:0.24%
controls:0.05%
—
—
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.28%
controls:0.01%
cases:0.38%
controls:0.05%
9
18
3796
37919
—
—
7
0
3801
37962
—
10
5
3529
35392
10
14
2625
25787
Ear pain/earache
H01 [2002000475]
6.4e-01
1.3e+00
3.0e+00
1.0e+50
—
8.7e-01
7.1e-01
cases:2.55%
controls:1.36%
cases:1.42%
controls:0.38%
cases:0.58%
controls:0.03%
cases:0.16%
controls:0.00%
—
—
cases:0.88%
controls:0.37%
cases:2.69%
controls:1.34%
97
517
3708
37420
54
145
3754
37817
22
11
3786
37951
6
0
3802
37962
—
31
130
3508
35267
71
346
2564
25455
Other peripheral vertigo
H81.3 [45543140]
1.3e+00
1.6e+00
—
1.0e+50
—
1.9e+00
1.4e+00
cases:0.74%
controls:0.19%
cases:0.34%
controls:0.07%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.40%
controls:0.06%
cases:0.83%
controls:0.20%
28
73
3777
37864
13
27
3795
37935
—
7
0
3801
37962
—
14
20
3525
35377
22
51
2613
25750
Microalbumin [Mass/volume] in Urine
14957-5 [3000034]
1.2e+00
1.9e+00
—
—
—
1.7e+00
1.5e+00
cases:1.31%
controls:0.40%
cases:0.84%
controls:0.13%
—
—
—
—
—
—
cases:0.68%
controls:0.13%
cases:2.01%
controls:0.43%
50
150
3755
37787
32
50
3776
37912
—
—
—
24
45
3515
35352
53
112
2582
25689
General Practice
1 [38004446]
1.4e-01
1.1e-01
3.8e-01
5.1e+00
8.6e-01
1.0e-01
2.6e-01
cases:19.29%
controls:17.22%
cases:8.19%
controls:7.39%
cases:1.76%
controls:1.21%
cases:3.44%
controls:0.02%
cases:2.82%
controls:1.22%
cases:9.18%
controls:8.37%
cases:25.46%
controls:20.77%
734
6531
3071
31406
312
2804
3496
35158
67
458
3741
37504
131
8
3677
37954
107
459
3681
37307
325
2963
3214
32434
671
5359
1964
20442
Essential (primary) hypertension
I10 [45591453]
1.9e-01
2.9e-01
1.8e-01
4.3e+00
8.7e-01
3.5e-01
2.0e-01
cases:29.67%
controls:25.96%
cases:17.20%
controls:13.41%
cases:3.07%
controls:2.57%
cases:9.74%
controls:0.14%
cases:5.86%
controls:2.53%
cases:19.33%
controls:14.42%
cases:34.50%
controls:30.10%
1129
9848
2676
28089
655
5092
3153
32870
117
977
3691
36985
371
53
3437
37909
222
957
3566
36809
684
5105
2855
30292
909
7767
1726
18034
Hypothyroidism, unspecified
E03.9 [45537945]
2.4e-01
5.9e-01
4.7e-01
4.3e+00
7.5e-01
7.4e-01
5.5e-01
cases:3.31%
controls:2.64%
cases:2.36%
controls:1.33%
cases:0.45%
controls:0.28%
cases:1.65%
controls:0.02%
cases:0.63%
controls:0.30%
cases:2.85%
controls:1.39%
cases:5.81%
controls:3.44%
126
1000
3679
36937
90
505
3718
37457
17
106
3791
37856
63
9
3745
37953
24
113
3764
37653
101
491
3438
34906
153
888
2482
24913
Supplier / Service Provider
OMOP5117446 [33004]
-4.4e-01
-4.5e-01
-1.1e-01
1.7e+00
2.5e+00
1.9e+00
2.5e+00
cases:17.61%
controls:24.86%
cases:4.52%
controls:6.91%
cases:0.63%
controls:0.71%
cases:0.13%
controls:0.02%
cases:0.74%
controls:0.06%
cases:4.15%
controls:0.64%
cases:13.32%
controls:1.22%
670
9432
3135
28505
172
2622
3636
35340
24
268
3784
37694
5
9
3803
37953
28
23
3760
37743
147
226
3392
35171
351
316
2284
25485
Inpatient Hospital
21 [8717]
1.5e-01
2.3e-01
4.4e-01
4.0e+00
5.8e-01
2.4e-01
2.4e-01
cases:33.85%
controls:30.52%
cases:12.47%
controls:10.19%
cases:2.44%
controls:1.59%
cases:2.78%
controls:0.05%
cases:2.82%
controls:1.60%
cases:12.01%
controls:9.66%
cases:27.89%
controls:23.31%
1288
11580
2517
26357
475
3870
3333
34092
93
603
3715
37359
106
20
3702
37942
107
606
3681
37160
425
3420
3114
31977
735
6015
1900
19786
Need for immunization against influenza
Z25.1 [45581017]
7.4e-01
9.9e-01
1.4e+00
—
1.3e+00
1.2e+00
1.4e+00
cases:2.92%
controls:1.41%
cases:2.36%
controls:0.89%
cases:0.32%
controls:0.08%
—
—
cases:0.26%
controls:0.07%
cases:2.66%
controls:0.80%
cases:6.38%
controls:1.66%
111
535
3694
37402
90
337
3718
37625
12
29
3796
37933
—
10
27
3778
37739
94
283
3445
35114
168
429
2467
25372
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
9.0e-01
8.5e-01
9.8e-01
—
1.5e+00
8.8e-01
5.5e-01
cases:9.96%
controls:4.29%
cases:5.28%
controls:2.32%
cases:1.08%
controls:0.41%
—
—
cases:1.53%
controls:0.34%
cases:5.57%
controls:2.39%
cases:10.55%
controls:6.40%
379
1629
3426
36308
201
879
3607
37083
41
155
3767
37807
—
58
129
3730
37637
197
846
3342
34551
278
1651
2357
24150
Remote contact by phone
ZYC01 [2001311579]
7.0e-02
8.9e-01
1.4e+00
—
2.0e+00
1.3e+00
1.5e+00
cases:0.79%
controls:0.74%
cases:0.79%
controls:0.32%
cases:0.21%
controls:0.05%
—
—
cases:0.29%
controls:0.04%
cases:1.22%
controls:0.35%
cases:3.83%
controls:0.88%
30
279
3775
37658
30
123
3778
37839
8
20
3800
37942
—
11
15
3777
37751
43
123
3496
35274
101
226
2534
25575
Emergency Room and Inpatient Visit
ERIP [262]
1.6e-01
2.5e-01
4.7e-01
4.4e+00
9.9e-01
1.2e-01
2.8e-01
cases:9.49%
controls:8.23%
cases:5.33%
controls:4.21%
cases:1.00%
controls:0.63%
cases:1.44%
controls:0.02%
cases:1.61%
controls:0.61%
cases:5.31%
controls:4.75%
cases:16.02%
controls:12.60%
361
3121
3444
34816
203
1597
3605
36365
38
238
3770
37724
55
7
3753
37955
61
229
3727
37537
188
1682
3351
33715
422
3251
2213
22550
Senile nuclear cataract
H25.1 [45581628]
2.8e-01
3.6e-01
-1.9e-01
3.8e+00
7.0e-01
3.3e-01
4.7e-01
cases:8.20%
controls:6.32%
cases:3.20%
controls:2.27%
cases:0.32%
controls:0.38%
cases:1.52%
controls:0.03%
cases:0.87%
controls:0.43%
cases:3.28%
controls:2.37%
cases:9.60%
controls:6.21%
312
2398
3493
35539
122
861
3686
37101
12
145
3796
37817
58
13
3750
37949
33
164
3755
37602
116
838
3423
34559
253
1601
2382
24200
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
2.2e-01
4.2e-01
5.5e-01
3.6e+00
6.2e-01
4.1e-01
3.2e-01
cases:9.88%
controls:8.07%
cases:5.12%
controls:3.41%
cases:0.95%
controls:0.55%
cases:1.26%
controls:0.03%
cases:1.06%
controls:0.57%
cases:5.17%
controls:3.49%
cases:10.78%
controls:8.08%
376
3060
3429
34877
195
1295
3613
36667
36
207
3772
37755
48
13
3760
37949
40
215
3748
37551
183
1235
3356
34162
284
2084
2351
23717
Case Management Agency
251B00000X [38004193]
7.6e-02
2.3e-01
6.8e-01
3.7e+00
5.1e-01
2.3e-01
2.9e-01
cases:73.75%
controls:72.25%
cases:71.06%
controls:66.09%
cases:44.20%
controls:28.69%
cases:43.99%
controls:1.99%
cases:40.50%
controls:28.98%
cases:72.05%
controls:67.29%
cases:87.06%
controls:83.41%
2806
27411
999
10526
2706
25088
1102
12874
1683
10893
2125
27069
1675
757
2133
37205
1534
10946
2254
26820
2550
23818
989
11579
2294
21521
341
4280
Plugged feeling ear
H13 [2002000480]
4.3e-01
1.3e+00
2.7e+00
—
8.4e-01
5.2e-01
5.8e-01
cases:5.44%
controls:3.62%
cases:4.44%
controls:1.21%
cases:1.81%
controls:0.13%
—
—
cases:0.32%
controls:0.14%
cases:2.09%
controls:1.25%
cases:7.13%
controls:4.12%
207
1372
3598
36565
169
460
3639
37502
69
49
3739
37913
—
12
52
3776
37714
74
442
3465
34955
188
1063
2447
24738
Other specified prophylactic measures
Z29.8 [45537623]
1.4e+00
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:1.05%
controls:0.27%
cases:0.55%
controls:0.14%
—
—
—
—
—
—
cases:0.48%
controls:0.15%
cases:1.78%
controls:0.37%
40
103
3765
37834
21
52
3787
37910
—
—
—
17
53
3522
35344
47
95
2588
25706
Removal wax from ear
TDA90 [2001301543]
—
1.9e+00
—
—
—
2.8e+00
2.7e+00
—
—
cases:0.16%
controls:0.02%
—
—
—
—
—
—
cases:0.23%
controls:0.01%
cases:0.53%
controls:0.03%
—
6
9
3802
37953
—
—
—
8
5
3531
35392
14
9
2621
25792
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.8e-01
4.0e-01
4.8e-01
2.7e+00
9.0e-01
3.1e-01
4.6e-01
cases:16.37%
controls:14.01%
cases:10.14%
controls:7.06%
cases:1.89%
controls:1.18%
cases:0.53%
controls:0.03%
cases:2.53%
controls:1.05%
cases:9.16%
controls:6.86%
cases:22.28%
controls:15.38%
623
5314
3182
32623
386
2679
3422
35283
72
448
3736
37514
20
13
3788
37949
96
397
3692
37369
324
2429
3215
32968
587
3967
2048
21834
Other therapy enhancing rehabilitation
R4160 [2001310240]
1.1e+00
—
—
—
—
3.1e+00
2.3e+00
cases:0.24%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.01%
cases:0.61%
controls:0.06%
9
30
3796
37907
—
—
—
—
11
5
3528
35392
16
16
2619
25785
Pulmonary Disease
29 [38004472]
3.7e-01
4.0e-01
1.0e-01
3.7e+00
3.0e-01
3.6e-01
5.5e-01
cases:14.64%
controls:10.59%
cases:7.90%
controls:5.44%
cases:1.08%
controls:0.97%
cases:1.37%
controls:0.03%
cases:1.32%
controls:0.98%
cases:7.32%
controls:5.25%
cases:16.81%
controls:10.46%
557
4019
3248
33918
301
2066
3507
35896
41
370
3767
37592
52
13
3756
37949
50
370
3738
37396
259
1857
3280
33540
443
2700
2192
23101
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.4e-01
4.4e-01
6.5e-01
2.7e+00
6.2e-01
3.8e-01
2.4e-01
cases:41.00%
controls:33.05%
cases:35.95%
controls:26.63%
cases:11.27%
controls:6.21%
cases:4.99%
controls:0.36%
cases:10.48%
controls:5.95%
cases:34.93%
controls:26.87%
cases:46.30%
controls:40.48%
1560
12539
2245
25398
1369
10109
2439
27853
429
2357
3379
35605
190
135
3618
37827
397
2246
3391
35520
1236
9512
2303
25885
1220
10444
1415
15357
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
8.2e-02
1.9e-01
5.8e-01
3.3e+00
8.8e-01
1.7e-01
3.2e-01
cases:18.98%
controls:17.74%
cases:9.77%
controls:8.19%
cases:2.07%
controls:1.17%
cases:1.26%
controls:0.04%
cases:2.30%
controls:0.97%
cases:9.24%
controls:7.92%
cases:25.84%
controls:20.17%
722
6730
3083
31207
372
3110
3436
34852
79
443
3729
37519
48
17
3760
37945
87
365
3701
37401
327
2805
3212
32592
681
5203
1954
20598
Rehabilitation for hearing problems
R4135 [2001310236]
1.9e+00
—
—
1.0e+50
—
—
3.4e+00
cases:0.26%
controls:0.04%
—
—
—
—
cases:0.42%
controls:0.00%
—
—
—
—
cases:1.02%
controls:0.03%
10
15
3795
37922
—
—
16
0
3792
37962
—
—
27
9
2608
25792
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.3e-01
2.7e-01
6.0e-01
2.9e+00
7.6e-01
3.4e-01
3.1e-01
cases:41.63%
controls:38.59%
cases:29.44%
controls:24.08%
cases:8.61%
controls:4.91%
cases:5.88%
controls:0.36%
cases:9.61%
controls:4.73%
cases:31.05%
controls:24.23%
cases:51.76%
controls:44.16%
1584
14638
2221
23299
1121
9142
2687
28820
328
1864
3480
36098
224
135
3584
37827
364
1786
3424
35980
1099
8576
2440
26821
1364
11395
1271
14406
Education on PEF monitoring
XG405 [2001303851]
1.5e+00
2.0e+00
—
—
—
1.2e+00
1.8e+00
cases:0.47%
controls:0.11%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.14%
controls:0.04%
cases:0.57%
controls:0.10%
18
40
3787
37897
8
11
3800
37951
—
—
—
5
15
3534
35382
15
25
2620
25776
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.7e-01
2.3e-01
5.3e-01
3.2e+00
1.2e+00
4.2e-01
4.2e-01
cases:7.12%
controls:6.08%
cases:3.05%
controls:2.44%
cases:0.58%
controls:0.34%
cases:0.32%
controls:0.01%
cases:0.87%
controls:0.26%
cases:3.08%
controls:2.04%
cases:8.69%
controls:5.90%
271
2305
3534
35632
116
925
3692
37037
22
129
3786
37833
12
5
3796
37957
33
99
3755
37667
109
723
3430
34674
229
1521
2406
24280
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.7e-01
2.5e-01
6.3e-01
2.9e+00
6.9e-01
2.9e-01
2.4e-01
cases:24.76%
controls:21.73%
cases:13.37%
controls:10.69%
cases:3.15%
controls:1.71%
cases:0.89%
controls:0.05%
cases:3.14%
controls:1.60%
cases:13.65%
controls:10.59%
cases:29.11%
controls:24.44%
942
8245
2863
29692
509
4059
3299
33903
120
649
3688
37313
34
18
3774
37944
119
605
3669
37161
483
3750
3056
31647
767
6306
1868
19495
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
8.3e-01
8.2e-01
1.4e+00
—
1.7e+00
9.8e-01
8.2e-01
cases:1.87%
controls:0.82%
cases:0.71%
controls:0.31%
cases:0.16%
controls:0.04%
—
—
cases:0.24%
controls:0.04%
cases:0.79%
controls:0.30%
cases:1.97%
controls:0.88%
71
311
3734
37626
27
119
3781
37843
6
15
3802
37947
—
9
16
3779
37750
28
106
3511
35291
52
226
2583
25575
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
4.1e-01
5.5e-01
1.3e+00
—
1.4e+00
7.9e-01
6.8e-01
cases:2.44%
controls:1.63%
cases:1.31%
controls:0.76%
cases:0.34%
controls:0.09%
—
—
cases:0.32%
controls:0.08%
cases:1.86%
controls:0.86%
cases:4.17%
controls:2.16%
93
618
3712
37319
50
288
3758
37674
13
35
3795
37927
—
12
29
3776
37737
66
303
3473
35094
110
557
2525
25244
No disease
A97 [2002000230]
3.2e-01
1.0e+00
1.5e+00
—
9.5e-01
9.0e-01
4.2e-01
cases:4.07%
controls:3.00%
cases:3.57%
controls:1.29%
cases:0.81%
controls:0.18%
—
—
cases:0.45%
controls:0.17%
cases:3.39%
controls:1.41%
cases:6.45%
controls:4.32%
155
1139
3650
36798
136
489
3672
37473
31
70
3777
37892
—
17
66
3771
37700
120
498
3419
34899
170
1114
2465
24687
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.0e-01
2.0e-01
6.3e-01
2.8e+00
1.1e+00
5.2e-01
4.8e-01
cases:10.07%
controls:8.39%
cases:4.02%
controls:3.32%
cases:0.81%
controls:0.43%
cases:0.39%
controls:0.02%
cases:1.06%
controls:0.36%
cases:4.52%
controls:2.74%
cases:12.11%
controls:7.82%
383
3182
3422
34755
153
1262
3655
36700
31
165
3777
37797
15
9
3793
37953
40
137
3748
37629
160
969
3379
34428
319
2017
2316
23784
Orthopedic Surgery
20 [38004465]
2.8e-01
4.3e-01
3.1e-01
3.2e+00
4.5e-01
3.5e-01
3.6e-01
cases:22.00%
controls:17.53%
cases:10.01%
controls:6.76%
cases:1.52%
controls:1.12%
cases:1.23%
controls:0.05%
cases:1.87%
controls:1.21%
cases:8.96%
controls:6.46%
cases:22.62%
controls:17.00%
837
6652
2968
31285
381
2567
3427
35395
58
424
3750
37538
47
19
3761
37943
71
456
3717
37310
317
2288
3222
33109
596
4387
2039
21414
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
4.3e-02
3.9e-01
5.2e-01
3.9e+00
6.5e-01
4.1e-01
3.3e-01
cases:6.23%
controls:5.98%
cases:3.28%
controls:2.24%
cases:0.60%
controls:0.36%
cases:1.08%
controls:0.02%
cases:0.71%
controls:0.37%
cases:3.50%
controls:2.35%
cases:9.79%
controls:7.22%
237
2269
3568
35668
125
851
3683
37111
23
137
3785
37825
41
8
3767
37954
27
141
3761
37625
124
832
3415
34565
258
1863
2377
23938
Thorax X-ray examination
GD1AA [2001303617]
-1.7e-03
3.0e-01
4.4e-01
4.2e+00
4.5e-01
2.9e-01
3.1e-01
cases:11.12%
controls:11.13%
cases:5.88%
controls:4.44%
cases:0.71%
controls:0.46%
cases:1.34%
controls:0.02%
cases:0.87%
controls:0.56%
cases:5.48%
controls:4.14%
cases:15.45%
controls:11.78%
423
4224
3382
33713
224
1687
3584
36275
27
174
3781
37788
51
8
3757
37954
33
211
3755
37555
194
1467
3345
33930
407
3040
2228
22761
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
8.5e-01
8.5e-01
1.4e+00
—
1.9e+00
8.4e-01
6.5e-01
cases:1.71%
controls:0.74%
cases:0.68%
controls:0.29%
cases:0.16%
controls:0.04%
—
—
cases:0.24%
controls:0.04%
cases:0.62%
controls:0.27%
cases:1.52%
controls:0.79%
65
281
3740
37656
26
111
3782
37851
6
15
3802
37947
—
9
14
3779
37752
22
95
3517
35302
40
205
2595
25596
Other difficulties with micturition
R39.1 [45534441]
1.1e+00
1.2e+00
—
—
—
1.3e+00
1.4e+00
cases:1.18%
controls:0.40%
cases:0.50%
controls:0.15%
—
—
—
—
—
—
cases:0.57%
controls:0.15%
cases:1.86%
controls:0.47%
45
151
3760
37786
19
56
3789
37906
—
—
—
20
54
3519
35343
49
120
2586
25681
Counselling and guidance concerning rehabilitation services and social security
R2120 [2001310195]
2.1e+00
—
—
—
—
—
2.9e+00
cases:0.39%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.05%
15
18
3790
37919
—
—
—
—
—
24
13
2611
25788
Short time oxymetry
XG460 [2001303865]
1.7e+00
1.8e+00
—
—
—
—
1.5e+00
cases:0.63%
controls:0.11%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.12%
24
43
3781
37894
8
13
3800
37949
—
—
—
—
14
32
2621
25769
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
5.5e-01
9.9e-01
1.7e+00
—
—
6.3e-01
1.1e+00
cases:3.63%
controls:2.12%
cases:1.71%
controls:0.64%
cases:0.24%
controls:0.04%
—
—
—
—
cases:0.99%
controls:0.53%
cases:3.26%
controls:1.08%
138
806
3667
37131
65
243
3743
37719
9
17
3799
37945
—
—
35
188
3504
35209
86
278
2549
25523
FEV1 --post bronchodilation
20155-8 [3023550]
5.5e-01
9.9e-01
1.7e+00
—
—
6.3e-01
1.1e+00
cases:3.63%
controls:2.12%
cases:1.71%
controls:0.64%
cases:0.24%
controls:0.04%
—
—
—
—
cases:0.99%
controls:0.53%
cases:3.26%
controls:1.08%
138
806
3667
37131
65
243
3743
37719
9
17
3799
37945
—
—
35
188
3504
35209
86
278
2549
25523
FEV1 percent change
69983-5 [42868472]
5.5e-01
9.9e-01
1.7e+00
—
—
6.3e-01
1.1e+00
cases:3.63%
controls:2.12%
cases:1.71%
controls:0.64%
cases:0.24%
controls:0.04%
—
—
—
—
cases:0.99%
controls:0.53%
cases:3.26%
controls:1.08%
138
806
3667
37131
65
243
3743
37719
9
17
3799
37945
—
—
35
188
3504
35209
86
278
2549
25523
FEV1/FVC --post bronchodilation
69970-2 [42868459]
5.5e-01
9.9e-01
1.7e+00
—
—
6.3e-01
1.1e+00
cases:3.63%
controls:2.12%
cases:1.71%
controls:0.64%
cases:0.24%
controls:0.04%
—
—
—
—
cases:0.99%
controls:0.53%
cases:3.26%
controls:1.08%
138
806
3667
37131
65
243
3743
37719
9
17
3799
37945
—
—
35
188
3504
35209
86
278
2549
25523
FVC percent change Respiratory system
69982-7 [42868471]
5.5e-01
9.9e-01
1.7e+00
—
—
6.3e-01
1.1e+00
cases:3.63%
controls:2.12%
cases:1.71%
controls:0.64%
cases:0.24%
controls:0.04%
—
—
—
—
cases:0.99%
controls:0.53%
cases:3.26%
controls:1.08%
138
806
3667
37131
65
243
3743
37719
9
17
3799
37945
—
—
35
188
3504
35209
86
278
2549
25523
Diffusion capacity of lung
54715006 [4182985]
1.1e+00
1.1e+00
—
—
—
1.4e+00
1.3e+00
cases:1.13%
controls:0.37%
cases:0.37%
controls:0.12%
—
—
—
—
—
—
cases:0.42%
controls:0.10%
cases:1.40%
controls:0.40%
43
139
3762
37798
14
47
3794
37915
—
—
—
15
37
3524
35360
37
102
2598
25699
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
5.0e-01
6.4e-01
—
—
2.2e+00
8.5e-01
6.6e-01
cases:2.39%
controls:1.47%
cases:1.02%
controls:0.54%
—
—
—
—
cases:0.40%
controls:0.04%
cases:1.27%
controls:0.55%
cases:3.38%
controls:1.78%
91
558
3714
37379
39
206
3769
37756
—
—
15
16
3773
37750
45
193
3494
35204
89
460
2546
25341
Issue of repeat prescription
Z76.0 [45542456]
7.4e-01
8.9e-01
9.4e-01
—
8.3e-01
8.0e-01
6.7e-01
cases:6.60%
controls:3.24%
cases:4.65%
controls:1.97%
cases:0.76%
controls:0.30%
—
—
cases:0.74%
controls:0.32%
cases:5.26%
controls:2.44%
cases:11.92%
controls:6.48%
251
1231
3554
36706
177
746
3631
37216
29
113
3779
37849
—
28
122
3760
37644
186
863
3353
34534
314
1673
2321
24128
Tension-type headache
G44.2 [45581495]
5.7e-01
9.1e-01
1.8e+00
—
1.4e+00
9.2e-01
6.4e-01
cases:2.50%
controls:1.42%
cases:0.97%
controls:0.40%
cases:0.26%
controls:0.04%
—
—
cases:0.24%
controls:0.06%
cases:1.10%
controls:0.44%
cases:2.81%
controls:1.50%
95
539
3710
37398
37
150
3771
37812
10
16
3798
37946
—
9
23
3779
37743
39
156
3500
35241
74
388
2561
25413
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
5.0e-01
6.6e-01
—
—
2.2e+00
8.4e-01
6.3e-01
cases:2.37%
controls:1.44%
cases:1.08%
controls:0.56%
—
—
—
—
cases:0.40%
controls:0.04%
cases:1.30%
controls:0.57%
cases:3.38%
controls:1.83%
90
548
3715
37389
41
212
3767
37750
—
—
15
16
3773
37750
46
201
3493
35196
89
472
2546
25329
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
5.0e-01
6.2e-01
—
—
2.3e+00
8.2e-01
6.0e-01
cases:2.39%
controls:1.46%
cases:1.05%
controls:0.57%
—
—
—
—
cases:0.40%
controls:0.04%
cases:1.27%
controls:0.57%
cases:3.42%
controls:1.90%
91
555
3714
37382
40
215
3768
37747
—
—
15
15
3773
37751
45
200
3494
35197
90
490
2545
25311
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
4.2e-01
7.4e-01
1.1e+00
1.0e+50
3.7e+00
6.2e-01
2.3e-01
cases:2.16%
controls:1.42%
cases:0.79%
controls:0.38%
cases:0.13%
controls:0.04%
cases:0.32%
controls:0.00%
cases:0.82%
controls:0.02%
cases:0.65%
controls:0.35%
cases:1.59%
controls:1.28%
82
540
3723
37397
30
143
3778
37819
5
16
3803
37946
12
0
3796
37962
31
8
3757
37758
23
124
3516
35273
42
329
2593
25472
Atherosclerotic heart disease
I25.1 [45596196]
1.5e-01
3.1e-01
3.5e-01
3.6e+00
6.7e-01
2.5e-01
2.6e-01
cases:8.78%
controls:7.67%
cases:5.25%
controls:3.92%
cases:1.13%
controls:0.80%
cases:1.68%
controls:0.05%
cases:1.53%
controls:0.79%
cases:5.34%
controls:4.21%
cases:11.50%
controls:9.09%
334
2909
3471
35028
200
1490
3608
36472
43
303
3765
37659
64
18
3744
37944
58
299
3730
37467
189
1490
3350
33907
303
2345
2332
23456
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.3e-02
1.2e-01
5.7e-01
2.7e+00
8.8e-01
3.3e-01
3.1e-01
cases:12.69%
controls:12.33%
cases:5.20%
controls:4.65%
cases:1.08%
controls:0.61%
cases:0.47%
controls:0.03%
cases:1.21%
controls:0.51%
cases:5.48%
controls:4.02%
cases:15.56%
controls:11.87%
483
4679
3322
33258
198
1764
3610
36198
41
232
3767
37730
18
12
3790
37950
46
192
3742
37574
194
1422
3345
33975
410
3063
2225
22738
Upper gastrointestinal surgery
106 [44777669]
2.1e-01
2.4e-01
5.4e-01
3.2e+00
6.0e-01
3.6e-01
4.5e-01
cases:13.88%
controls:11.52%
cases:5.75%
controls:4.59%
cases:1.16%
controls:0.68%
cases:0.55%
controls:0.02%
cases:1.21%
controls:0.67%
cases:6.19%
controls:4.40%
cases:16.36%
controls:11.08%
528
4371
3277
33566
219
1743
3589
36219
44
258
3764
37704
21
9
3787
37953
46
252
3742
37514
219
1558
3320
33839
431
2859
2204
22942
Person consulting for explanation of investigation findings
Z71.2 [45552100]
7.6e-01
8.5e-01
8.6e-01
—
9.7e-01
8.1e-01
5.1e-01
cases:11.12%
controls:5.51%
cases:5.44%
controls:2.39%
cases:0.74%
controls:0.31%
—
—
cases:0.84%
controls:0.32%
cases:5.54%
controls:2.54%
cases:10.59%
controls:6.66%
423
2089
3382
35848
207
907
3601
37055
28
119
3780
37843
—
32
122
3756
37644
196
898
3343
34499
279
1719
2356
24082
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.4 [45572067]
—
—
1.0e+50
1.0e+50
—
—
4.8e+00
—
—
—
—
cases:0.18%
controls:0.00%
cases:1.21%
controls:0.00%
—
—
—
—
cases:2.62%
controls:0.02%
—
—
7
0
3801
37962
46
0
3762
37962
—
—
69
6
2566
25795
Headache
R51.80 [2000503603]
6.7e-01
8.7e-01
1.2e+00
1.0e+50
1.6e+00
7.8e-01
8.0e-01
cases:3.29%
controls:1.71%
cases:1.18%
controls:0.50%
cases:0.18%
controls:0.06%
cases:0.29%
controls:0.00%
cases:0.24%
controls:0.05%
cases:0.93%
controls:0.43%
cases:3.80%
controls:1.74%
125
647
3680
37290
45
189
3763
37773
7
22
3801
37940
11
0
3797
37962
9
18
3779
37748
33
152
3506
35245
100
448
2535
25353
Rheumatology
66 [38004491]
3.6e-01
3.8e-01
7.3e-01
2.7e+00
5.4e-01
3.2e-01
5.0e-01
cases:5.23%
controls:3.69%
cases:2.97%
controls:2.05%
cases:0.74%
controls:0.36%
cases:0.34%
controls:0.02%
cases:0.63%
controls:0.37%
cases:2.68%
controls:1.96%
cases:5.16%
controls:3.19%
199
1400
3606
36537
113
777
3695
37185
28
135
3780
37827
13
9
3795
37953
24
140
3764
37626
95
693
3444
34704
136
823
2499
24978
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.2e-01
8.9e-01
—
1.0e+50
1.9e+00
1.1e+00
7.8e-01
cases:0.95%
controls:0.84%
cases:0.63%
controls:0.26%
—
—
cases:0.21%
controls:0.00%
cases:0.21%
controls:0.03%
cases:0.65%
controls:0.22%
cases:1.52%
controls:0.70%
36
318
3769
37619
24
99
3784
37863
—
8
0
3800
37962
8
12
3780
37754
23
78
3516
35319
40
181
2595
25620
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.4e-01
3.2e-01
4.8e-01
2.6e+00
7.7e-01
2.1e-01
2.9e-01
cases:17.58%
controls:15.68%
cases:10.87%
controls:8.10%
cases:2.21%
controls:1.38%
cases:0.58%
controls:0.04%
cases:2.75%
controls:1.29%
cases:9.78%
controls:8.10%
cases:22.54%
controls:17.85%
669
5950
3136
31987
414
3075
3394
34887
84
522
3724
37440
22
17
3786
37945
104
489
3684
37277
346
2866
3193
32531
594
4606
2041
21195
Cardiology
6 [38004451]
2.0e-01
3.1e-01
1.3e-01
2.9e+00
4.7e-01
3.1e-01
3.9e-01
cases:17.82%
controls:15.08%
cases:9.45%
controls:7.12%
cases:1.34%
controls:1.17%
cases:0.89%
controls:0.05%
cases:1.69%
controls:1.06%
cases:9.30%
controls:6.97%
cases:20.95%
controls:15.21%
678
5722
3127
32215
360
2704
3448
35258
51
446
3757
37516
34
18
3774
37944
64
402
3724
37364
329
2468
3210
32929
552
3924
2083
21877
Suppurative otitis media, unspecified
H66.4 [45547964]
2.3e+00
—
—
—
—
—
2.3e+00
cases:0.32%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.04%
12
12
3793
37925
—
—
—
—
—
11
11
2624
25790
Internal Medicine
11 [38004456]
1.5e-01
1.6e-01
4.6e-01
3.3e+00
4.4e-01
2.3e-01
1.1e-01
cases:27.57%
controls:24.62%
cases:11.19%
controls:9.69%
cases:2.34%
controls:1.49%
cases:1.76%
controls:0.07%
cases:2.43%
controls:1.58%
cases:11.56%
controls:9.42%
cases:24.21%
controls:22.17%
1049
9340
2756
28597
426
3678
3382
34284
89
565
3719
37397
67
25
3741
37937
92
595
3696
37171
409
3336
3130
32061
638
5721
1997
20080
Epilepsy, unspecified
G40.9 [45562083]
3.8e-01
1.1e+00
—
—
1.7e+00
1.1e+00
7.4e-01
cases:0.66%
controls:0.45%
cases:0.63%
controls:0.22%
—
—
—
—
cases:0.24%
controls:0.05%
cases:0.68%
controls:0.23%
cases:1.06%
controls:0.51%
25
171
3780
37766
24
83
3784
37879
—
—
9
17
3779
37749
24
80
3515
35317
28
131
2607
25670
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
3.1e-01
7.8e-01
1.3e+00
1.0e+50
3.8e+00
5.0e-01
3.3e-01
cases:1.79%
controls:1.31%
cases:0.74%
controls:0.34%
cases:0.13%
controls:0.03%
cases:0.32%
controls:0.00%
cases:0.79%
controls:0.02%
cases:0.57%
controls:0.34%
cases:1.59%
controls:1.15%
68
498
3737
37439
28
128
3780
37834
5
13
3803
37949
12
0
3796
37962
30
7
3758
37759
20
121
3519
35276
42
298
2593
25503
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.8e-01
2.6e-01
5.4e-01
2.8e+00
5.7e-01
2.1e-01
1.3e-01
cases:39.11%
controls:34.92%
cases:35.03%
controls:29.30%
cases:10.37%
controls:6.32%
cases:5.07%
controls:0.33%
cases:10.40%
controls:6.17%
cases:34.28%
controls:29.74%
cases:47.10%
controls:43.85%
1488
13246
2317
24691
1334
11121
2474
26841
395
2398
3413
35564
193
126
3615
37836
394
2329
3394
35437
1213
10526
2326
24871
1241
11315
1394
14486
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.7e-01
3.1e-01
5.7e-01
2.6e+00
5.6e-01
2.8e-01
-4.1e-03
cases:40.92%
controls:36.81%
cases:34.64%
controls:28.02%
cases:10.29%
controls:6.10%
cases:5.04%
controls:0.38%
cases:10.14%
controls:6.05%
cases:34.02%
controls:27.99%
cases:43.72%
controls:43.82%
1557
13964
2248
23973
1319
10638
2489
27324
392
2316
3416
35646
192
146
3616
37816
384
2283
3404
35483
1204
9907
2335
25490
1152
11306
1483
14495
Mixed asthma
J45.8 [45548118]
8.9e-01
1.2e+00
-1.0e+50
—
—
1.3e+00
1.0e+00
cases:0.81%
controls:0.33%
cases:0.37%
controls:0.11%
cases:0.00%
controls:0.02%
—
—
—
—
cases:0.42%
controls:0.11%
cases:0.76%
controls:0.27%
31
127
3774
37810
14
41
3794
37921
0
9
3808
37953
—
—
15
40
3524
35357
20
70
2615
25731
Medical assessment of need and possibilities to rehabilitation
R1210 [2001310174]
1.6e+00
—
—
—
—
—
2.9e+00
cases:0.21%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.03%
8
16
3797
37921
—
—
—
—
—
16
9
2619
25792
Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]
2.6e-01
1.1e+00
2.6e+00
—
4.9e-01
5.2e-01
3.1e-01
cases:5.36%
controls:4.19%
cases:3.20%
controls:1.14%
cases:1.73%
controls:0.13%
—
—
cases:0.24%
controls:0.15%
cases:1.84%
controls:1.10%
cases:4.97%
controls:3.68%
204
1588
3601
36349
122
432
3686
37530
66
49
3742
37913
—
9
55
3779
37711
65
391
3474
35006
131
949
2504
24852
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
5.1e-01
8.7e-01
—
—
1.7e+00
6.4e-01
7.2e-01
cases:3.34%
controls:2.04%
cases:1.92%
controls:0.81%
—
—
—
—
cases:0.48%
controls:0.09%
cases:1.70%
controls:0.90%
cases:5.54%
controls:2.78%
127
774
3678
37163
73
307
3735
37655
—
—
18
33
3770
37733
60
319
3479
35078
146
716
2489
25085
Aortic (valve) stenosis
I35.0 [45576869]
4.3e-02
3.4e-01
6.2e-01
3.3e+00
1.1e+00
-1.0e-02
2.4e-01
cases:1.84%
controls:1.76%
cases:1.42%
controls:1.01%
cases:0.37%
controls:0.20%
cases:0.58%
controls:0.02%
cases:0.55%
controls:0.18%
cases:1.07%
controls:1.08%
cases:2.50%
controls:1.98%
70
669
3735
37268
54
384
3754
37578
14
75
3794
37887
22
8
3786
37954
21
69
3767
37697
38
384
3501
35013
66
510
2569
25291
Sequelae of cerebral infarction
I69.3 [45533476]
8.3e-02
4.4e-01
3.8e-01
3.4e+00
1.0e+00
3.8e-01
3.2e-01
cases:1.66%
controls:1.53%
cases:1.31%
controls:0.85%
cases:0.26%
controls:0.18%
cases:0.63%
controls:0.02%
cases:0.55%
controls:0.20%
cases:1.58%
controls:1.09%
cases:3.45%
controls:2.53%
63
579
3742
37358
50
321
3758
37641
10
68
3798
37894
24
8
3784
37954
21
77
3767
37689
56
385
3483
35012
91
654
2544
25147
Fitting and adjustment of other specified devices
Z46.8 [45581035]
6.7e-01
1.5e+00
—
—
—
1.3e+00
1.6e+00
cases:0.66%
controls:0.34%
cases:0.74%
controls:0.17%
—
—
—
—
—
—
cases:0.54%
controls:0.15%
cases:2.24%
controls:0.44%
25
128
3780
37809
28
64
3780
37898
—
—
—
19
53
3520
35344
59
114
2576
25687
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
3.3e-02
6.5e-02
2.6e-01
3.8e+00
6.0e-01
1.3e-01
9.2e-02
cases:8.15%
controls:7.91%
cases:4.57%
controls:4.29%
cases:1.10%
controls:0.86%
cases:2.52%
controls:0.06%
cases:1.40%
controls:0.77%
cases:5.14%
controls:4.54%
cases:10.13%
controls:9.32%
310
2999
3495
34938
174
1630
3634
36332
42
325
3766
37637
96
22
3712
37940
53
292
3735
37474
182
1606
3357
33791
267
2405
2368
23396
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
7.2e-01
7.2e-01
1.2e+00
—
1.6e+00
6.9e-01
6.1e-01
cases:2.13%
controls:1.05%
cases:0.89%
controls:0.44%
cases:0.21%
controls:0.06%
—
—
cases:0.34%
controls:0.07%
cases:0.88%
controls:0.44%
cases:2.20%
controls:1.21%
81
399
3724
37538
34
166
3774
37796
8
24
3800
37938
—
13
25
3775
37741
31
156
3508
35241
58
313
2577
25488
Psychiatry
26 [38004469]
2.9e-01
4.1e-01
4.1e-01
2.4e+00
4.3e-01
5.4e-01
7.3e-01
cases:5.31%
controls:4.03%
cases:2.68%
controls:1.80%
cases:0.87%
controls:0.58%
cases:0.53%
controls:0.05%
cases:0.95%
controls:0.62%
cases:3.00%
controls:1.76%
cases:7.17%
controls:3.60%
202
1527
3603
36410
102
682
3706
37280
33
220
3775
37742
20
18
3788
37944
36
235
3752
37531
106
624
3433
34773
189
929
2446
24872
Other otitis externa
H60.8 [45567109]
1.1e+00
1.7e+00
—
—
—
1.6e+00
2.4e-01
cases:0.58%
controls:0.20%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.37%
controls:0.08%
cases:0.42%
controls:0.33%
22
77
3783
37860
17
30
3791
37932
—
—
—
13
27
3526
35370
11
85
2624
25716
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
7.1e-01
7.1e-01
1.2e+00
—
1.6e+00
6.8e-01
6.0e-01
cases:2.13%
controls:1.05%
cases:0.89%
controls:0.44%
cases:0.21%
controls:0.06%
—
—
cases:0.34%
controls:0.07%
cases:0.88%
controls:0.44%
cases:2.20%
controls:1.22%
81
400
3724
37537
34
168
3774
37794
8
24
3800
37938
—
13
25
3775
37741
31
157
3508
35240
58
315
2577
25486
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
7.1e-01
7.1e-01
1.2e+00
—
1.6e+00
6.8e-01
6.0e-01
cases:2.13%
controls:1.05%
cases:0.89%
controls:0.44%
cases:0.21%
controls:0.06%
—
—
cases:0.34%
controls:0.07%
cases:0.88%
controls:0.44%
cases:2.20%
controls:1.22%
81
400
3724
37537
34
168
3774
37794
8
24
3800
37938
—
13
25
3775
37741
31
157
3508
35240
58
315
2577
25486
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
4.7e-01
7.1e-01
9.1e-01
—
1.2e+00
5.3e-01
4.7e-01
cases:10.22%
controls:6.65%
cases:7.33%
controls:3.75%
cases:1.50%
controls:0.61%
—
—
cases:1.50%
controls:0.45%
cases:6.44%
controls:3.90%
cases:15.03%
controls:9.94%
389
2521
3416
35416
279
1422
3529
36540
57
231
3751
37731
—
57
170
3731
37596
228
1379
3311
34018
396
2564
2239
23237
Other rehabilitation service
R5599 [2001310270]
7.5e-01
—
—
—
—
2.1e+00
2.2e+00
cases:0.39%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.04%
cases:0.91%
controls:0.10%
15
71
3790
37866
—
—
—
—
12
15
3527
35382
24
26
2611
25775
Laboratory test
15220000 [4034850]
8.2e-01
7.9e-01
6.9e-01
-1.0e+50
9.4e-01
8.2e-01
8.9e-01
cases:7.07%
controls:3.25%
cases:3.62%
controls:1.68%
cases:0.66%
controls:0.33%
cases:0.00%
controls:0.02%
cases:0.63%
controls:0.25%
cases:4.01%
controls:1.80%
cases:10.89%
controls:4.79%
269
1232
3536
36705
138
637
3670
37325
25
126
3783
37836
0
6
3808
37956
24
94
3764
37672
142
638
3397
34759
287
1236
2348
24565
Ophthalmology
18 [38004463]
2.3e-01
3.2e-01
2.7e-01
3.1e+00
2.0e-01
2.4e-01
3.4e-01
cases:25.10%
controls:20.96%
cases:12.24%
controls:9.19%
cases:2.28%
controls:1.75%
cases:1.76%
controls:0.08%
cases:2.30%
controls:1.89%
cases:11.25%
controls:9.04%
cases:27.02%
controls:20.78%
955
7953
2850
29984
466
3489
3342
34473
87
664
3721
37298
67
31
3741
37931
87
712
3701
37054
398
3200
3141
32197
712
5362
1923
20439
Sudden idiopathic hearing loss
H91.2 [45552760]
4.2e+00
—
—
1.0e+50
1.0e+50
—
—
cases:0.89%
controls:0.01%
—
—
—
—
cases:1.89%
controls:0.00%
cases:2.48%
controls:0.00%
—
—
—
—
34
5
3771
37932
—
—
72
0
3736
37962
94
0
3694
37766
—
—
formoterol and fluticasone
R03AK11 [44819166]
5.5e-01
8.6e-01
1.0e+00
—
1.3e+00
9.8e-01
1.1e+00
cases:0.63%
controls:0.36%
cases:0.60%
controls:0.26%
cases:0.24%
controls:0.08%
—
—
cases:0.29%
controls:0.08%
cases:0.71%
controls:0.27%
cases:1.02%
controls:0.35%
24
138
3781
37799
23
97
3785
37865
9
32
3799
37930
—
11
30
3777
37736
25
94
3514
35303
27
91
2608
25710
methylprednisolone; oral, parenteral
H02AB04 [21602732]
6.5e-01
6.9e-01
8.4e-01
—
2.2e+00
2.5e-01
6.2e-01
cases:2.84%
controls:1.51%
cases:1.05%
controls:0.53%
cases:0.26%
controls:0.11%
—
—
cases:0.87%
controls:0.09%
cases:0.59%
controls:0.46%
cases:1.94%
controls:1.05%
108
571
3697
37366
40
201
3768
37761
10
43
3798
37919
—
33
35
3755
37731
21
164
3518
35233
51
272
2584
25529
Plastic And Reconstructive Surgery
24 [38004467]
3.0e-01
3.0e-01
9.5e-03
2.8e+00
3.3e-01
5.8e-01
4.9e-01
cases:4.39%
controls:3.28%
cases:1.52%
controls:1.13%
cases:0.21%
controls:0.21%
cases:0.26%
controls:0.02%
cases:0.26%
controls:0.19%
cases:1.95%
controls:1.10%
cases:5.09%
controls:3.17%
167
1243
3638
36694
58
428
3750
37534
8
79
3800
37883
10
6
3798
37956
10
72
3778
37694
69
388
3470
35009
134
818
2501
24983
Pain in limb
M79.6 [45587063]
5.2e-01
3.7e-01
5.9e-01
2.5e+00
4.8e-01
4.0e-01
4.3e-01
cases:12.85%
controls:8.05%
cases:4.57%
controls:3.22%
cases:0.74%
controls:0.41%
cases:0.18%
controls:0.02%
cases:0.61%
controls:0.38%
cases:5.20%
controls:3.56%
cases:15.18%
controls:10.45%
489
3053
3316
34884
174
1221
3634
36741
28
156
3780
37806
7
6
3801
37956
23
142
3765
37624
184
1260
3355
34137
400
2695
2235
23106
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.0e-02
1.9e-01
4.6e-01
2.7e+00
5.5e-01
1.9e-01
1.2e-01
cases:46.25%
controls:45.02%
cases:39.52%
controls:35.01%
cases:10.74%
controls:7.06%
cases:6.14%
controls:0.43%
cases:11.48%
controls:6.93%
cases:39.64%
controls:35.22%
cases:56.74%
controls:53.65%
1760
17078
2045
20859
1505
13289
2303
24673
409
2680
3399
35282
234
165
3574
37797
435
2619
3353
35147
1403
12468
2136
22929
1495
13843
1140
11958
Bacteria identified in Blood by Culture
600-7 [3023368]
1.4e-01
2.0e-01
4.1e-01
3.3e+00
7.9e-01
1.9e-01
1.7e-01
cases:7.46%
controls:6.57%
cases:3.55%
controls:2.92%
cases:0.63%
controls:0.42%
cases:0.50%
controls:0.02%
cases:0.84%
controls:0.38%
cases:3.90%
controls:3.25%
cases:10.47%
controls:9.00%
284
2491
3521
35446
135
1108
3673
36854
24
159
3784
37803
19
7
3789
37955
32
145
3756
37621
138
1152
3401
34245
276
2322
2359
23479
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
5.9e-02
2.1e-01
4.7e-01
2.7e+00
5.4e-01
1.9e-01
1.2e-01
cases:46.75%
controls:45.29%
cases:40.23%
controls:35.38%
cases:11.03%
controls:7.18%
cases:6.09%
controls:0.44%
cases:11.54%
controls:7.04%
cases:40.10%
controls:35.69%
cases:56.74%
controls:53.89%
1779
17180
2026
20757
1532
13431
2276
24531
420
2725
3388
35237
232
168
3576
37794
437
2660
3351
35106
1419
12633
2120
22764
1495
13904
1140
11897
Physiotherapy
R4110 [2001310233]
6.1e-01
7.2e-01
4.0e-01
—
1.5e+00
6.9e-01
5.9e-01
cases:11.04%
controls:6.33%
cases:4.44%
controls:2.20%
cases:0.45%
controls:0.30%
—
—
cases:1.21%
controls:0.28%
cases:3.98%
controls:2.05%
cases:9.41%
controls:5.46%
420
2400
3385
35537
169
837
3639
37125
17
114
3791
37848
—
46
105
3742
37661
141
725
3398
34672
248
1409
2387
24392
Other obesity
E66.8 [45533036]
6.0e-01
9.5e-01
—
1.0e+50
1.7e+00
8.8e-01
5.1e-01
cases:1.08%
controls:0.60%
cases:0.63%
controls:0.24%
—
—
cases:0.47%
controls:0.00%
cases:0.29%
controls:0.06%
cases:0.76%
controls:0.32%
cases:1.14%
controls:0.69%
41
226
3764
37711
24
93
3784
37869
—
18
0
3790
37962
11
21
3777
37745
27
113
3512
35284
30
177
2605
25624
Paracentesis of tympanic membrane
DCA10 [2001301562]
2.0e+00
—
—
1.0e+50
1.0e+50
—
2.1e+00
cases:0.42%
controls:0.06%
—
—
—
—
cases:0.55%
controls:0.00%
cases:0.16%
controls:0.00%
—
—
cases:0.34%
controls:0.04%
16
22
3789
37915
—
—
21
0
3787
37962
6
0
3782
37766
—
9
11
2626
25790
Creatine [Moles/volume] in Urine
15046-6 [3022689]
—
—
—
—
—
1.7e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.05%
cases:0.95%
controls:0.09%
—
—
—
—
—
9
16
3530
35381
25
24
2610
25777
Amylase [Enzymatic activity/volume] in Urine
1799-6 [3017315]
8.7e-01
—
—
—
—
2.1e+00
2.0e+00
cases:0.26%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.68%
controls:0.09%
10
42
3795
37895
—
—
—
—
7
9
3532
35388
18
24
2617
25777
Acute upper respiratory infection, unspecified
J06.9 [45562437]
4.1e-01
4.5e-01
6.3e-01
2.5e+00
8.7e-02
4.2e-01
3.1e-01
cases:11.09%
controls:7.66%
cases:4.46%
controls:2.89%
cases:0.66%
controls:0.35%
cases:0.18%
controls:0.02%
cases:0.37%
controls:0.34%
cases:4.80%
controls:3.21%
cases:12.64%
controls:9.63%
422
2906
3383
35031
170
1097
3638
36865
25
133
3783
37829
7
6
3801
37956
14
128
3774
37638
170
1135
3369
34262
333
2484
2302
23317
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2.4e-01
5.0e-01
1.2e+00
—
1.5e+00
7.4e-01
5.5e-01
cases:2.10%
controls:1.67%
cases:1.18%
controls:0.72%
cases:0.34%
controls:0.10%
—
—
cases:0.37%
controls:0.08%
cases:1.47%
controls:0.71%
cases:2.69%
controls:1.57%
80
633
3725
37304
45
273
3763
37689
13
39
3795
37923
—
14
30
3774
37736
52
251
3487
35146
71
404
2564
25397
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
8.4e-01
8.3e-01
7.1e-01
—
1.3e+00
7.2e-01
3.7e-01
cases:4.89%
controls:2.17%
cases:2.13%
controls:0.94%
cases:0.29%
controls:0.14%
—
—
cases:0.40%
controls:0.11%
cases:1.84%
controls:0.90%
cases:3.83%
controls:2.68%
186
825
3619
37112
81
358
3727
37604
11
54
3797
37908
—
15
42
3773
37724
65
320
3474
35077
101
692
2534
25109
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
6.5e-01
5.8e-01
8.2e-01
—
1.4e+00
5.8e-01
2.0e-01
cases:7.88%
controls:4.28%
cases:4.41%
controls:2.51%
cases:0.97%
controls:0.43%
—
—
cases:1.48%
controls:0.37%
cases:4.58%
controls:2.63%
cases:8.12%
controls:6.76%
300
1624
3505
36313
168
954
3640
37008
37
163
3771
37799
—
56
141
3732
37625
162
930
3377
34467
214
1744
2421
24057
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
2.2e-01
3.0e-01
3.5e-01
3.5e+00
6.9e-01
4.9e-01
1.3e-01
cases:2.79%
controls:2.24%
cases:1.76%
controls:1.31%
cases:0.34%
controls:0.24%
cases:0.71%
controls:0.02%
cases:0.58%
controls:0.29%
cases:2.26%
controls:1.40%
cases:3.61%
controls:3.17%
106
849
3699
37088
67
496
3741
37466
13
91
3795
37871
27
8
3781
37954
22
110
3766
37656
80
495
3459
34902
95
819
2540
24982
Myalgia
M79.1 [45587062]
3.8e-01
6.6e-01
8.7e-01
1.0e+50
1.4e+00
8.5e-01
7.3e-01
cases:2.63%
controls:1.81%
cases:1.02%
controls:0.53%
cases:0.16%
controls:0.07%
cases:0.29%
controls:0.00%
cases:0.26%
controls:0.07%
cases:1.27%
controls:0.55%
cases:3.87%
controls:1.91%
100
685
3705
37252
39
202
3769
37760
6
25
3802
37937
11
0
3797
37962
10
25
3778
37741
45
194
3494
35203
102
492
2533
25309
12 lead EKG panel
34534-8 [3044889]
1.7e-01
3.1e-01
6.6e-01
1.9e+00
4.6e-01
3.4e-01
2.0e-01
cases:28.96%
controls:25.61%
cases:16.28%
controls:12.44%
cases:2.70%
controls:1.42%
cases:0.29%
controls:0.04%
cases:2.19%
controls:1.40%
cases:15.94%
controls:11.94%
cases:32.41%
controls:28.26%
1102
9715
2703
28222
620
4721
3188
33241
103
538
3705
37424
11
17
3797
37945
83
529
3705
37237
564
4226
2975
31171
854
7291
1781
18510
Other specified special examinations
Z01.8 [45581003]
5.1e-01
6.0e-01
1.3e+00
—
8.7e-01
9.6e-01
6.1e-01
cases:5.68%
controls:3.47%
cases:1.97%
controls:1.09%
cases:0.39%
controls:0.11%
—
—
cases:0.26%
controls:0.11%
cases:2.71%
controls:1.05%
cases:6.07%
controls:3.39%
216
1318
3589
36619
75
412
3733
37550
15
41
3793
37921
—
10
42
3778
37724
96
373
3443
35024
160
874
2475
24927
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
8.2e-01
7.8e-01
1.3e+00
—
1.7e+00
7.3e-01
6.5e-01
cases:1.71%
controls:0.76%
cases:0.68%
controls:0.31%
cases:0.16%
controls:0.04%
—
—
cases:0.24%
controls:0.04%
cases:0.62%
controls:0.30%
cases:1.59%
controls:0.84%
65
289
3740
37648
26
119
3782
37843
6
16
3802
37946
—
9
16
3779
37750
22
106
3517
35291
42
217
2593
25584
Atrial fibrillation and atrial flutter, unspecified
I48.9 [45755409]
2.1e-01
6.1e-01
1.3e+00
—
1.3e+00
6.9e-01
9.2e-02
cases:1.18%
controls:0.96%
cases:1.05%
controls:0.57%
cases:0.37%
controls:0.10%
—
—
cases:0.42%
controls:0.11%
cases:1.47%
controls:0.74%
cases:2.09%
controls:1.91%
45
364
3760
37573
40
217
3768
37745
14
37
3794
37925
—
16
42
3772
37724
52
263
3487
35134
55
492
2580
25309
montelukast; oral
R03DC03 [21603356]
5.8e-01
5.8e-01
8.4e-01
—
6.9e-01
5.9e-01
6.8e-01
cases:5.23%
controls:3.00%
cases:3.49%
controls:1.99%
cases:1.05%
controls:0.46%
—
—
cases:1.00%
controls:0.51%
cases:3.39%
controls:1.92%
cases:5.69%
controls:2.98%
199
1139
3606
36798
133
754
3675
37208
40
173
3768
37789
—
38
191
3750
37575
120
678
3419
34719
150
768
2485
25033
Persons encountering health services in other specified circumstances
Z76.8 [45542457]
1.0e+00
9.6e-01
—
—
—
9.7e-01
9.2e-01
cases:0.97%
controls:0.34%
cases:0.42%
controls:0.16%
—
—
—
—
—
—
cases:0.45%
controls:0.17%
cases:1.33%
controls:0.53%
37
130
3768
37807
16
61
3792
37901
—
—
—
16
61
3523
35336
35
138
2600
25663
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
5.0e-02
1.9e-01
5.1e-01
2.5e+00
4.8e-01
1.5e-01
8.3e-02
cases:49.01%
controls:47.76%
cases:43.91%
controls:39.23%
cases:13.45%
controls:8.56%
cases:5.91%
controls:0.49%
cases:12.83%
controls:8.35%
cases:43.18%
controls:39.45%
cases:59.13%
controls:57.10%
1865
18118
1940
19819
1672
14894
2136
23068
512
3249
3296
34713
225
186
3583
37776
486
3152
3302
34614
1528
13963
2011
21434
1558
14733
1077
11068
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.8e-01
2.8e-01
4.7e-01
1.7e+00
4.8e-01
3.6e-01
3.3e-01
cases:20.18%
controls:17.43%
cases:12.68%
controls:9.90%
cases:3.78%
controls:2.39%
cases:0.55%
controls:0.10%
cases:3.48%
controls:2.19%
cases:13.53%
controls:9.82%
cases:24.86%
controls:19.14%
768
6613
3037
31324
483
3759
3325
34203
144
908
3664
37054
21
37
3787
37925
132
828
3656
36938
479
3476
3060
31921
655
4938
1980
20863
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
4.6e-01
8.6e-01
1.5e+00
—
8.7e-01
5.8e-01
1.0e+00
cases:3.84%
controls:2.45%
cases:1.84%
controls:0.78%
cases:0.26%
controls:0.06%
—
—
cases:0.13%
controls:0.06%
cases:1.13%
controls:0.64%
cases:3.38%
controls:1.22%
146
928
3659
37009
70
297
3738
37665
10
23
3798
37939
—
5
21
3783
37745
40
226
3499
35171
89
316
2546
25485
FEV1
20150-9 [3024653]
4.6e-01
8.6e-01
1.5e+00
—
8.7e-01
5.8e-01
1.0e+00
cases:3.84%
controls:2.45%
cases:1.84%
controls:0.78%
cases:0.26%
controls:0.06%
—
—
cases:0.13%
controls:0.06%
cases:1.13%
controls:0.64%
cases:3.38%
controls:1.22%
146
928
3659
37009
70
297
3738
37665
10
23
3798
37939
—
5
21
3783
37745
40
226
3499
35171
89
316
2546
25485
FEV1/FVC
19926-5 [3011505]
4.6e-01
8.6e-01
1.5e+00
—
8.7e-01
5.8e-01
1.0e+00
cases:3.84%
controls:2.45%
cases:1.84%
controls:0.78%
cases:0.26%
controls:0.06%
—
—
cases:0.13%
controls:0.06%
cases:1.13%
controls:0.64%
cases:3.38%
controls:1.22%
146
928
3659
37009
70
297
3738
37665
10
23
3798
37939
—
5
21
3783
37745
40
226
3499
35171
89
316
2546
25485
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
4.8e-01
6.9e-01
—
1.0e+50
2.4e+00
1.4e+00
1.1e-01
cases:0.34%
controls:0.21%
cases:0.26%
controls:0.13%
—
—
cases:0.37%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.51%
controls:0.13%
cases:0.34%
controls:0.31%
13
80
3792
37857
10
50
3798
37912
—
14
0
3794
37962
8
7
3780
37759
18
45
3521
35352
9
79
2626
25722
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.9e-02
1.9e-01
6.7e-01
1.9e+00
5.8e-01
1.8e-01
3.2e-01
cases:26.25%
controls:25.32%
cases:14.13%
controls:11.94%
cases:3.10%
controls:1.61%
cases:0.34%
controls:0.05%
cases:2.80%
controls:1.59%
cases:13.48%
controls:11.49%
cases:33.06%
controls:26.35%
999
9607
2806
28330
538
4532
3270
33430
118
610
3690
37352
13
20
3795
37942
106
600
3682
37166
477
4067
3062
31330
871
6798
1764
19003
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
7.1e-01
7.7e-01
1.2e+00
—
1.7e+00
6.6e-01
5.7e-01
cases:2.02%
controls:1.01%
cases:0.84%
controls:0.39%
cases:0.21%
controls:0.06%
—
—
cases:0.32%
controls:0.06%
cases:0.73%
controls:0.38%
cases:1.78%
controls:1.02%
77
382
3728
37555
32
149
3776
37813
8
23
3800
37939
—
12
21
3776
37745
26
135
3513
35262
47
262
2588
25539
Measurement of heart muscle perfusion with exercise
XF655 [2001303392]
8.4e-01
—
—
—
—
1.7e+00
1.2e+00
cases:0.81%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.05%
cases:0.53%
controls:0.16%
31
134
3774
37803
—
—
—
—
9
16
3530
35381
14
41
2621
25760
Polymyalgia rheumatica
M35.3 [45533830]
3.0e-01
6.8e-02
2.2e-01
3.0e+00
8.3e-01
4.4e-01
7.5e-01
cases:1.16%
controls:0.86%
cases:0.42%
controls:0.39%
cases:0.13%
controls:0.11%
cases:0.32%
controls:0.02%
cases:0.24%
controls:0.10%
cases:0.68%
controls:0.44%
cases:1.71%
controls:0.81%
44
327
3761
37610
16
149
3792
37813
5
40
3803
37922
12
6
3796
37956
9
39
3779
37727
24
155
3515
35242
45
209
2590
25592
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.7e-01
2.5e-01
3.3e-01
2.2e+00
5.0e-01
3.2e-01
3.4e-01
cases:17.21%
controls:14.91%
cases:9.38%
controls:7.45%
cases:2.07%
controls:1.50%
cases:0.53%
controls:0.06%
cases:2.38%
controls:1.46%
cases:10.00%
controls:7.45%
cases:22.43%
controls:17.13%
655
5658
3150
32279
357
2829
3451
35133
79
569
3729
37393
20
23
3788
37939
90
551
3698
37215
354
2638
3185
32759
591
4419
2044
21382
Platelets [#/volume] in Blood
26515-7 [3007461]
2.6e-02
1.8e-01
4.5e-01
2.5e+00
4.5e-01
1.4e-01
5.5e-02
cases:50.51%
controls:49.86%
cases:45.98%
controls:41.63%
cases:14.00%
controls:9.37%
cases:6.28%
controls:0.54%
cases:13.70%
controls:9.21%
cases:44.96%
controls:41.61%
cases:60.65%
controls:59.32%
1922
18914
1883
19023
1751
15803
2057
22159
533
3557
3275
34405
239
206
3569
37756
519
3478
3269
34288
1591
14729
1948
20668
1598
15304
1037
10497
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.2e-02
1.8e-01
4.5e-01
2.5e+00
4.5e-01
1.4e-01
5.3e-02
cases:50.51%
controls:49.96%
cases:46.03%
controls:41.68%
cases:13.97%
controls:9.39%
cases:6.28%
controls:0.54%
cases:13.73%
controls:9.22%
cases:45.04%
controls:41.68%
cases:60.68%
controls:59.40%
1922
18954
1883
18983
1753
15823
2055
22139
532
3563
3276
34399
239
206
3569
37756
520
3483
3268
34283
1594
14754
1945
20643
1599
15326
1036
10475
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.2e-02
1.8e-01
4.5e-01
2.5e+00
4.5e-01
1.4e-01
5.4e-02
cases:50.51%
controls:49.95%
cases:45.98%
controls:41.64%
cases:13.94%
controls:9.38%
cases:6.28%
controls:0.54%
cases:13.73%
controls:9.21%
cases:44.98%
controls:41.64%
cases:60.68%
controls:59.38%
1922
18951
1883
18986
1751
15807
2057
22155
531
3560
3277
34402
239
206
3569
37756
520
3480
3268
34286
1592
14740
1947
20657
1599
15321
1036
10480
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.3e-02
1.8e-01
4.5e-01
2.5e+00
4.5e-01
1.4e-01
5.1e-02
cases:50.54%
controls:49.97%
cases:46.03%
controls:41.67%
cases:13.94%
controls:9.39%
cases:6.28%
controls:0.54%
cases:13.73%
controls:9.21%
cases:45.01%
controls:41.69%
cases:60.65%
controls:59.43%
1923
18959
1882
18978
1753
15819
2055
22143
531
3565
3277
34397
239
206
3569
37756
520
3480
3268
34286
1593
14756
1946
20641
1598
15334
1037
10467
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
2.9e-01
1.8e-01
1.3e+00
—
1.6e+00
4.9e-01
3.6e-01
cases:3.89%
controls:2.95%
cases:1.42%
controls:1.18%
cases:0.37%
controls:0.10%
—
—
cases:0.45%
controls:0.09%
cases:1.61%
controls:0.99%
cases:4.48%
controls:3.15%
148
1118
3657
36819
54
449
3754
37513
14
39
3794
37923
—
17
35
3771
37731
57
350
3482
35047
118
814
2517
24987
Outpatient Hospital
22 [8756]
1.6e-01
2.5e-01
4.9e-01
2.8e+00
4.5e-01
2.5e-01
2.6e-01
cases:27.73%
controls:24.55%
cases:8.56%
controls:6.77%
cases:1.42%
controls:0.88%
cases:0.89%
controls:0.06%
cases:1.29%
controls:0.83%
cases:7.80%
controls:6.18%
cases:21.25%
controls:17.27%
1055
9313
2750
28624
326
2571
3482
35391
54
333
3754
37629
34
21
3774
37941
49
313
3739
37453
276
2186
3263
33211
560
4457
2075
21344
MCH [Entitic mass]
28539-5 [3035941]
2.4e-02
1.7e-01
4.5e-01
2.5e+00
4.5e-01
1.4e-01
5.2e-02
cases:50.51%
controls:49.91%
cases:45.90%
controls:41.61%
cases:13.92%
controls:9.38%
cases:6.28%
controls:0.54%
cases:13.70%
controls:9.21%
cases:45.01%
controls:41.63%
cases:60.61%
controls:59.37%
1922
18933
1883
19004
1748
15795
2060
22167
530
3560
3278
34402
239
206
3569
37756
519
3477
3269
34289
1593
14735
1946
20662
1597
15318
1038
10483
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2.7e-01
8.3e-01
—
—
2.7e+00
6.0e-01
1.1e+00
cases:0.63%
controls:0.48%
cases:0.32%
controls:0.14%
—
—
—
—
cases:0.26%
controls:0.02%
cases:0.23%
controls:0.12%
cases:0.95%
controls:0.33%
24
183
3781
37754
12
52
3796
37910
—
—
10
7
3778
37759
8
44
3531
35353
25
86
2610
25715
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.2e-02
1.8e-01
4.4e-01
2.5e+00
4.5e-01
1.4e-01
5.0e-02
cases:50.54%
controls:50.00%
cases:46.06%
controls:41.71%
cases:13.94%
controls:9.41%
cases:6.28%
controls:0.55%
cases:13.75%
controls:9.23%
cases:45.07%
controls:41.73%
cases:60.65%
controls:59.44%
1923
18968
1882
18969
1754
15835
2054
22127
531
3573
3277
34389
239
207
3569
37755
521
3486
3267
34280
1595
14771
1944
20626
1598
15336
1037
10465
Bacteria identified in Urine by Culture
630-4 [3026008]
1.3e-01
2.3e-01
5.4e-01
2.8e+00
6.7e-01
2.7e-01
1.8e-01
cases:9.99%
controls:8.85%
cases:5.44%
controls:4.35%
cases:1.13%
controls:0.66%
cases:0.42%
controls:0.03%
cases:1.21%
controls:0.63%
cases:5.88%
controls:4.55%
cases:13.40%
controls:11.48%
380
3356
3425
34581
207
1651
3601
36311
43
251
3765
37711
16
10
3792
37952
46
237
3742
37529
208
1611
3331
33786
353
2963
2282
22838
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.3e-02
1.8e-01
4.5e-01
2.5e+00
4.5e-01
1.4e-01
5.3e-02
cases:50.51%
controls:49.95%
cases:46.01%
controls:41.67%
cases:13.94%
controls:9.40%
cases:6.30%
controls:0.55%
cases:13.73%
controls:9.21%
cases:45.01%
controls:41.68%
cases:60.65%
controls:59.38%
1922
18948
1883
18989
1752
15819
2056
22143
531
3570
3277
34392
240
208
3568
37754
520
3480
3268
34286
1593
14753
1946
20644
1598
15321
1037
10480
Heart failure, unspecified
I50.9 [45576879]
1.3e-02
7.8e-02
2.3e-01
2.9e+00
7.7e-01
9.3e-02
8.9e-02
cases:3.13%
controls:3.09%
cases:2.05%
controls:1.90%
cases:0.53%
controls:0.42%
cases:0.74%
controls:0.04%
cases:0.90%
controls:0.42%
cases:2.35%
controls:2.14%
cases:5.16%
controls:4.74%
119
1172
3686
36765
78
720
3730
37242
20
159
3788
37803
28
15
3780
37947
34
157
3754
37609
83
758
3456
34639
136
1224
2499
24577
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
-1.4e-02
5.4e-02
3.1e-01
3.7e+00
5.4e-01
-1.0e-01
-8.5e-02
cases:2.44%
controls:2.48%
cases:1.58%
controls:1.49%
cases:0.45%
controls:0.33%
cases:0.74%
controls:0.02%
cases:0.48%
controls:0.28%
cases:1.50%
controls:1.65%
cases:2.96%
controls:3.21%
93
940
3712
36997
60
567
3748
37395
17
125
3791
37837
28
7
3780
37955
18
105
3770
37661
53
585
3486
34812
78
829
2557
24972
Obstruction of Eustachian tube
H68.1 [45586536]
—
1.9e+00
—
—
—
1.8e+00
1.0e+00
—
—
cases:0.29%
controls:0.04%
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.23%
controls:0.08%
—
11
16
3797
37946
—
—
—
7
12
3532
35385
6
21
2629
25780
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.5e-01
2.2e-01
5.2e-01
1.8e+00
4.4e-01
2.7e-01
3.0e-01
cases:29.72%
controls:26.70%
cases:18.62%
controls:15.46%
cases:4.83%
controls:2.93%
cases:0.74%
controls:0.12%
cases:4.12%
controls:2.70%
cases:19.04%
controls:15.19%
cases:36.02%
controls:29.46%
1131
10130
2674
27807
709
5868
3099
32094
184
1111
3624
36851
28
47
3780
37915
156
1020
3632
36746
674
5377
2865
30020
949
7601
1686
18200
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
5.1e-01
4.5e-01
9.6e-01
—
1.2e+00
5.4e-01
2.3e-01
cases:9.17%
controls:5.74%
cases:4.15%
controls:2.67%
cases:0.89%
controls:0.34%
—
—
cases:0.98%
controls:0.29%
cases:4.44%
controls:2.64%
cases:8.35%
controls:6.74%
349
2178
3456
35759
158
1015
3650
36947
34
130
3774
37832
—
37
109
3751
37657
157
933
3382
34464
220
1738
2415
24063
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
2.2e-01
9.2e-01
—
—
2.6e+00
8.2e-01
1.1e+00
cases:0.55%
controls:0.45%
cases:0.32%
controls:0.13%
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.20%
controls:0.09%
cases:0.91%
controls:0.31%
21
169
3784
37768
12
48
3796
37914
—
—
8
6
3780
37760
7
31
3532
35366
24
80
2611
25721
Chronic rhinitis
J31.0 [45572165]
9.1e-01
8.7e-01
1.3e+00
1.0e+50
—
1.2e+00
6.4e-01
cases:1.71%
controls:0.70%
cases:0.60%
controls:0.25%
cases:0.13%
controls:0.03%
cases:0.53%
controls:0.00%
—
—
cases:0.82%
controls:0.24%
cases:1.67%
controls:0.88%
65
264
3740
37673
23
96
3785
37866
5
13
3803
37949
20
0
3788
37962
—
29
85
3510
35312
44
228
2591
25573
Hypertrophy of nasal turbinates
J34.3 [45543264]
7.7e-01
1.2e+00
—
—
—
2.2e+00
1.5e+00
cases:0.26%
controls:0.12%
cases:0.18%
controls:0.06%
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.42%
controls:0.09%
10
46
3795
37891
7
21
3801
37941
—
—
—
6
7
3533
35390
11
24
2624
25777
Dentistry
C5 [903277]
4.2e-01
6.9e-01
1.1e+00
—
7.9e-01
7.2e-01
7.0e-01
cases:3.02%
controls:2.00%
cases:1.44%
controls:0.73%
cases:0.34%
controls:0.11%
—
—
cases:0.29%
controls:0.13%
cases:1.38%
controls:0.68%
cases:3.80%
controls:1.93%
115
760
3690
37177
55
278
3753
37684
13
42
3795
37920
—
11
50
3777
37716
49
241
3490
35156
100
497
2535
25304
Monocytes [#/volume] in Blood
26484-6 [3001604]
2.1e-01
2.9e-01
5.3e-01
1.5e+00
5.3e-01
3.2e-01
2.8e-01
cases:17.11%
controls:14.38%
cases:10.61%
controls:8.19%
cases:2.63%
controls:1.56%
cases:0.26%
controls:0.06%
cases:2.40%
controls:1.42%
cases:10.85%
controls:8.09%
cases:21.06%
controls:16.72%
651
5455
3154
32482
404
3108
3404
34854
100
591
3708
37371
10
23
3798
37939
91
537
3697
37229
384
2862
3155
32535
555
4314
2080
21487
Counselling and guidance which enhance independent living
R2130 [2001310196]
6.5e-01
8.3e-01
—
—
—
1.1e+00
1.1e+00
cases:2.29%
controls:1.21%
cases:1.05%
controls:0.46%
—
—
—
—
—
—
cases:1.33%
controls:0.47%
cases:4.29%
controls:1.47%
87
458
3718
37479
40
175
3768
37787
—
—
—
47
165
3492
35232
113
378
2522
25423
Basophils [#/volume] in Blood
26444-0 [3006315]
2.0e-01
2.9e-01
5.4e-01
1.5e+00
5.2e-01
3.3e-01
2.9e-01
cases:17.06%
controls:14.41%
cases:10.66%
controls:8.20%
cases:2.65%
controls:1.56%
cases:0.26%
controls:0.06%
cases:2.40%
controls:1.44%
cases:10.94%
controls:8.13%
cases:21.21%
controls:16.82%
649
5467
3156
32470
406
3113
3402
34849
101
592
3707
37370
10
23
3798
37939
91
544
3697
37222
387
2878
3152
32519
559
4341
2076
21460
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
2.1e-01
9.2e-01
—
—
2.6e+00
8.5e-01
1.0e+00
cases:0.55%
controls:0.45%
cases:0.32%
controls:0.13%
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.20%
controls:0.08%
cases:0.87%
controls:0.31%
21
170
3784
37767
12
48
3796
37914
—
—
8
6
3780
37760
7
30
3532
35367
23
80
2612
25721
Presence of electronic cardiac devices
Z95.0 [45571406]
2.6e-01
3.1e-01
5.7e-01
3.6e+00
6.6e-01
2.6e-01
3.4e-01
cases:1.94%
controls:1.51%
cases:1.29%
controls:0.95%
cases:0.39%
controls:0.22%
cases:0.68%
controls:0.02%
cases:0.37%
controls:0.19%
cases:1.38%
controls:1.07%
cases:2.35%
controls:1.69%
74
574
3731
37363
49
361
3759
37601
15
85
3793
37877
26
7
3782
37955
14
72
3774
37694
49
378
3490
35019
62
435
2573
25366
Irritable bowel syndrome without diarrhoea
K58.9 [45538539]
9.0e-01
8.5e-01
—
1.0e+50
—
1.7e+00
9.8e-01
cases:0.71%
controls:0.29%
cases:0.21%
controls:0.09%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.34%
controls:0.06%
cases:0.65%
controls:0.24%
27
110
3778
37827
8
34
3800
37928
—
7
0
3801
37962
—
12
22
3527
35375
17
63
2618
25738
Oral Surgery
19 [38004464]
1.5e-01
2.8e-01
—
—
1.9e+00
9.6e-01
7.2e-01
cases:1.00%
controls:0.86%
cases:0.37%
controls:0.28%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.62%
controls:0.24%
cases:1.44%
controls:0.71%
38
326
3767
37611
14
106
3794
37856
—
—
8
12
3780
37754
22
85
3517
35312
38
183
2597
25618
Neurosurgery
14 [38004459]
3.6e-01
5.1e-01
1.1e+00
—
5.8e-01
8.1e-01
7.8e-01
cases:3.92%
controls:2.77%
cases:1.71%
controls:1.03%
cases:0.53%
controls:0.18%
—
—
cases:0.32%
controls:0.18%
cases:2.18%
controls:0.98%
cases:4.97%
controls:2.35%
149
1050
3656
36887
65
390
3743
37572
20
67
3788
37895
—
12
67
3776
37699
77
348
3462
35049
131
606
2504
25195
Pharmacy visit
OMOP4822462 [581458]
3.0e-01
5.1e-01
3.3e-01
1.2e+00
3.3e-01
5.1e-01
3.7e-01
cases:95.66%
controls:94.25%
cases:92.80%
controls:88.55%
cases:64.34%
controls:56.52%
cases:9.85%
controls:3.16%
cases:63.97%
controls:56.15%
cases:92.85%
controls:88.64%
cases:95.79%
controls:94.01%
3640
35757
165
2180
3534
33616
274
4346
2450
21456
1358
16506
375
1200
3433
36762
2423
21205
1365
16561
3286
31377
253
4020
2524
24256
111
1545
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.0e-01
2.8e-01
5.5e-01
1.4e+00
4.9e-01
3.1e-01
2.8e-01
cases:17.63%
controls:14.98%
cases:10.92%
controls:8.48%
cases:2.81%
controls:1.63%
cases:0.26%
controls:0.06%
cases:2.43%
controls:1.51%
cases:11.10%
controls:8.37%
cases:21.78%
controls:17.36%
671
5682
3134
32255
416
3220
3392
34742
107
620
3701
37342
10
24
3798
37938
92
570
3696
37196
393
2962
3146
32435
574
4479
2061
21322
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
3.3e-01
2.6e-01
2.9e-01
2.9e+00
3.3e-01
8.3e-02
3.7e-02
cases:17.48%
controls:13.26%
cases:7.17%
controls:5.64%
cases:1.02%
controls:0.77%
cases:0.50%
controls:0.03%
cases:0.98%
controls:0.70%
cases:5.43%
controls:5.01%
cases:16.32%
controls:15.82%
665
5029
3140
32908
273
2140
3535
35822
39
292
3769
37670
19
10
3789
37952
37
265
3751
37501
192
1775
3347
33622
430
4082
2205
21719
Urology
34 [38004474]
1.5e-01
2.2e-01
2.7e-01
2.9e+00
2.3e-01
3.4e-01
2.6e-01
cases:10.70%
controls:9.32%
cases:6.04%
controls:4.89%
cases:1.16%
controls:0.89%
cases:0.81%
controls:0.04%
cases:1.00%
controls:0.80%
cases:6.30%
controls:4.58%
cases:12.03%
controls:9.53%
407
3536
3398
34401
230
1855
3578
36107
44
336
3764
37626
31
17
3777
37945
38
302
3750
37464
223
1622
3316
33775
317
2459
2318
23342
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
5.1e-01
6.7e-01
1.4e+00
—
1.8e+00
2.8e-01
5.0e-01
cases:2.16%
controls:1.31%
cases:0.97%
controls:0.50%
cases:0.24%
controls:0.06%
—
—
cases:0.34%
controls:0.06%
cases:0.62%
controls:0.47%
cases:2.31%
controls:1.41%
82
496
3723
37441
37
190
3771
37772
9
23
3799
37939
—
13
21
3775
37745
22
167
3517
35230
61
364
2574
25437
Progressive vascular leukoencephalopathy
I67.3 [45538402]
6.7e-01
7.5e-01
1.8e+00
1.0e+50
1.7e+00
8.3e-01
7.9e-01
cases:0.39%
controls:0.20%
cases:0.26%
controls:0.12%
cases:0.21%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.21%
controls:0.04%
cases:0.40%
controls:0.17%
cases:0.57%
controls:0.26%
15
77
3790
37860
10
47
3798
37915
8
13
3800
37949
10
0
3798
37962
8
15
3780
37751
14
61
3525
35336
15
67
2620
25734
azithromycin; oral, parenteral
J01FA10 [21602978]
4.3e-01
6.4e-01
1.5e+00
—
6.1e-01
5.4e-01
4.0e-01
cases:8.54%
controls:5.70%
cases:2.73%
controls:1.46%
cases:0.60%
controls:0.14%
—
—
cases:0.24%
controls:0.13%
cases:2.29%
controls:1.35%
cases:6.53%
controls:4.48%
325
2163
3480
35774
104
553
3704
37409
23
53
3785
37909
—
9
49
3779
37717
81
477
3458
34920
172
1156
2463
24645
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
3.0e-01
8.2e-01
—
—
2.4e+00
4.6e-01
1.0e+00
cases:0.58%
controls:0.43%
cases:0.26%
controls:0.12%
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.17%
controls:0.11%
cases:0.83%
controls:0.30%
22
163
3783
37774
10
44
3798
37918
—
—
8
7
3780
37759
6
38
3533
35359
22
77
2613
25724
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.9e-01
2.6e-01
5.4e-01
1.4e+00
5.1e-01
3.0e-01
2.8e-01
cases:17.37%
controls:14.87%
cases:10.71%
controls:8.43%
cases:2.70%
controls:1.59%
cases:0.26%
controls:0.07%
cases:2.43%
controls:1.47%
cases:10.99%
controls:8.38%
cases:21.52%
controls:17.20%
661
5642
3144
32295
408
3201
3400
34761
103
604
3705
37358
10
25
3798
37937
92
556
3696
37210
389
2966
3150
32431
567
4438
2068
21363
Tinnitus, ringing/buzzing ear
H03 [2002000477]
5.6e-01
3.4e+00
—
—
—
—
4.9e-01
cases:0.26%
controls:0.15%
cases:0.58%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.27%
controls:0.16%
10
57
3795
37880
22
7
3786
37955
—
—
—
—
7
42
2628
25759
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
5.7e-01
9.0e-01
—
—
—
1.1e+00
1.4e+00
cases:0.87%
controls:0.49%
cases:0.47%
controls:0.19%
—
—
—
—
—
—
cases:0.54%
controls:0.18%
cases:2.39%
controls:0.59%
33
186
3772
37751
18
73
3790
37889
—
—
—
19
62
3520
35335
63
153
2572
25648
Attention to surgical dressings and sutures
Z48.0 [45609943]
6.0e-01
1.2e+00
—
—
—
1.1e+00
1.1e+00
cases:0.97%
controls:0.54%
cases:0.66%
controls:0.19%
—
—
—
—
—
—
cases:0.57%
controls:0.19%
cases:2.13%
controls:0.70%
37
203
3768
37734
25
73
3783
37889
—
—
—
20
69
3519
35328
56
180
2579
25621
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
7.2e-01
8.8e-01
6.9e-01
—
1.1e+00
8.1e-01
1.0e+00
cases:1.89%
controls:0.93%
cases:0.76%
controls:0.32%
cases:0.13%
controls:0.07%
—
—
cases:0.18%
controls:0.06%
cases:0.68%
controls:0.30%
cases:2.01%
controls:0.74%
72
352
3733
37585
29
120
3779
37842
5
25
3803
37937
—
7
23
3781
37743
24
107
3515
35290
53
192
2582
25609
Benign paroxysmal vertigo
H81.1 [45572061]
4.7e-01
5.9e-01
1.5e+00
1.0e+50
1.6e+00
7.9e-01
6.0e-01
cases:2.13%
controls:1.34%
cases:0.84%
controls:0.47%
cases:0.16%
controls:0.04%
cases:0.58%
controls:0.00%
cases:0.26%
controls:0.06%
cases:0.99%
controls:0.45%
cases:2.43%
controls:1.35%
81
507
3724
37430
32
177
3776
37785
6
14
3802
37948
22
0
3786
37962
10
21
3778
37745
35
160
3504
35237
64
348
2571
25453
Gas panel - Venous blood
24339-4 [3000991]
5.3e-01
5.2e-01
4.0e-01
—
1.1e+00
5.3e-01
6.3e-01
cases:3.36%
controls:2.02%
cases:1.76%
controls:1.05%
cases:0.26%
controls:0.18%
—
—
cases:0.53%
controls:0.17%
cases:1.75%
controls:1.03%
cases:4.86%
controls:2.64%
128
765
3677
37172
67
398
3741
37564
10
67
3798
37895
—
20
64
3768
37702
62
366
3477
35031
128
682
2507
25119
Laboratory Visit
OMOP4822461 [32036]
-7.4e-03
1.5e-01
4.1e-01
2.2e+00
4.1e-01
1.3e-01
-1.4e-02
cases:53.32%
controls:53.51%
cases:53.15%
controls:49.42%
cases:22.43%
controls:16.09%
cases:8.85%
controls:1.03%
cases:22.18%
controls:15.95%
cases:53.04%
controls:49.70%
cases:63.23%
controls:63.56%
2029
20300
1776
17637
2024
18759
1784
19203
854
6108
2954
31854
337
391
3471
37571
840
6023
2948
31743
1877
17594
1662
17803
1666
16399
969
9402
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]
-1.2e-01
-4.8e-01
—
3.3e+00
—
-2.9e-01
2.0e-02
cases:1.00%
controls:1.13%
cases:0.47%
controls:0.76%
—
—
cases:0.37%
controls:0.01%
—
—
cases:0.57%
controls:0.76%
cases:0.95%
controls:0.93%
38
427
3767
37510
18
288
3790
37674
—
14
5
3794
37957
—
20
268
3519
35129
25
240
2610
25561
Predominantly allergic asthma
J45.0 [45557624]
7.3e-01
1.1e+00
8.5e-01
—
1.2e+00
7.9e-01
7.4e-01
cases:2.13%
controls:1.04%
cases:1.29%
controls:0.45%
cases:0.21%
controls:0.09%
—
—
cases:0.29%
controls:0.09%
cases:1.07%
controls:0.49%
cases:2.24%
controls:1.08%
81
395
3724
37542
49
170
3759
37792
8
34
3800
37928
—
11
33
3777
37733
38
173
3501
35224
59
278
2576
25523
Nonallergic asthma
J45.1 [45557625]
7.6e-01
9.7e-01
6.2e-01
—
8.9e-01
9.6e-01
6.4e-01
cases:2.18%
controls:1.03%
cases:1.29%
controls:0.49%
cases:0.21%
controls:0.11%
—
—
cases:0.29%
controls:0.12%
cases:1.30%
controls:0.50%
cases:2.09%
controls:1.11%
83
392
3722
37545
49
187
3759
37775
8
43
3800
37919
—
11
45
3777
37721
46
178
3493
35219
55
287
2580
25514
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
5.5e-01
5.2e-01
—
—
2.0e+00
7.6e-01
3.0e-01
cases:2.05%
controls:1.19%
cases:0.92%
controls:0.55%
—
—
—
—
cases:0.40%
controls:0.06%
cases:1.13%
controls:0.53%
cases:2.20%
controls:1.64%
78
451
3727
37486
35
209
3773
37753
—
—
15
21
3773
37745
40
189
3499
35208
58
424
2577
25377
Tissue Pathology biopsy report
66121-5 [40768804]
1.5e-01
6.1e-02
1.9e-01
2.9e+00
6.3e-01
3.4e-01
2.1e-01
cases:13.14%
controls:11.55%
cases:4.10%
controls:3.86%
cases:0.50%
controls:0.41%
cases:0.34%
controls:0.02%
cases:0.71%
controls:0.38%
cases:4.27%
controls:3.06%
cases:11.50%
controls:9.57%
500
4381
3305
33556
156
1466
3652
36496
19
157
3789
37805
13
7
3795
37955
27
144
3761
37622
151
1084
3388
34313
303
2469
2332
23332
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-1.7e-01
4.0e-02
3.7e-01
2.9e+00
5.7e-01
6.7e-02
3.3e-01
cases:9.51%
controls:11.08%
cases:5.04%
controls:4.85%
cases:1.00%
controls:0.69%
cases:0.71%
controls:0.04%
cases:1.03%
controls:0.59%
cases:5.43%
controls:5.09%
cases:17.69%
controls:13.33%
362
4203
3443
33734
192
1843
3616
36119
38
262
3770
37700
27
15
3781
37947
39
221
3749
37545
192
1803
3347
33594
466
3439
2169
22362
Peak expiratory flow measurement
29893006 [4106714]
1.7e+00
1.8e+00
—
—
—
—
1.5e+00
cases:0.34%
controls:0.06%
cases:0.13%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.07%
13
24
3792
37913
5
8
3803
37954
—
—
—
—
9
19
2626
25782
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
3.2e-01
4.8e-01
5.0e-01
—
1.5e+00
5.6e-01
3.8e-01
cases:5.15%
controls:3.80%
cases:2.31%
controls:1.44%
cases:0.37%
controls:0.22%
—
—
cases:0.71%
controls:0.16%
cases:2.37%
controls:1.37%
cases:5.62%
controls:3.90%
196
1442
3609
36495
88
548
3720
37414
14
85
3794
37877
—
27
62
3761
37704
84
486
3455
34911
148
1007
2487
24794
Lumbago with sciatica
M54.4 [45553205]
4.7e-01
5.1e-01
1.2e+00
—
7.6e-01
5.4e-01
4.9e-01
cases:3.94%
controls:2.51%
cases:1.52%
controls:0.92%
cases:0.34%
controls:0.10%
—
—
cases:0.24%
controls:0.11%
cases:1.41%
controls:0.83%
cases:4.59%
controls:2.87%
150
953
3655
36984
58
350
3750
37612
13
39
3795
37923
—
9
42
3779
37724
50
293
3489
35104
121
740
2514
25061
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
4.2e-01
4.2e-01
5.6e-01
—
1.4e+00
4.7e-01
4.6e-01
cases:4.73%
controls:3.15%
cases:2.10%
controls:1.39%
cases:0.37%
controls:0.21%
—
—
cases:0.58%
controls:0.14%
cases:2.35%
controls:1.47%
cases:6.45%
controls:4.15%
180
1196
3625
36741
80
526
3728
37436
14
80
3794
37882
—
22
54
3766
37712
83
521
3456
34876
170
1072
2465
24729
ABO and Rh group [Type] in Blood
882-1 [3003694]
6.1e-02
1.4e-01
8.8e-01
2.9e+00
7.3e-01
1.8e-01
2.9e-01
cases:6.31%
controls:5.96%
cases:2.15%
controls:1.89%
cases:0.37%
controls:0.15%
cases:0.24%
controls:0.01%
cases:0.29%
controls:0.14%
cases:1.78%
controls:1.49%
cases:7.17%
controls:5.45%
240
2260
3565
35677
82
716
3726
37246
14
58
3794
37904
9
5
3799
37957
11
53
3777
37713
63
527
3476
34870
189
1405
2446
24396
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
4.9e-01
5.8e-01
7.0e-01
—
1.1e+00
3.5e-01
1.6e-01
cases:9.65%
controls:6.15%
cases:6.28%
controls:3.62%
cases:1.02%
controls:0.51%
—
—
cases:1.40%
controls:0.49%
cases:5.43%
controls:3.88%
cases:11.65%
controls:10.06%
367
2333
3438
35604
239
1375
3569
36587
39
195
3769
37767
—
53
184
3735
37582
192
1373
3347
34024
307
2596
2328
23205
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
2.0e-01
1.6e-01
4.7e-01
2.4e+00
5.5e-01
2.7e-01
3.0e-01
cases:10.33%
controls:8.62%
cases:5.49%
controls:4.71%
cases:1.05%
controls:0.66%
cases:0.26%
controls:0.02%
cases:0.98%
controls:0.56%
cases:6.19%
controls:4.82%
cases:15.29%
controls:11.79%
393
3271
3412
34666
209
1787
3599
36175
40
250
3768
37712
10
9
3798
37953
37
213
3751
37553
219
1705
3320
33692
403
3042
2232
22759
Cathetrisation of vein
TPH04 [2001309597]
3.6e-01
6.1e-01
1.0e+00
—
2.0e-01
6.9e-01
4.6e-01
cases:5.76%
controls:4.08%
cases:2.26%
controls:1.24%
cases:0.42%
controls:0.15%
—
—
cases:0.18%
controls:0.15%
cases:2.46%
controls:1.25%
cases:5.81%
controls:3.75%
219
1547
3586
36390
86
469
3722
37493
16
58
3792
37904
—
7
57
3781
37709
87
443
3452
34954
153
968
2482
24833
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
1.8e-01
6.2e-01
1.4e+00
—
3.7e-01
6.3e-01
4.8e-01
cases:3.18%
controls:2.68%
cases:1.60%
controls:0.87%
cases:0.42%
controls:0.11%
—
—
cases:0.18%
controls:0.13%
cases:1.81%
controls:0.97%
cases:4.71%
controls:2.96%
121
1017
3684
36920
61
330
3747
37632
16
40
3792
37922
—
7
48
3781
37718
64
345
3475
35052
124
764
2511
25037
Perimetry
XCK00 [2001301380]
5.0e-01
1.1e+00
—
—
—
8.7e-01
5.8e-01
cases:1.68%
controls:1.03%
cases:0.89%
controls:0.28%
—
—
—
—
—
—
cases:0.57%
controls:0.24%
cases:1.56%
controls:0.88%
64
389
3741
37548
34
108
3774
37854
—
—
—
20
84
3519
35313
41
227
2594
25574
Congestive heart failure
I50.0 [45567179]
-1.6e-01
1.6e-01
3.2e-01
3.1e+00
8.2e-01
2.9e-01
-3.4e-02
cases:1.13%
controls:1.32%
cases:0.87%
controls:0.74%
cases:0.21%
controls:0.15%
cases:0.34%
controls:0.02%
cases:0.40%
controls:0.17%
cases:1.13%
controls:0.85%
cases:2.16%
controls:2.24%
43
501
3762
37436
33
281
3775
37681
8
58
3800
37904
13
6
3795
37956
15
66
3773
37700
40
300
3499
35097
57
577
2578
25224
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
2.2e-01
2.3e-01
3.9e-01
1.5e+00
5.9e-01
3.0e-01
2.2e-01
cases:16.32%
controls:13.56%
cases:9.40%
controls:7.61%
cases:2.13%
controls:1.44%
cases:0.24%
controls:0.05%
cases:2.40%
controls:1.34%
cases:9.97%
controls:7.56%
cases:18.63%
controls:15.57%
621
5145
3184
32792
358
2890
3450
35072
81
548
3727
37414
9
20
3799
37942
91
506
3697
37260
353
2675
3186
32722
491
4016
2144
21785
Other seropositive rheumatoid arthritis
M05.8 [45538634]
1.4e-01
1.3e-01
3.0e-01
3.1e+00
3.7e-01
1.1e-01
2.6e-01
cases:1.58%
controls:1.37%
cases:1.13%
controls:0.99%
cases:0.37%
controls:0.27%
cases:0.39%
controls:0.02%
cases:0.42%
controls:0.29%
cases:1.19%
controls:1.07%
cases:1.67%
controls:1.30%
60
521
3745
37416
43
376
3765
37586
14
103
3794
37859
15
7
3793
37955
16
110
3772
37656
42
377
3497
35020
44
335
2591
25466
Review, maintenance and user education for hearing aid
DFX03 [2001301657]
-1.0e+50
—
—
1.0e+50
—
—
3.1e+00
cases:0.00%
controls:0.01%
—
—
—
—
cases:0.13%
controls:0.00%
—
—
—
—
cases:0.49%
controls:0.02%
0
5
3805
37932
—
—
5
0
3803
37962
—
—
13
6
2622
25795
Gastroenterology
10 [38004455]
1.8e-01
3.3e-01
1.4e-01
1.9e+00
3.7e-01
3.8e-01
4.5e-01
cases:7.78%
controls:6.61%
cases:3.65%
controls:2.64%
cases:0.50%
controls:0.43%
cases:0.21%
controls:0.03%
cases:0.63%
controls:0.44%
cases:3.62%
controls:2.50%
cases:9.72%
controls:6.43%
296
2507
3509
35430
139
1004
3669
36958
19
164
3789
37798
8
12
3800
37950
24
165
3764
37601
128
884
3411
34513
256
1659
2379
24142
Chronic kidney disease, unspecified
N18.9 [45553438]
1.6e-01
2.3e-01
6.5e-01
3.0e+00
7.6e-01
4.0e-01
3.3e-01
cases:1.42%
controls:1.21%
cases:1.02%
controls:0.82%
cases:0.39%
controls:0.21%
cases:0.55%
controls:0.03%
cases:0.48%
controls:0.22%
cases:1.36%
controls:0.92%
cases:2.58%
controls:1.86%
54
460
3751
37477
39
311
3769
37651
15
78
3793
37884
21
10
3787
37952
18
84
3770
37682
48
324
3491
35073
68
480
2567
25321
Instruction on medicine inhalation technique
ZX109 [2001311490]
1.3e+00
—
—
—
—
—
1.7e+00
cases:0.29%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.09%
11
30
3794
37907
—
—
—
—
—
14
24
2621
25777
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.0e-01
1.4e-01
4.3e-01
1.8e+00
6.4e-01
1.7e-01
1.6e-01
cases:24.68%
controls:22.86%
cases:12.66%
controls:11.23%
cases:2.57%
controls:1.68%
cases:0.29%
controls:0.05%
cases:2.85%
controls:1.52%
cases:12.63%
controls:10.91%
cases:27.93%
controls:24.87%
939
8671
2866
29266
482
4263
3326
33699
98
639
3710
37323
11
18
3797
37944
108
574
3680
37192
447
3861
3092
31536
736
6416
1899
19385
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
3.1e-01
4.8e-01
—
—
1.7e+00
6.9e-01
6.4e-01
cases:3.00%
controls:2.21%
cases:1.44%
controls:0.90%
—
—
—
—
cases:0.42%
controls:0.08%
cases:1.75%
controls:0.88%
cases:5.12%
controls:2.78%
114
839
3691
37098
55
341
3753
37621
—
—
16
29
3772
37737
62
313
3477
35084
135
716
2500
25085
Immunoglobulin typing, IgG
1712009 [4062490]
-1.9e-01
1.8e+00
—
—
—
9.7e-01
1.2e+00
cases:0.16%
controls:0.19%
cases:0.24%
controls:0.04%
—
—
—
—
—
—
cases:0.14%
controls:0.05%
cases:0.46%
controls:0.13%
6
72
3799
37865
9
15
3799
37947
—
—
—
5
19
3534
35378
12
34
2623
25767
General Surgery
2 [38004447]
1.6e-01
1.9e-01
3.1e-02
2.9e+00
1.5e-01
1.4e-01
1.1e-01
cases:19.76%
controls:17.34%
cases:6.09%
controls:5.11%
cases:0.71%
controls:0.69%
cases:0.55%
controls:0.03%
cases:0.82%
controls:0.71%
cases:5.37%
controls:4.70%
cases:14.57%
controls:13.30%
752
6579
3053
31358
232
1938
3576
36024
27
261
3781
37701
21
12
3787
37950
31
267
3757
37499
190
1663
3349
33734
384
3432
2251
22369
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.8e-01
3.8e-01
7.0e-01
—
7.4e-01
5.0e-01
4.2e-01
cases:12.22%
controls:9.48%
cases:7.43%
controls:5.21%
cases:2.00%
controls:1.00%
—
—
cases:1.93%
controls:0.93%
cases:8.17%
controls:5.12%
cases:14.88%
controls:10.31%
465
3596
3340
34341
283
1976
3525
35986
76
380
3732
37582
—
73
350
3715
37416
289
1814
3250
33583
392
2661
2243
23140
pH of Serum or Plasma
2753-2 [3018418]
2.5e-01
5.1e-01
6.9e-01
—
9.6e-01
3.0e-01
3.0e-01
cases:11.20%
controls:8.97%
cases:7.33%
controls:4.53%
cases:1.50%
controls:0.76%
—
—
cases:1.85%
controls:0.71%
cases:6.10%
controls:4.58%
cases:13.62%
controls:10.50%
426
3402
3379
34535
279
1719
3529
36243
57
287
3751
37675
—
70
270
3718
37496
216
1622
3323
33775
359
2710
2276
23091
Atherosclerosis of arteries of extremities
I70.2 [45538421]
7.2e-02
-5.8e-02
1.1e-01
3.0e+00
1.4e-02
-2.6e-02
1.8e-01
cases:2.47%
controls:2.30%
cases:1.23%
controls:1.31%
cases:0.45%
controls:0.40%
cases:0.47%
controls:0.02%
cases:0.32%
controls:0.31%
cases:1.38%
controls:1.42%
cases:3.26%
controls:2.75%
94
874
3711
37063
47
496
3761
37466
17
152
3791
37810
18
9
3790
37953
12
118
3776
37648
49
503
3490
34894
86
709
2549
25092
Otosclerosis involving oval window, nonobliterative
H80.0 [45572058]
3.0e+00
—
—
—
—
1.0e+50
—
cases:0.32%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.00%
—
—
12
6
3793
37931
—
—
—
—
12
0
3527
35397
—
Endocrinology
46 [38004485]
9.5e-02
-1.7e-02
9.6e-02
3.0e+00
5.7e-01
2.7e-01
2.4e-01
cases:3.76%
controls:3.43%
cases:1.79%
controls:1.81%
cases:0.42%
controls:0.38%
cases:0.26%
controls:0.01%
cases:0.63%
controls:0.36%
cases:2.20%
controls:1.69%
cases:4.59%
controls:3.63%
143
1301
3662
36636
68
689
3740
37273
16
145
3792
37817
10
5
3798
37957
24
136
3764
37630
78
599
3461
34798
121
937
2514
24864
Vascular Surgery
77 [38004496]
1.2e-01
1.1e-01
1.1e-01
2.6e+00
8.4e-02
3.0e-01
4.0e-01
cases:4.47%
controls:3.99%
cases:1.86%
controls:1.67%
cases:0.37%
controls:0.33%
cases:0.21%
controls:0.02%
cases:0.32%
controls:0.29%
cases:2.23%
controls:1.66%
cases:6.22%
controls:4.28%
170
1514
3635
36423
71
635
3737
37327
14
125
3794
37837
8
6
3800
37956
12
110
3776
37656
79
587
3460
34810
164
1104
2471
24697
Nutritional therapy
R4190 [2001310243]
7.8e-01
9.3e-01
—
—
1.3e+00
1.2e+00
9.9e-01
cases:0.76%
controls:0.35%
cases:0.42%
controls:0.17%
—
—
—
—
cases:0.13%
controls:0.03%
cases:0.42%
controls:0.13%
cases:0.99%
controls:0.37%
29
133
3776
37804
16
63
3792
37899
—
—
5
13
3783
37753
15
46
3524
35351
26
95
2609
25706
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
6.9e-01
6.5e-01
1.0e+00
—
1.6e+00
6.5e-01
6.4e-01
cases:1.97%
controls:1.00%
cases:0.79%
controls:0.41%
cases:0.16%
controls:0.06%
—
—
cases:0.32%
controls:0.06%
cases:0.79%
controls:0.42%
cases:2.16%
controls:1.15%
75
379
3730
37558
30
157
3778
37805
6
21
3802
37941
—
12
24
3776
37742
28
147
3511
35250
57
296
2578
25505
Persistent somatoform pain disorder
F45.4 [45605498]
—
4.4e-01
—
—
—
1.4e+00
1.5e+00
—
—
cases:0.13%
controls:0.08%
—
—
—
—
—
—
cases:0.28%
controls:0.07%
cases:0.65%
controls:0.14%
—
5
32
3803
37930
—
—
—
10
24
3529
35373
17
37
2618
25764
Malignant neoplasm of prostate
C61 [45547509]
-6.3e-03
3.5e-02
1.5e-01
2.9e+00
5.3e-01
2.2e-01
2.4e-01
cases:3.39%
controls:3.41%
cases:2.55%
controls:2.46%
cases:0.79%
controls:0.68%
cases:1.00%
controls:0.06%
cases:1.11%
controls:0.65%
cases:3.00%
controls:2.42%
cases:4.44%
controls:3.52%
129
1294
3676
36643
97
935
3711
37027
30
257
3778
37705
38
21
3770
37941
42
247
3746
37519
106
857
3433
34540
117
907
2518
24894
General and Unspecified, Medical examin/health eval partial
A31 [2002000165]
3.9e-01
1.6e+00
—
—
—
—
1.3e+00
cases:0.34%
controls:0.23%
cases:0.21%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.18%
13
88
3792
37849
8
16
3800
37946
—
—
—
—
17
46
2618
25755
Plastic repair of septum of nose
DJD20 [2001301709]
1.4e+00
—
—
—
—
1.6e+00
1.5e+00
cases:0.47%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.03%
cases:0.34%
controls:0.08%
18
44
3787
37893
—
—
—
—
5
10
3534
35387
9
20
2626
25781
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
3.2e-01
4.2e-01
8.1e-01
—
1.1e+00
6.1e-01
4.8e-01
cases:5.26%
controls:3.89%
cases:2.10%
controls:1.39%
cases:0.34%
controls:0.15%
—
—
cases:0.40%
controls:0.14%
cases:2.15%
controls:1.18%
cases:5.92%
controls:3.76%
200
1476
3605
36461
80
529
3728
37433
13
58
3795
37904
—
15
51
3773
37715
76
419
3463
34978
156
971
2479
24830
Intravenous
ZX120 [2001311495]
4.7e-01
7.6e-01
5.7e-01
—
1.6e-01
9.0e-01
7.6e-01
cases:2.13%
controls:1.34%
cases:1.13%
controls:0.53%
cases:0.24%
controls:0.13%
—
—
cases:0.16%
controls:0.14%
cases:1.07%
controls:0.44%
cases:2.20%
controls:1.05%
81
509
3724
37428
43
201
3765
37761
9
51
3799
37911
—
6
51
3782
37715
38
155
3501
35242
58
270
2577
25531
Obstetrics / Gynecology
16 [38004461]
2.4e-01
1.1e-01
4.1e-01
2.4e+00
3.7e-01
2.1e-01
2.3e-01
cases:12.35%
controls:10.00%
cases:4.10%
controls:3.69%
cases:0.87%
controls:0.58%
cases:0.24%
controls:0.02%
cases:0.84%
controls:0.58%
cases:4.18%
controls:3.42%
cases:10.70%
controls:8.66%
470
3795
3335
34142
156
1402
3652
36560
33
220
3775
37742
9
8
3799
37954
32
220
3756
37546
148
1209
3391
34188
282
2234
2353
23567
Polyneuropathy, unspecified
G62.9 [45566898]
3.6e-01
4.9e-01
-1.0e+50
2.9e+00
9.1e-01
4.7e-01
4.5e-01
cases:0.84%
controls:0.59%
cases:0.50%
controls:0.31%
cases:0.00%
controls:0.05%
cases:0.24%
controls:0.01%
cases:0.16%
controls:0.06%
cases:0.48%
controls:0.30%
cases:1.02%
controls:0.66%
32
224
3773
37713
19
116
3789
37846
0
20
3808
37942
9
5
3799
37957
6
24
3782
37742
17
106
3522
35291
27
170
2608
25631
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 [2000500792]
3.3e-02
2.8e-01
4.3e-01
2.9e+00
4.4e-01
2.2e-01
3.0e-01
cases:1.45%
controls:1.40%
cases:0.74%
controls:0.56%
cases:0.16%
controls:0.10%
cases:0.24%
controls:0.01%
cases:0.18%
controls:0.12%
cases:0.79%
controls:0.64%
cases:1.97%
controls:1.47%
55
531
3750
37406
28
212
3780
37750
6
39
3802
37923
9
5
3799
37957
7
45
3781
37721
28
226
3511
35171
52
378
2583
25423
Oxygen content in Venous blood
19220-3 [3011648]
1.6e+00
1.2e+00
-1.0e+50
—
—
1.3e+00
4.1e-01
cases:0.66%
controls:0.13%
cases:0.29%
controls:0.09%
cases:0.00%
controls:0.02%
—
—
—
—
cases:0.34%
controls:0.09%
cases:0.38%
controls:0.25%
25
51
3780
37886
11
33
3797
37929
0
8
3808
37954
—
—
12
33
3527
35364
10
65
2625
25736
bromfenac
S01BC11 [21603649]
7.4e-01
9.3e-01
—
—
—
1.3e+00
8.8e-01
cases:0.74%
controls:0.35%
cases:0.34%
controls:0.13%
—
—
—
—
—
—
cases:0.51%
controls:0.14%
cases:1.33%
controls:0.55%
28
134
3777
37803
13
51
3795
37911
—
—
—
18
51
3521
35346
35
143
2600
25658
Follow-up examination after treatment of fracture
Z09.4 [45561611]
2.5e-01
1.2e+00
—
—
—
1.0e+00
6.2e-01
cases:0.71%
controls:0.55%
cases:0.58%
controls:0.17%
—
—
—
—
—
—
cases:0.45%
controls:0.16%
cases:1.40%
controls:0.76%
27
209
3778
37728
22
65
3786
37897
—
—
—
16
57
3523
35340
37
197
2598
25604
Fibromyalgia
M79.7 [45553272]
3.6e-01
1.1e+00
—
—
1.7e+00
1.0e+00
7.6e-01
cases:0.63%
controls:0.44%
cases:0.53%
controls:0.18%
—
—
—
—
cases:0.16%
controls:0.03%
cases:0.57%
controls:0.20%
cases:0.91%
controls:0.43%
24
168
3781
37769
20
69
3788
37893
—
—
6
11
3782
37755
20
71
3519
35326
24
110
2611
25691
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
4.1e-01
5.4e-01
—
—
1.7e+00
7.4e-01
4.1e-01
cases:2.08%
controls:1.39%
cases:1.16%
controls:0.68%
—
—
—
—
cases:0.40%
controls:0.07%
cases:1.19%
controls:0.57%
cases:2.47%
controls:1.65%
79
527
3726
37410
44
258
3764
37704
—
—
15
27
3773
37739
42
202
3497
35195
65
425
2570
25376
Dry eye syndrome
H04.10 [2000502254]
4.0e-01
5.4e-01
—
—
1.2e+00
5.9e-01
6.2e-01
cases:2.10%
controls:1.41%
cases:1.13%
controls:0.66%
—
—
—
—
cases:0.32%
controls:0.09%
cases:1.24%
controls:0.69%
cases:3.38%
controls:1.84%
80
536
3725
37401
43
250
3765
37712
—
—
12
35
3776
37731
44
246
3495
35151
89
474
2546
25327
Pain, unspecified
R52.9 [45544151]
4.9e-01
9.8e-01
—
—
—
7.3e-01
6.4e-01
cases:2.05%
controls:1.27%
cases:1.05%
controls:0.40%
—
—
—
—
—
—
cases:0.79%
controls:0.38%
cases:3.04%
controls:1.62%
78
481
3727
37456
40
151
3768
37811
—
—
—
28
136
3511
35261
80
418
2555
25383
pH of Urine
2756-5 [3015736]
2.4e-01
4.6e-01
7.4e-01
—
8.7e-01
2.9e-01
2.2e-01
cases:13.59%
controls:11.04%
cases:8.72%
controls:5.67%
cases:1.79%
controls:0.86%
—
—
cases:1.74%
controls:0.74%
cases:7.86%
controls:6.01%
cases:18.33%
controls:15.20%
517
4188
3288
33749
332
2151
3476
35811
68
326
3740
37636
—
66
278
3722
37488
278
2128
3261
33269
483
3923
2152
21878
Oxygen saturation in Arterial blood
2708-6 [3016502]
2.2e-01
4.4e-01
—
—
1.6e+00
6.0e-01
5.9e-01
cases:3.05%
controls:2.45%
cases:1.47%
controls:0.96%
—
—
—
—
cases:0.45%
controls:0.09%
cases:1.72%
controls:0.96%
cases:5.35%
controls:3.05%
116
931
3689
37006
56
363
3752
37599
—
—
17
33
3771
37733
61
339
3478
35058
141
787
2494
25014
codeine and paracetamol
N02AJ06 [1123647]
3.1e-01
2.2e-01
3.3e-01
1.7e+00
2.8e-01
2.6e-01
3.1e-01
cases:19.71%
controls:15.27%
cases:7.67%
controls:6.23%
cases:1.68%
controls:1.21%
cases:0.26%
controls:0.05%
cases:1.56%
controls:1.18%
cases:7.71%
controls:6.07%
cases:20.61%
controls:16.00%
750
5793
3055
32144
292
2364
3516
35598
64
460
3744
37502
10
18
3798
37944
59
445
3729
37321
273
2150
3266
33247
543
4127
2092
21674
Glucose [Moles/volume] in Serum or Plasma --baseline
14768-6 [3007821]
1.3e+00
—
—
—
—
-1.0e+50
1.6e+00
cases:0.37%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.53%
controls:0.11%
14
40
3791
37897
—
—
—
—
0
12
3539
35385
14
29
2621
25772
Traumatic subdural haemorrhage
S06.5 [45563422]
9.1e-02
4.1e-01
1.8e+00
—
9.7e-01
9.7e-01
2.2e-01
cases:0.47%
controls:0.43%
cases:0.26%
controls:0.17%
cases:0.21%
controls:0.03%
—
—
cases:0.13%
controls:0.05%
cases:0.45%
controls:0.17%
cases:0.68%
controls:0.55%
18
164
3787
37773
10
66
3798
37896
8
13
3800
37949
—
5
19
3783
37747
16
61
3523
35336
18
142
2617
25659
Tympanometry
SPAT1044 [2001700145]
9.5e-01
1.8e+00
—
—
—
-1.0e+50
7.1e-01
cases:0.42%
controls:0.16%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.23%
controls:0.11%
16
62
3789
37875
8
13
3800
37949
—
—
—
0
9
3539
35388
6
29
2629
25772
Ambulatory ECG
XF404 [2001303370]
4.6e-01
8.2e-01
—
—
—
8.5e-01
6.1e-01
cases:2.29%
controls:1.45%
cases:0.68%
controls:0.30%
—
—
—
—
—
—
cases:0.57%
controls:0.24%
cases:1.78%
controls:0.98%
87
551
3718
37386
26
115
3782
37847
—
—
—
20
86
3519
35311
47
253
2588
25548
General anaesthesia
WX402 [2001310806]
3.0e-01
3.2e-01
1.1e-02
—
1.4e+00
5.9e-01
4.3e-01
cases:4.60%
controls:3.45%
cases:1.92%
controls:1.40%
cases:0.18%
controls:0.18%
—
—
cases:0.45%
controls:0.11%
cases:2.18%
controls:1.22%
cases:6.11%
controls:4.04%
175
1308
3630
36629
73
533
3735
37429
7
69
3801
37893
—
17
42
3771
37724
77
432
3462
34965
161
1043
2474
24758
Short blood count panel - Blood
55429-5 [40758558]
2.7e-01
-6.1e-02
5.9e-02
1.9e+00
2.0e-01
6.7e-02
5.7e-01
cases:9.09%
controls:7.09%
cases:3.60%
controls:3.82%
cases:0.92%
controls:0.87%
cases:0.24%
controls:0.04%
cases:0.98%
controls:0.80%
cases:4.46%
controls:4.19%
cases:14.00%
controls:8.40%
346
2690
3459
35247
137
1449
3671
36513
35
329
3773
37633
9
14
3799
37948
37
302
3751
37464
158
1482
3381
33915
369
2167
2266
23634
Chronic maxillary sinusitis
J32.0 [45586667]
7.0e-01
7.2e-01
—
—
1.4e+00
1.2e+00
8.3e-01
cases:1.31%
controls:0.66%
cases:0.53%
controls:0.26%
—
—
—
—
cases:0.13%
controls:0.03%
cases:0.73%
controls:0.23%
cases:1.33%
controls:0.58%
50
250
3755
37687
20
97
3788
37865
—
—
5
12
3783
37754
26
82
3513
35315
35
150
2600
25651

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1228
6268
2.38
127.07
3.7
3.2
3.43
2.33
e6/l
2.18
652
3076
1678
10773
1.95
88.50
7.8
6.5
—
—
—
0
0
1992
13735
1.88
82.77
5.8
4.2
110.71
107.22
e6/l
0.04
1383
9797
3275
26721
2.17
81.38
28.3
22.3
13.79
13.79
%
0.05
3259
26343
1798
12322
1.82
73.21
4.3
3.5
47.02
77.25
e6/l
1.23
1331
9426
148
288
5.30
72.16
3.2
2.9
59.95
41.52
mg/l
0.44
112
213
291
975
3.14
67.06
8.3
10.7
—
—
—
0
0
1441
9483
1.81
65.07
4.2
4.3
88.05
86.96
%
0.92
1414
9288
2215
16655
1.73
61.37
7.7
6.9
1.21
1.21
mmol/l
0.25
2126
15408
1093
6772
1.84
59.10
3.4
3.1
0.89
1.12
e6/l
1.46
523
3601
3737
33390
2.50
56.08
25.7
21.6
139.69
139.60
mmol/l
1.17
3713
32714
3741
33443
2.51
56.05
26.0
21.8
3.97
3.98
mmol/l
1.92
3713
32709
1536
10682
1.70
54.71
3.9
3.4
0.41
0.48
e6/l
0.26
1049
7867
2139
16232
1.67
54.60
2.5
2.2
95.66
94.13
pmol/l
0.89
1195
8517
1404
9552
1.72
54.06
3.1
3.1
0.00
0.06
2.67
12
274
74
95
7.92
54.04
1.4
1.3
7.74
7.40
mmol/l
0.20
74
95
3639
32282
2.23
53.28
22.0
18.0
25.19
26.40
mg/l
1.46
3154
27091
2038
15421
1.65
51.39
12.2
11.9
0.00
0.00
e9/l
1.16
1581
12433
2292
17868
1.65
51.28
4.2
4.1
0.00
0.00
estimate
1.08
366
3804
3138
26681
1.78
49.55
27.8
23.3
331.11
331.50
g/l
1.58
3128
26494
2317
18218
1.63
49.17
4.3
4.1
0.00
0.09
estimate
0.58
355
3660
3778
34304
2.46
47.89
28.0
23.6
81.96
80.07
umol/l
1.91
3761
33824
2769
22849
1.67
47.75
5.7
5.0
823.04
2092.43
e6/l
0.74
26
366
2294
18082
1.62
47.41
4.2
4.1
9.99
4.87
estimate
0.41
385
3928
3738
33817
2.33
47.26
13.9
12.7
25.41
25.59
u/l
0.23
3683
32771
2042
15688
1.61
46.63
2.6
2.4
78.71
78.32
nmol/l
0.26
1929
14069
3111
26557
1.73
46.35
8.8
8.5
79.06
81.97
u/l
3.10
3013
25171
655
3695
1.92
46.16
6.9
7.6
1.33
1.36
mmol/l
0.21
631
3614
1118
7433
1.70
45.22
4.3
4.1
405.75
511.61
ng/l
0.27
901
6165
3412
29999
1.86
44.96
6.0
5.4
1.92
1.98
mu/l
1.92
3267
27560
3800
34823
2.42
43.08
31.9
26.9
91.53
91.48
fl
0.25
3783
34371
3800
34824
2.42
43.06
31.9
26.9
30.42
30.38
pg
0.89
3784
34371
3800
34826
2.42
43.02
32.0
27.0
4.41
4.42
e12/l
0.93
3711
33881
3800
34827
2.42
42.99
32.7
27.5
39.87
39.86
%
0.03
3782
34360
3800
34834
2.42
42.85
32.0
27.0
6.83
6.85
e9/l
0.11
3710
33880
3800
34835
2.42
42.83
32.2
27.2
132.95
133.34
g/l
0.88
3782
34398
3798
34819
2.41
42.62
32.0
27.0
241.82
247.89
e9/l
7.28
3720
34018
558
3093
1.93
41.12
3.2
2.5
0.38
0.55
e6/l
1.37
530
2983
1548
11427
1.57
39.87
4.7
4.2
7.40
7.40
ph
0.03
921
8253
2299
18589
1.55
38.95
7.8
7.6
1.21
1.21
mmol/l
1.03
2149
16052
617
3612
1.84
38.17
2.7
2.5
33.75
41.27
u/l
2.36
522
3041
3475
31142
1.80
37.41
5.6
5.4
6.00
6.02
mmol/l
0.48
3334
28374
2520
20910
1.54
37.00
5.8
5.3
6.72
6.79
mmol/l
1.01
2423
19884
2903
24873
1.59
36.85
4.9
4.4
13.08
13.57
mm/h
1.02
2793
23138
3543
31974
1.85
36.76
6.5
6.0
2.58
2.63
mmol/l
2.84
3416
29519
2418
19913
1.53
36.53
10.2
9.7
4.12
4.22
e9/l
1.27
2011
17044
1126
7849
1.60
36.32
4.1
4.3
1.02
1.21
kg/l
0.50
707
5339
2302
18837
1.51
35.24
6.3
6.8
12.41
12.34
umol/l
0.05
2223
18010
2917
25121
1.57
35.22
4.7
4.4
14.89
14.91
pmol/l
0.14
2760
22907
1971
15623
1.51
35.12
3.5
3.1
138.93
137.76
ug/l
0.05
1885
14512
3408
30529
1.72
34.69
7.1
6.7
39.71
39.84
mmol/mol
0.41
3309
28406
2072
16638
1.50
34.39
5.3
5.2
35.63
34.99
g/l
5.99
1972
15542
1443
10789
1.52
33.50
1.8
1.7
21.60
20.01
nmol/l
3.54
1321
9160
2735
23326
1.53
33.50
5.1
4.8
1.61
2.04
—
5
32
1546
11751
1.51
33.08
3.4
3.3
1559.01
1759.31
ng/l
1.12
1401
10292
1103
7800
1.57
32.86
3.1
3.1
2.46
2.46
mmol/l
1.09
999
6960
2156
17593
1.48
32.11
6.9
6.3
0.63
0.60
e9/l
0.61
1777
14827
2161
17646
1.48
32.05
6.9
6.3
0.04
0.04
e9/l
0.06
1767
14886
2187
17974
1.47
30.89
7.0
6.3
1.94
1.89
e9/l
0.25
1828
15533
2205
18156
1.47
30.81
7.4
6.5
0.19
0.20
e9/l
0.32
1837
15572
3452
31345
1.68
29.55
5.3
5.2
4.45
4.55
mmol/l
7.29
3326
29032
1807
14396
1.46
29.46
3.8
3.6
6.11
6.25
ph
4.71
731
7875
2004
16328
1.45
28.76
6.9
6.4
57.73
57.94
%
0.34
1931
15538
659
4252
1.66
28.18
2.8
2.8
8.51
9.23
umol/l
0.27
581
3727
848
5865
1.56
27.06
2.2
2.1
29.81
29.81
s
0.01
841
5711
3414
31107
1.61
26.53
5.0
5.1
1.43
1.46
mmol/l
4.04
3276
28610
1017
7353
1.51
26.37
4.0
3.0
539.61
529.86
mosm/kgh2o
0.83
903
6407
1991
16374
1.42
26.16
7.2
6.6
9.11
9.01
%
0.68
1907
15270
2018
16665
1.42
25.74
7.1
6.5
26.97
26.83
%
0.22
1941
15726
1985
16345
1.42
25.74
7.1
6.5
2.80
2.84
%
0.34
1898
15246
1981
16341
1.41
25.23
7.2
6.6
0.67
0.66
%
0.26
1895
15232
1299
9938
1.45
25.09
2.4
2.4
2.66
2.86
mg/l
2.00
1136
8604
1603
12844
1.41
23.58
3.6
3.6
2.36
2.35
mmol/l
0.78
1491
11619
1206
9232
1.44
22.73
2.9
2.9
346.72
350.12
umol/l
0.51
1097
8062
2048
17215
1.38
22.16
16.3
17.0
1.28
1.31
inr
1.14
1656
14382
1432
11374
1.40
21.65
3.3
3.3
30.16
37.21
u/l
3.34
1367
10706
740
5192
1.52
21.57
2.2
2.0
—
—
—
0
0
607
4078
1.57
21.52
2.0
1.8
—
—
—
0
0
210
3986
0.50
21.29
5.5
5.1
31.70
33.02
%
1.06
151
2553
1453
11596
1.39
21.25
3.6
3.4
—
—
—
0
0
875
6372
1.48
21.22
1.6
1.5
2.33
2.54
g/l
2.23
498
3785
578
3864
1.58
20.90
8.0
8.4
120.80
119.98
g/l
0.47
572
3767
791
5672
1.49
20.66
2.8
2.7
22.56
21.69
%
1.06
759
5290
889
6536
1.46
20.42
2.8
2.7
13.02
12.30
umol/l
2.27
854
6085
411
2547
1.68
20.15
8.3
9.3
24.54
24.23
mmol/l
1.24
399
2488
615
4211
1.54
19.93
7.6
7.9
95.39
95.32
%
0.08
601
4065
838
6121
1.47
19.84
2.8
2.6
2.27
2.27
g/l
0.10
802
5665
1452
11696
1.38
19.66
2.6
2.6
—
—
—
0
0
1632
13470
1.35
18.64
2.0
1.9
1.36
1.34
mmol/l
0.61
1497
11298
3240
29759
1.44
18.56
4.2
4.3
1.31
1.28
mmol/l
1.08
3056
27062
670
4745
1.49
18.40
7.2
7.6
12.45
12.17
kpa
0.67
648
4540
670
4746
1.49
18.38
7.2
7.6
5.10
5.10
kpa
0.01
649
4537
668
4730
1.49
18.36
7.3
7.6
7.42
7.42
ph
0.94
283
2537
666
4713
1.49
18.35
7.3
7.5
0.89
0.92
mmol/l
0.07
580
3858
531
3591
1.55
18.09
9.3
8.7
—
—
—
0
0
581
4020
1.52
17.80
1.6
1.5
—
—
—
0
0
571
3943
1.52
17.65
2.0
2.3
122.91
145.82
ug/g
0.95
479
3121
947
7222
1.41
17.40
1.3
1.3
1.42
1.70
u/ml
0.34
239
1873
414
2671
1.61
17.23
9.4
9.4
1.25
1.28
%
0.36
409
2652
187
3410
0.53
16.49
3.8
4.7
7.36
7.36
ph
0.07
130
2484
776
5771
1.43
16.32
1.3
1.3
26.48
34.47
iu/ml
1.37
209
1768
1083
8557
1.36
15.79
3.0
2.8
4.51
5.54
e6/l
2.65
988
7761
356
2262
1.63
15.74
1.3
1.3
—
—
—
0
0
284
1706
1.71
15.56
2.5
2.3
3.69
3.75
g/l
0.17
271
1556
284
1707
1.71
15.53
2.5
2.3
4.16
4.18
g/l
0.16
271
1557
284
1708
1.71
15.50
2.5
2.3
7.19
7.50
g/l
2.74
271
1556
1614
13575
1.31
15.20
4.8
4.0
38.23
92.65
ng/l
1.04
1194
10068
340
2155
1.63
15.17
2.5
2.4
23.08
20.90
au/ml
0.19
37
188
270
1611
1.72
15.16
2.5
2.3
2.81
2.98
g/l
2.19
257
1460
1610
13601
1.30
14.46
2.3
2.2
—
—
—
0
0
640
4701
1.43
14.24
1.3
1.3
—
—
—
0
0
1369
11360
1.31
13.88
2.4
2.2
183.43
210.20
u/l
0.67
1327
10704
308
1968
1.61
13.29
1.4
1.3
46.19
56.86
au/ml
0.44
18
140
1336
11107
1.30
13.20
2.9
2.7
59.73
67.38
u/l
0.51
1273
10282
1311
10875
1.30
13.16
5.0
4.5
—
—
—
0
0
1373
11483
1.30
12.89
5.9
5.7
3.13
3.34
ug/l
0.13
1286
10314
936
7493
1.32
11.96
1.9
1.8
1.44
1.42
mg/l
0.06
743
5870
241
1494
1.65
11.75
2.3
2.3
9.79
10.31
g/l
1.26
226
1325
565
4199
1.40
11.61
4.3
4.0
7.38
7.38
ph
0.11
254
2487
477
3468
1.43
11.09
3.5
3.3
4.52
4.48
kpa
0.11
459
3368
689
5390
1.34
10.16
1.3
1.3
11.83
13.38
u/ml
0.21
238
2016
615
4738
1.35
10.04
2.6
2.5
1.74
1.78
%
0.59
574
4206
622
4801
1.35
10.03
1.4
1.4
—
—
—
0
0
360
2531
1.46
10.00
1.2
1.2
—
—
—
0
0
805
6462
1.31
9.85
3.4
3.3
0.81
0.81
mmol/l
0.02
759
6056
491
3661
1.39
9.83
2.3
2.6
66.45
69.33
e9/l
1.06
323
2594
305
2082
1.50
9.82
3.8
2.9
1.23
1.20
%
0.20
305
2069
853
6904
1.30
9.81
3.5
3.3
0.82
0.82
ug/l
0.01
678
4786
549
4179
1.36
9.67
4.3
3.9
5.85
5.83
kpa
0.17
528
4070
206
1292
1.63
9.63
1.1
1.1
—
—
—
0
0
535
4062
1.37
9.57
4.3
3.9
1.78
1.82
mmol/l
0.08
476
3522
213
1352
1.61
9.49
1.6
2.1
21.51
21.21
s
0.25
200
1216
505
3817
1.37
9.28
1.3
1.4
—
—
—
0
0
169
2708
0.61
9.17
5.2
4.2
—
—
—
0
0
1099
9254
1.26
9.07
4.7
4.7
23.10
22.25
%
0.94
551
4792
1514
13207
1.23
9.07
4.3
4.1
2.23
0.24
estimate
0.43
226
3100
297
2053
1.48
9.00
3.7
2.9
0.61
0.62
%
0.13
297
2043
458
3438
1.37
8.78
2.7
2.6
65.98
66.12
g/l
0.16
435
3137
195
2985
0.64
8.68
5.2
3.8
1.22
1.23
mmol/l
0.34
169
2588
227
1513
1.53
8.21
2.7
2.7
—
—
—
0
0
245
1660
1.51
8.20
2.1
2.2
0.00
0.52
estimate
0.53
133
509
184
1174
1.59
8.07
1.7
1.6
29.45
18.59
u/ml
0.60
31
240
598
4739
1.31
7.92
1.8
1.8
—
—
—
0
0
1807
16248
1.20
7.52
2.9
2.9
—
—
estimate
—
0
0
1153
9940
1.22
7.39
4.6
4.2
0.01
0.00
estimate
0.34
352
3463
1407
12422
1.20
6.97
3.7
3.5
7.15
7.24
mmol/l
0.33
1264
10419
556
4439
1.29
6.93
1.4
1.3
555.81
492.00
titre
0.30
105
983
150
947
1.61
6.92
1.1
1.2
—
—
—
0
0
125
754
1.68
6.90
1.3
1.5
35.52
26.21
e6/l
0.12
93
560
340
2540
1.37
6.71
2.4
2.2
12.04
12.60
nmol/l
0.62
300
2256
159
1029
1.57
6.62
2.6
3.1
61.62
60.11
%
0.33
153
998
125
765
1.65
6.55
1.3
1.5
522.33
1261.67
e6/l
1.00
100
603
161
1069
1.53
6.01
3.2
3.5
2.29
1.96
index
0.29
69
567
385
2983
1.32
5.98
4.8
4.0
109.73
93.54
ng/l
1.41
343
2554
161
1073
1.52
5.91
2.5
2.5
3.71
3.65
g/l
0.23
156
1024
121
761
1.61
5.73
1.3
1.3
3.82
3.78
mmol/l
0.15
115
725
39
168
2.33
5.73
1.1
1.2
0.46
0.54
ratio
3.55
27
100
624
5167
1.25
5.70
6.8
6.1
1.04
1.05
mmol/l
0.63
587
4790
1360
12172
1.18
5.44
4.3
4.2
7.80
10.98
mg/mmol
1.00
927
7639
2260
21052
1.17
5.42
3.3
3.3
51.05
52.70
u/l
0.35
2133
19567
259
1930
1.37
5.24
1.8
1.7
1.44
1.55
g/l
1.29
239
1669
261
1949
1.36
5.21
1.4
1.3
174.89
223.18
u/ml
0.81
244
1796
110
696
1.60
5.13
1.3
1.2
31.40
47.39
u/ml
—
7
76
419
3354
1.28
5.10
2.2
2.2
0.00
0.01
estimate
0.78
145
653
296
2271
1.33
4.95
9.5
9.9
16.24
15.82
%
2.06
290
2188
128
847
1.53
4.92
2.3
2.7
61.64
60.68
%
0.18
128
842
309
2391
1.32
4.87
6.9
6.8
24.61
24.54
mmol/l
0.12
300
2275
247
1860
1.35
4.70
2.2
2.4
—
—
—
0
0
331
2605
1.29
4.62
3.4
2.9
10.26
10.66
g/l
0.74
315
2403
291
2260
1.31
4.49
1.5
1.4
—
—
—
0
0
125
845
1.49
4.39
1.2
1.2
—
—
—
0
0
52
280
1.87
4.36
1.0
1.1
—
—
—
0
0
17
55
3.10
4.35
1.1
1.0
5.42
9.69
mg/g
2.63
17
55
412
3359
1.25
4.32
1.7
1.6
—
—
—
0
0
86
537
1.61
4.29
1.7
1.6
0.67
0.87
g/l
1.31
72
420
28
120
2.34
4.24
2.8
2.7
29.30
29.26
umol/l
0.01
21
89
139
968
1.45
4.21
1.6
1.6
0.24
0.24
g/l
0.09
131
920
155
1104
1.42
4.17
1.4
1.4
253.16
268.95
ug/g
0.39
91
667
393
3201
1.25
4.16
2.4
2.4
385.53
381.94
nmol/l
0.11
365
2964
116
787
1.49
4.03
2.0
1.7
326.87
307.47
mu/l
0.25
109
727
1311
11918
1.15
4.00
3.6
3.5
44.36
51.27
mg/l
0.53
882
7709
141
996
1.43
3.98
1.6
1.6
1.24
1.19
g/l
0.99
133
945
173
1268
1.38
3.96
3.6
3.1
8.41
3.22
ratio
0.57
87
734
443
3683
1.23
3.90
7.9
7.2
10.46
10.72
mmol/l
0.28
423
3519
1040
9319
1.16
3.86
1.3
1.4
—
—
—
0
0
173
1279
1.37
3.77
1.5
1.6
0.24
0.32
mg/l
1.71
79
582
259
2033
1.29
3.74
2.0
1.9
1.29
1.37
g/l
0.24
243
1855
29
136
2.14
3.60
2.3
2.8
0.62
0.61
mmol/l
0.49
29
136
17
63
2.71
3.48
1.8
1.5
—
—
—
0
0
102
698
1.47
3.45
1.3
1.4
9.44
10.31
u/l
0.27
70
567
126
899
1.41
3.42
1.1
1.1
—
—
—
0
0
59
359
1.65
3.34
1.4
1.6
—
—
—
0
0
19
77
2.47
3.29
3.2
2.2
5.58
0.17
e9/l
0.50
14
35
28
135
2.08
3.27
1.0
1.2
0.25
1.59
u/ml
1.30
16
52
17
394
0.43
3.21
2.8
2.7
—
—
—
0
0
184
1410
1.32
3.21
3.8
3.3
62.49
49.37
mg/l
0.26
169
1202
8
15
5.34
3.19
1.1
1.3
0.31
0.60
iu/ml
—
8
9
62
388
1.61
3.16
1.3
1.4
—
—
—
0
0
69
444
1.56
3.14
1.4
1.3
—
—
—
0
0
183
1411
1.31
3.07
3.8
3.3
95.17
94.86
mg/l
0.00
167
1203
71
466
1.53
2.98
1.2
1.1
15.08
21.71
au/ml
—
10
97
92
1305
0.70
2.96
4.1
4.8
25.34
24.86
mmol/l
0.67
81
1182
63
403
1.57
2.96
2.3
1.9
—
—
—
0
0
142
1064
1.35
2.92
1.4
1.4
29.75
30.40
iu/l
0.08
116
904
733
6529
1.15
2.90
1.7
1.8
1157.39
1153.96
nmol/l
0.03
583
4942
199
1567
1.28
2.87
1.3
1.2
—
—
—
0
0
66
433
1.53
2.79
1.2
1.3
0.17
0.23
nmol/l
0.87
54
340
97
689
1.42
2.77
1.3
1.2
—
—
—
0
0
44
262
1.69
2.76
1.0
1.1
—
—
—
0
0
244
1981
1.25
2.74
2.8
3.5
4.45
4.46
pmol/l
0.04
218
1764
22
105
2.10
2.68
1.0
1.1
0.27
3.32
u/ml
—
10
33
35
198
1.77
2.63
2.1
1.5
—
—
—
0
0
58
377
1.55
2.58
3.2
3.7
12.65
11.97
index
0.28
37
212
8
20
4.01
2.56
1.3
1.2
0.94
1.27
iu/ml
—
8
10
66
443
1.50
2.54
2.1
1.8
—
—
—
0
0
64
428
1.50
2.51
1.1
1.1
0.31
1.43
u/ml
1.97
27
195
39
232
1.69
2.48
1.3
1.3
3.63
2.94
u/ml
0.10
28
138
34
195
1.75
2.46
1.2
1.2
—
—
—
0
0
20
392
0.51
2.45
1.5
1.2
—
—
—
0
0
19
89
2.14
2.44
7.5
4.7
—
—
—
0
0
7
189
0.37
2.40
3.3
3.2
—
—
—
0
0
110
824
1.34
2.33
2.1
2.7
29.32
35.02
umol/l
1.88
92
740
69
477
1.45
2.33
5.1
5.2
354.07
349.70
umol/l
0.08
60
420
42
260
1.62
2.32
1.1
1.1
32.00
146.98
titre
—
5
43
15
317
0.47
2.31
1.3
2.0
1.88
1.61
u/field
—
8
170
205
1672
1.24
2.26
2.3
2.0
—
—
—
0
0
362
3119
1.18
2.25
5.3
4.5
0.10
0.21
%
0.48
91
839
70
490
1.44
2.22
1.2
1.3
0.55
4.29
nmol/l
0.52
65
470
47
304
1.55
2.18
1.3
1.2
—
—
—
0
0
31
515
0.60
2.18
2.8
2.8
—
—
—
0
0
121
931
1.31
2.16
1.1
1.1
—
—
—
0
0
78
562
1.40
2.13
1.8
1.5
155.66
155.95
au/ml
0.01
37
171
66
463
1.43
2.09
1.4
1.4
—
—
—
0
0
66
463
1.43
2.09
1.4
1.4
—
—
—
0
0
66
463
1.43
2.09
1.4
1.4
—
—
—
0
0
66
463
1.43
2.09
1.4
1.4
—
—
—
0
0
469
4152
1.15
2.05
1.7
1.6
—
—
—
0
0
63
443
1.43
1.99
1.1
1.1
5.56
4.48
u/ml
0.15
33
243
23
126
1.83
1.98
1.0
1.2
0.53
2.62
u/ml
0.93
12
42
31
186
1.67
1.97
6.5
7.1
2.37
122.18
ug/l
0.68
19
114
59
412
1.44
1.94
1.9
2.0
—
2.75
—
0
8
118
921
1.29
1.93
1.3
1.2
188.33
107.76
titre
0.35
12
85
160
1296
1.24
1.92
1.3
1.3
—
—
—
0
0
48
701
0.68
1.92
1.4
1.5
226.26
194.14
pmol/l
0.15
48
686
110
852
1.30
1.91
1.8
1.6
—
—
—
0
0
47
315
1.50
1.90
1.2
1.3
15.81
12.13
u/l
0.58
42
290
155
1254
1.25
1.89
1.3
1.2
0.26
1.39
u/ml
1.83
19
97
47
317
1.49
1.85
1.6
1.3
—
—
—
0
0
80
595
1.35
1.84
1.7
1.9
4.95
4.87
mmol/24h
0.06
73
520
58
409
1.42
1.83
1.1
1.3
—
—
nmol/l
—
0
0
5
12
4.17
1.82
1.0
1.1
292.88
237.33
nmol/l
—
5
12
59
418
1.42
1.81
1.5
1.9
—
—
—
0
0
20
109
1.84
1.77
1.3
1.1
—
—
—
0
0
6
18
3.34
1.74
2.0
2.2
—
—
—
0
0
84
636
1.33
1.74
1.9
1.4
—
—
—
0
0
23
132
1.75
1.73
1.1
1.3
147.11
158.67
mmol/24h
0.36
23
132
119
945
1.27
1.73
1.4
1.2
40.41
37.88
u/ml
—
8
45
29
458
0.63
1.72
3.2
2.4
4.12
4.09
mmol/l
0.15
29
452
29
458
0.63
1.72
3.2
2.4
106.59
105.29
mmol/l
0.80
29
452
353
3108
1.15
1.70
5.3
4.4
0.10
0.12
%
0.18
90
904
96
744
1.30
1.69
2.1
1.4
59.52
60.71
mmol/l
0.10
81
598
47
324
1.46
1.69
1.6
1.3
6.19
6.98
g/l
1.56
39
236
47
324
1.46
1.69
1.6
1.3
0.39
0.40
g/l
0.14
38
236
47
324
1.46
1.69
1.6
1.3
2.87
3.02
g/l
0.26
39
234
50
349
1.44
1.68
1.1
1.2
—
—
—
0
0
54
751
0.72
1.68
4.0
3.6
27.05
28.17
mg/l
0.09
37
540
25
149
1.68
1.66
1.1
1.1
—
—
—
0
0
367
3247
1.14
1.66
5.3
4.3
0.81
0.93
%
0.42
104
1041
177
1479
1.21
1.62
3.9
3.3
38.75
3781.96
u/ml
1.28
154
1264
26
158
1.65
1.62
1.2
1.4
—
73.38
%
—
0
21
29
447
0.65
1.56
3.2
2.5
1.21
1.20
mmol/l
0.74
29
441
54
740
0.73
1.56
8.0
4.6
3.01
2.76
mmol/l
0.25
36
528
46
322
1.43
1.55
1.5
1.3
—
—
—
0
0
28
432
0.65
1.52
4.0
1.8
89.56
89.53
%
0.01
28
423
5
15
3.34
1.52
1.6
1.3
881.72
500.18
nmol/l
—
5
15
18
309
0.58
1.52
1.5
1.5
—
—
—
0
0
461
4166
1.12
1.50
3.8
4.1
5.79
26.86
ug/l
4.83
368
3444
111
893
1.25
1.48
1.4
1.2
5.48
3.24
u/ml
0.55
11
72
83
645
1.29
1.47
2.2
2.0
7206.90
4779.25
u/l
0.25
25
266
245
2808
0.86
1.44
2.7
2.8
6.03
6.05
ph
0.12
168
1988
18
303
0.59
1.43
1.4
1.5
—
—
—
0
0
31
204
1.52
1.42
3.1
2.0
0.59
0.62
e9/l
0.13
31
190
16
88
1.82
1.41
1.1
1.1
—
—
—
0
0
11
53
2.08
1.38
11.2
13.7
4.60
5.67
mmol/l
1.17
11
53
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
29
191
1.52
1.34
2.9
2.4
35.12
39.79
%
0.65
17
100
109
888
1.23
1.33
1.6
1.9
2.99
4.18
iu/l
1.00
30
341
0
40
0.00
1.32
0.0
2.3
—
0.68
—
0
40
69
532
1.30
1.32
1.2
1.1
0.74
2.03
u/ml
2.28
40
302
109
889
1.23
1.32
2.1
1.9
13.06
11.82
mg/l
1.14
100
833
40
283
1.42
1.31
6.6
5.5
145.64
71.99
u/ml
0.24
14
90
18
294
0.61
1.29
1.4
1.4
1.10
1.27
mm
1.48
13
213
100
812
1.24
1.27
1.1
1.2
—
—
—
0
0
177
1518
1.17
1.27
1.6
1.7
25.70
20.82
iu/ml
—
7
44
31
210
1.48
1.27
1.0
1.1
20.99
9.44
iu/ml
—
9
60
208
1808
1.16
1.26
4.7
3.5
25.27
25.22
mmol/l
0.08
198
1747
143
1690
0.84
1.26
3.7
4.5
—
—
—
0
0
52
389
1.34
1.24
1.3
1.2
—
—
—
0
0
10
49
2.04
1.22
1.1
1.1
0.50
8.10
u/ml
—
10
40
37
263
1.41
1.20
1.3
1.3
2.15
2.21
mmol/l
0.07
37
247
31
213
1.46
1.20
1.1
1.1
7.44
10.47
nmol/l
—
10
43
16
94
1.70
1.17
2.2
1.9
—
—
—
0
0
108
895
1.21
1.16
1.4
1.3
11.96
5.74
u/ml
0.43
13
116
44
325
1.36
1.15
1.1
1.1
6.44
3.75
u/ml
0.29
25
149
26
174
1.50
1.15
1.4
1.6
71.84
68.03
%
0.24
19
148
234
2641
0.88
1.15
1.9
2.0
3.47
3.44
ratio
0.16
180
2089
57
734
0.77
1.14
3.3
3.5
59.10
58.22
%
0.25
57
734
59
457
1.30
1.13
1.1
1.2
—
—
—
0
0
67
529
1.27
1.11
6.0
6.3
11.43
12.19
mg/l
0.84
61
482
974
9241
1.07
1.10
3.7
3.6
0.00
0.31
estimate
1.43
226
2974
60
468
1.29
1.10
1.3
1.3
384.44
308.93
pmol/l
0.58
52
396
194
1700
1.15
1.09
1.3
1.3
—
—
—
0
0
14
81
1.73
1.08
1.1
1.4
23.13
22.14
%
—
8
69
386
4218
0.91
1.08
3.8
3.3
4.69
4.71
e9/l
0.01
342
3622
53
409
1.30
1.06
1.2
1.1
1.21
1.52
u/ml
0.16
33
223
6
122
0.49
1.05
1.2
1.9
0.00
0.00
estimate
—
6
122
45
340
1.33
1.04
1.3
1.2
—
—
—
0
0
27
187
1.45
1.03
1.0
1.2
140.04
138.53
nmol/l
0.05
27
187
63
500
1.26
1.02
1.2
1.2
2.63
4.68
u/ml
1.01
30
230
112
945
1.19
1.02
1.6
1.6
14073.77
12393.74
e6/l
0.17
75
638
5
23
2.18
0.98
1.6
1.3
8.84
7.36
u/ml
—
5
18
14
84
1.67
0.97
1.1
1.1
—
—
—
0
0
23
157
1.47
0.96
1.4
1.7
1.29
7.60
nmol/l
1.46
18
134
46
355
1.30
0.94
2.3
2.3
—
—
—
0
0
104
881
1.19
0.93
3.5
3.3
0.76
0.84
nmol/l
1.38
92
704
63
777
0.81
0.92
1.0
1.1
0.60
0.61
ratio
0.06
12
118
22
150
1.47
0.92
1.8
2.2
132.29
121.18
umol/l
0.06
14
85
221
1982
1.12
0.91
1.7
1.7
—
—
—
0
0
61
491
1.25
0.91
1.5
1.5
—
—
—
0
0
14
86
1.63
0.90
1.0
1.0
—
—
—
0
0
69
840
0.82
0.90
1.1
1.2
1.52
1.54
g/l
0.37
69
840
23
325
0.71
0.89
2.0
2.4
—
—
—
0
0
101
859
1.18
0.88
1.3
1.3
—
—
—
0
0
55
442
1.25
0.84
1.3
1.4
6.33
6.43
mmol/l
0.12
50
420
16
104
1.54
0.84
2.2
1.9
16.72
67.90
u/l
1.40
16
98
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
6
32
1.88
0.81
1.5
1.1
69.33
102.00
titre
—
6
32
16
105
1.53
0.81
1.1
1.5
75.00
142.58
nmol/24h
0.56
16
105
69
573
1.21
0.79
1.4
1.3
262.23
273.71
u/ml
0.16
47
340
51
410
1.25
0.79
1.5
1.4
279.83
277.74
mosm/kgh2o
0.23
29
303
45
358
1.26
0.77
1.1
1.1
1.45
3.90
u/ml
1.40
26
188
10
161
0.62
0.75
6.0
3.3
—
—
—
0
0
76
642
1.19
0.74
1.4
1.5
33.01
31.76
g/l
0.35
68
577
1069
11093
0.95
0.74
3.1
3.3
—
—
—
0
0
7
38
1.84
0.73
1.9
3.3
—
—
—
0
0
109
951
1.15
0.72
1.9
2.2
132.18
127.44
g/l
1.15
77
725
55
666
0.82
0.72
1.7
1.6
836.31
1003.78
mu/l
0.71
46
558
152
1357
1.12
0.72
1.6
1.7
4.70
6.75
iu/ml
0.73
32
310
25
185
1.35
0.71
1.0
1.1
34.90
17.05
u/ml
—
8
69
7
40
1.75
0.71
1.6
2.4
—
—
—
0
0
9
57
1.58
0.71
1.0
1.0
—
—
—
0
0
66
554
1.19
0.70
1.2
1.1
—
—
—
0
0
331
3078
1.08
0.70
4.6
4.3
0.47
0.67
%
1.06
95
972
53
436
1.22
0.69
1.6
1.6
32.23
29.22
ng/l
0.11
53
436
19
135
1.41
0.69
2.3
1.6
—
—
—
0
0
12
77
1.56
0.68
1.1
1.4
—
—
—
0
0
19
136
1.40
0.66
1.3
1.1
48.63
411.03
ng/l
—
8
33
347
3241
1.08
0.66
2.7
3.0
146.06
234.50
ng/l
6.75
324
2955
70
820
0.85
0.66
2.7
3.5
201.83
744.67
u/ml
0.82
65
753
181
1989
0.91
0.64
1.3
1.4
—
—
—
0
0
57
477
1.20
0.64
1.5
1.3
—
—
—
0
0
8
127
0.63
0.64
1.3
1.4
3.54
3.28
mmol/l
—
8
113
44
359
1.23
0.63
1.5
1.5
0.28
0.31
nmol/l
0.23
33
266
25
190
1.32
0.62
1.1
1.0
—
—
—
0
0
10
63
1.59
0.61
1.3
1.4
—
—
—
0
0
65
554
1.18
0.61
1.5
1.5
2058.76
3480.79
e6/l
0.40
41
384
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
12
175
0.68
0.60
5.3
3.2
—
—
—
0
0
174
1906
0.91
0.59
1.7
1.8
3.36
3.46
mmol/l
0.33
119
1349
8
52
1.54
0.59
1.3
1.3
15.16
7.23
mg/l
—
8
46
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
11
72
1.53
0.59
3.5
2.6
322.91
91.53
ug/l
0.31
11
72
35
430
0.81
0.57
2.1
2.9
11.24
10.41
mmol/l
0.86
35
423
5
87
0.57
0.56
7.4
8.3
5.98
5.93
kpa
—
5
78
24
185
1.30
0.56
1.2
1.1
—
—
—
0
0
15
206
0.73
0.55
2.5
2.2
117.07
133.46
e6/l
0.13
15
195
38
312
1.22
0.54
1.1
1.0
0.45
0.33
u/ml
0.13
16
120
22
282
0.78
0.52
3.5
2.8
15.50
31.52
mg/l
2.18
12
207
52
607
0.85
0.51
2.8
4.1
15.57
33.80
u/ml
4.82
52
591
41
343
1.20
0.50
2.6
2.4
—
—
—
0
0
32
389
0.82
0.49
1.2
1.2
—
—
—
0
0
7
110
0.64
0.48
1.0
1.2
—
—
—
0
0
57
493
1.16
0.48
2.4
2.1
0.93
1.30
g/24h
0.56
35
290
252
2363
1.07
0.48
1.5
1.4
—
—
—
0
0
79
704
1.12
0.45
1.9
2.0
—
—
—
0
0
53
460
1.15
0.44
1.5
1.4
—
—
—
0
0
19
148
1.29
0.43
11.5
13.3
0.63
0.62
mmol/l
0.06
19
137
45
387
1.16
0.42
1.0
1.2
—
—
—
0
0
28
230
1.22
0.42
2.2
1.9
175.84
122.62
ng/l
0.37
28
230
57
500
1.14
0.42
1.5
1.4
241096.20
57182.30
e6/l
1.02
30
282
66
743
0.89
0.42
1.3
1.3
222.01
209.33
miu/ml
0.09
27
314
30
249
1.21
0.41
2.2
2.1
4.57
7.42
umol/l
1.34
22
180
0
16
0.00
0.41
0.0
1.1
—
0.12
—
0
10
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
161
1726
0.93
0.39
3.8
5.1
1.81
1.59
%
1.19
156
1621
94
857
1.10
0.37
2.7
2.3
129.54
95.73
ug/min
0.27
69
510
45
515
0.87
0.37
1.7
1.6
—
—
—
0
0
9
68
1.32
0.37
1.6
1.9
—
—
—
0
0
52
589
0.88
0.37
2.2
2.1
0.83
0.87
%
0.24
41
413
63
562
1.12
0.37
1.1
1.1
—
—
—
0
0
39
337
1.16
0.36
1.1
1.1
—
—
—
0
0
12
90
1.33
0.35
1.2
1.3
—
—
—
0
0
5
78
0.64
0.35
7.4
8.6
7.32
5.36
kpa
—
5
78
147
1574
0.93
0.35
4.4
5.3
0.88
0.85
%
0.35
142
1478
19
153
1.24
0.35
1.1
1.1
1690.08
1619.02
miu/ml
0.12
19
153
24
199
1.21
0.35
1.8
1.6
—
—
—
0
0
54
480
1.13
0.34
1.6
1.5
—
—
—
0
0
10
73
1.37
0.34
1.5
1.1
138.50
138.53
mmol/l
—
10
58
28
237
1.18
0.33
1.1
1.1
—
—
—
0
0
82
749
1.10
0.33
1.9
1.9
—
—
—
0
0
38
331
1.15
0.33
1.5
1.4
29.59
27.32
u/l
0.16
33
274
769
7508
1.03
0.30
1.8
1.7
79511145.52
29046144.18
pmol/l
0.91
654
6235
7
55
1.27
0.30
1.0
1.4
—
—
—
0
0
7
56
1.25
0.29
1.3
5.0
29.71
40.19
umol/l
—
7
47
29
250
1.16
0.29
1.7
1.9
8.62
8.32
mmol/l
0.15
29
250
9
118
0.76
0.27
1.0
1.0
—
—
—
0
0
9
118
0.76
0.27
1.0
1.0
—
—
—
0
0
9
118
0.76
0.27
1.0
1.0
—
—
—
0
0
16
131
1.22
0.27
1.3
1.5
13.88
19.18
%
0.40
16
122
82
760
1.08
0.26
1.9
2.0
—
—
—
0
0
234
2439
0.96
0.26
3.9
4.3
7.42
7.42
ph
0.12
205
2018
82
761
1.08
0.25
1.9
1.9
—
—
—
0
0
30
263
1.14
0.25
1.2
1.2
—
—
—
0
0
19
160
1.19
0.25
1.3
1.3
185.92
220.38
pmol/l
0.25
19
160
20
233
0.86
0.23
1.4
1.3
—
—
—
0
0
5
38
1.32
0.23
3.2
6.0
76.00
56.31
ug/min
—
5
32
82
767
1.07
0.22
1.9
2.0
—
—
—
0
0
5
41
1.22
0.22
1.4
1.3
—
619.04
—
0
8
10
124
0.81
0.21
1.3
1.8
—
—
—
0
0
13
107
1.22
0.21
12.3
7.7
24.56
24.94
mmol/l
0.16
13
97
13
107
1.22
0.21
1.1
1.3
27.08
28.40
s
0.64
13
107
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
0.04
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.16
0.21
1.0
1.0
—
-3.08
—
0
17
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
0.12
—
0
8
117
1229
0.95
0.19
3.5
3.5
319.41
422.40
mg/l
0.58
70
548
11
133
0.83
0.19
2.1
2.0
9.73
8.09
%
0.14
11
125
34
308
1.10
0.19
1.4
1.5
34.70
28.52
%
0.41
25
187
37
338
1.10
0.18
1.2
1.4
184812.13
109067.75
e6/l
0.17
24
224
23
204
1.13
0.18
1.2
1.8
3.22
4.58
ug/l
0.30
18
166
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
11
131
0.84
0.17
2.1
2.1
34.18
28.85
%
0.63
11
131
336
3280
1.03
0.17
2.1
2.3
7.12
7.40
ug/l
0.07
301
2853
374
3661
1.02
0.15
2.4
2.2
0.22
0.20
g/l
2.82
358
3407
54
506
1.07
0.15
2.5
2.4
—
—
—
0
0
6
79
0.76
0.15
1.7
1.8
—
—
—
0
0
32
293
1.09
0.15
1.1
1.1
—
—
—
0
0
77
810
0.95
0.15
1.2
1.3
—
—
—
0
0
24
265
0.91
0.15
1.2
1.3
0.83
1.05
promille
0.39
18
212
22
244
0.90
0.14
1.5
1.4
7.37
7.41
ph
0.27
12
165
23
208
1.11
0.14
2.4
1.6
—
—
—
0
0
42
392
1.07
0.14
1.4
1.6
62.38
60.94
%
0.08
29
243
47
441
1.07
0.13
6.6
5.8
7.88
7.49
mmol/l
0.23
42
373
74
776
0.95
0.13
3.4
2.6
16.33
16.12
%
0.25
74
758
187
1922
0.97
0.13
3.5
3.4
1.02
1.02
ratio
1.23
161
1731
64
673
0.95
0.13
1.4
1.8
0.84
0.87
nmol/l
0.15
54
566
49
519
0.94
0.12
1.1
1.1
21.92
92.51
iu/ml
—
6
108
15
168
0.89
0.11
28.2
18.0
1483.80
1435.56
nmol/l
0.09
15
163
28
259
1.08
0.11
1.1
1.4
—
—
—
0
0
10
115
0.87
0.10
1.0
1.1
—
—
—
0
0
107
1103
0.97
0.10
5.3
6.1
1.37
1.29
mmol/l
0.27
98
973
5
48
1.04
0.09
1.6
1.6
—
—
—
0
0
115
1182
0.97
0.09
1.5
1.7
—
—
—
0
0
6
54
1.11
0.09
1.0
1.3
70.00
64.20
ug/l
—
6
54
6
55
1.09
0.08
1.3
1.8
—
82.42
—
0
6
7
64
1.09
0.08
1.0
1.0
32.39
41.56
iu/ml
—
7
64
28
264
1.06
0.07
1.0
1.0
283.79
292.83
mg/l
0.31
28
241
8
75
1.07
0.07
1.4
2.2
—
—
—
0
0
7
80
0.87
0.07
1.4
1.5
—
—
—
0
0
9
88
1.02
0.07
2.9
1.2
14.71
16.94
umol/l
—
9
77
165
1623
1.02
0.06
2.1
1.9
1.62
2.57
ug/l
0.67
153
1422
15
162
0.93
0.06
22.5
13.5
940.80
813.24
nmol/l
0.39
15
157
91
890
1.02
0.05
4.7
4.3
—
—
—
0
0
24
253
0.95
0.05
2.7
2.1
16.69
15.96
%
0.51
24
253
12
110
1.09
0.05
1.3
1.3
51.11
62.57
%
0.52
12
90
13
120
1.08
0.04
1.0
1.2
10.92
10.78
mm/h
0.02
13
120
37
383
0.97
0.04
1.1
1.1
1.45
2.38
eliau/ml
0.94
11
148
76
745
1.02
0.04
1.1
1.1
0.84
6.93
eliau/ml
—
9
80
35
362
0.97
0.04
1.2
1.1
—
—
—
0
0
729
7264
1.00
0.03
5.0
4.8
—
—
—
0
0
46
449
1.02
0.03
1.1
1.1
—
—
—
0
0
204
2024
1.01
0.03
1.2
1.2
144.63
140.94
u/ml
0.04
73
712
46
450
1.02
0.02
1.1
1.1
—
—
—
0
0
84
851
0.99
0.02
4.9
4.0
—
—
—
0
0
332
3335
1.00
0.02
1.5
1.4
—
—
—
0
0
35
358
0.98
0.01
1.3
1.2
—
—
—
0
0
15
143
1.05
0.01
1.2
2.0
793.20
737.29
e6/l
—
10
99
27
263
1.03
0.01
1.1
1.0
313.09
307.01
ng/l
0.04
22
179
27
263
1.03
0.01
1.1
1.0
642.52
694.56
ng/l
0.22
21
172
11
104
1.06
0.01
1.3
1.1
—
—
—
0
0
13
131
0.99
0.00
1.1
1.3
2.14
355.01
ug/l
—
5
63
16
159
1.01
0.00
2.6
1.7
39.04
39.74
g/l
0.20
16
159
23
229
1.00
0.00
1.5
1.6
150.48
85.16
umol/l
0.62
23
229
13
126
1.03
0.00
1.2
1.8
2842.43
22089.68
e6/l
—
7
71
29
286
1.01
0.00
1.0
1.2
93.76
104.66
pmol/l
0.78
29
286
251
2513
1.00
0.00
3.9
4.3
5.11
5.15
kpa
0.32
238
2397
69
693
1.00
0.00
1.6
1.5
—
1.00
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
92
0.98
-0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
1.96
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
51
0.98
-0.00
1.6
1.6
0.58
0.50
e9/l
—
5
51
0
6
0.00
-0.00
0.0
1.7
—
343.83
—
0
6
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
6
63
0.95
-0.00
1.3
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_NAS and mortality.

Females

Parameter HR [95% CI] p-value
H8_HL_NAS 1.051 [0.94, 1.18] 0.386
Birth year 0.994 [0.99, 1.0] 0.125

During the follow-up period (1.1.1998 — 31.12.2019), 3190 out of 11949 females with H8_HL_NAS died.

Males

Parameter HR [95% CI] p-value
H8_HL_NAS 1.146 [1.0, 1.31] 0.048
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2866 out of 10220 males with H8_HL_NAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_NAS.

N-year risk Females Males
1 0.097% 0.217%
5 0.537% 1.333%
10 1.297% 3.267%
15 2.614% 6.252%
20 4.635% 10.136%

Relationships between endpoints

↥

Index endpoint: H8_HL_NAS – Other specified/unspecified hearing loss

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data